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When a person realizes he has been deeply heard, his eyes moisten.
I think in some sense he is weeping for joy. It is as though he were saying
“Thank God somebody heard me.
Someone knows what it’s like to be me”
~Carl Rogers

I do have to say this is one of the first times anyone in a medical setting has asked me my
perception of the disorder I have, which is one of the things I had a really hard time
understanding. Especially whenever I would tell the doctor my understanding of my disorder and
they would tell me that I was wrong and not want to listen. So I think that’s already extremely
important, and I’m very happy someone even bothered to ask.
-Participant D

Because if people find out they look at you differently. They look at you like they’re waiting for
something to happen, like a crazy person. They look at you like you’re just weird. And it’s
totally different. And it sucks. Honestly, it’s deplorable. I’m kind of glad you’re doing this
research study because maybe it’ll go viral and a whole bunch of people will read it, and think
differently about the things that they say…
-Participant E
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Abstract
While early-onset bipolar disorder (EOBD) has increased in prevalence, much remains to be
understood about its phenomenology. Research and treatment models remain rooted in
neurobiological conceptualizations of the illness that borrow heavily from models for the
traditional adult-onset form of bipolar disorder. This study utilized a transcendental
phenomenological design as a first step in obtaining an understanding of the lived experience of
EOBD. A purposive sample of eight participants ages 18-25 participated in semi-structured
interviews that elicited information on experiences of EOBD symptomatology and course of
illness, stigma, experience with healthcare and treatment, and impact on identity, interpersonal
relationships, and coping responses. Transcendental phenomenological analysis was used to
construct individual and composite descriptions of participants’ experience of EOBD between
ages 13 and 17. Implications of findings are presented for research and treatment of EOBD, as
well as social work education and policy reform.
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Chapter One: Introduction
Bipolar disorder is a significant, pervasive mental disorder comprised of a spectrum of
manic and depressive symptoms manifested during episodic mood states (American Psychiatric
Association, 2013; Price & Marzani-Nissen, 2012). While symptoms may remit partially or in
full between episodes, bipolar disorder has an unremitting longitudinal course. Bipolar disorder
is associated with significant and pervasive impairments in occupational, educational,
interpersonal, and daily functioning that persist across the lifespan.
Bipolar disorder has historically been conceptualized and operationalized across research
and clinical settings as an adult disorder, with the onset and course of symptoms diagnosed and
treated after 18 years of age (Garnham et al., 2007). However, bipolar symptoms often begin in
adolescence. Twenty-eight percent of adults with bipolar disorder report experiencing manic and
depressive symptoms prior to age 13, and 66% of adults with bipolar disorder report
experiencing symptoms prior to age 18 (Perlis et al., 2004). Early-onset bipolar disorder
(EOBD), in which the illness manifests in full prior to age 18, is regarded as potentially difficult
to diagnose accurately and treat effectively; this is largely due to dispute regarding diagnostic
criteria, nosology, and treatment interventions for the juvenile population (Ghaemi & Martin,
2007).
The impact of bipolar disorder extends beyond its symptoms and affects the individual’s
sense of self, identity, and self-esteem. The stigma of bipolar disorder is reflected through the
individuals’ sense of loss of control over their lives due to persistent symptoms, self-blame for
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symptoms, and believing a healthy sense of self is contingent upon successful symptom
management (Crowe et al., 2012).
Bipolar disorder influences psychosocial development extending through adolescence
and into emerging adulthood. The presence of patterns of conflict, communication, and support
within the family system and peer relationships during adolescence impact not only psychosocial
functioning during adolescence but identity development, relationships, and goal attainment
during the period of emerging adulthood (Aquilino, 2006; Arnett, 2006a; Collins & van Dulmen,
2006; Miklowitz, 2008). Protective factors in peer and family relationships, including reappraisal
support, validation, and increased capacity to build intimacy facilitate adjustment and acceptance
of bipolar disorder and counteract the inception of associated stigma and self-stigma (Dahl,
2004; Doherty & MacGeorge, 2012).
Theoretical Underpinnings
To achieve a more accurate and thorough understanding of the phenomenology of
EOBD, the incorporation of multiple theoretical frameworks is needed. A greater understanding
of the individual course of illness and treatment response, family history and functioning, and
biological markers can improve diagnosis and treatment of EOBD (Ghaemi and Martin, 2007).
Theories of neurology and biology, stigma, and interpersonal functioning provide both
explanatory and predictive properties to better understand the etiology, nosology, prognosis,
course of illness, and associated psychological and developmental changes in functioning
incurred by EOBD.
Neurological and biological theories have largely dominated the study of bipolar
disorder. Neurobiological theories propose a bipolar disorder etiology consisting of biological
vulnerabilities such as smaller amygdala volumes (Bitter et al., 2011), enlarged portions of the
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basal ganglia (Ahn et al., 2007), variances in limbic volumes (Frazier et al., 2008), and different
psychophysiological responses to stimuli for frustration and reward (Alloy et al., 2012b; Rich et
al., 2007). Much of the cumulative literature has been devoted to identifying biological or
genetic risk factors for bipolar disorder, including patterns of heredity and factors associated with
onset of symptoms (Alloy et al., 2012a; Berk et al., 2009; Daban, Colom, Sanchez-Moreno,
García-Amador, & Vieta, 2006; Goldstein, 2012).
While neurobiological theories address the etiology of bipolar disorder, they offer limited
contributions toward other facets of the phenomenology of bipolar disorder. Individuals with
bipolar disorder are subject to critical and judgmental messages from both external and internal
sources, affecting developmental processes such as development of identity and self-esteem
(Moses, 2009). Indeed, modified labeling theory describes stigma as the byproduct of the social
exchange between the individuals with bipolar disorder and larger society. Furthermore, higher
levels of stigma and self-stigma correlate with poorer prognosis, management of the illness,
recovery between episodes, and overall functioning in individuals with bipolar disorder (Alreja,
Mishra, Sengar, & Singh, 2009; Cerit, Filizer, Tural, & Tufan, 2012; Moses, 2009).
The theory of emerging adulthood offers explanatory properties for the experience of
early-onset bipolar disorder in the present study’s sample. Theory of emerging adulthood
identifies a unique and distinct period between adolescence and adulthood (between ages 18-25),
characterized by increased opportunity and independence, as well as a lack of stability regarding
attainment of adult goals. This conflict includes struggles in building relationships and intimacy,
identity development, and goal attainment (Arnett, 2006a; Bynner, 2005).

4
Gaps in Cumulative and Existing Research
The literature on EOBD is characterized by efforts to conceptualize bipolar disorder and
prescribe appropriate interventions for the juvenile population. This movement, however, has
occurred largely without the inclusion of the qualitative perspectives of the individuals with an
EOBD diagnosis. This may be due in part to the domination of clinical research by the medical
sciences; however, even within the medical sciences, various authors (Parry & Levin, 2012;
Sullivan & Miklowitz, 2010) have stated the need for qualitative research to explore the full
phenomenon of bipolar disorder. Current literature includes quantitative inquiries into
epidemiology (e.g., Goldstein, 2012; Harris, 2005), differential diagnosis (e.g., Carlson, 2012;
Galanter et al., 2012), psychopharmacology (e.g., Dusetzina et al., 2011; Raven & Parry, 2012)
and prognosis of EOBD (e.g., Axelson et al., 2011; Berk et al., 2009; Daban et al., 2006; Perlis et
al., 2004), but does not incorporate the perspectives of the individuals with the disorder. One
exception is a study by Moses (2009) that combined both qualitative and quantitative data from
54 adolescents with various mental illnesses. While the interviews and standardized measures
created a more thorough understanding of the adolescents’ experiences with stigma and selflabeling through interviews and standardized measures, the study was not specific to EOBD.
These limitations notwithstanding, the literature to date has not incorporated such qualitative
approaches to better understand adolescents’ experiences of mental health.
Moreover, while the literature on bipolar disorder references the importance of
interventions to address families and stigma (Heflinger & Hinshaw, 2010; Perlick et al., 2007;
Perlick et al., 2008), these studies focus on adult-onset bipolar disorder and incorporate
quantitative approaches to evaluate the effectiveness of interventions (e.g., Brown, Rempfer, &
Hamera, 2008; Struening et al., 2001) rather than eliciting the first-person experience of bipolar
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disorder. Aquilino (2006) highlights the absence of qualitative inquiries in research on emerging
adulthood incorporating both clinical and community samples.
Purpose of the Study
The purpose of the present qualitative study is to explore the experience of EOBD
through semi-structured interviews of emerging adults with a history of EOBD diagnosis. Semistructured interviews will elicit a deeper knowledge of EOBD through participants’ descriptive
accounts. First-person qualitative reports are perhaps the most important and overlooked
resource in the search to conceptualize and treat EOBD. This study will address aspects of
EOBD such as onset, diagnosis, and experience of symptoms; psychosocial and identity
development; stigma; treatment interventions; and developmental changes occurring through
emerging adulthood.
Research questions
This qualitative study will address the following research questions:
1) How do emerging adults (ages 18-25) describe the experience of EOBD during
adolescence (ages 13-17) in terms of experience of symptoms; changes in individual,
social, and family functioning caused by course of illness; and the experience and
perception of stigma and self-stigma?
2) How do emerging adults (ages 18-25) characterize the cumulative influence of
interactions with healthcare systems and treatment interventions on their experience of
EOBD?
3) What are the characteristics of the relationship between EOBD, social and family
relationships and the developmental transition to adulthood according to emerging
adults?
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4) How have stigma and self-stigma associated with EOBD affected the social, emotional,
and cognitive development of emerging adults ages 18-25?
Relevance and Significance of Study
Within the last 20 years, the prevalence of bipolar disorder diagnoses prior to age 18 has
increased at a rate disproportionate to our understanding of its phenomenology (Carlson, 2012;
Ghaemi & Martin, 2007; Harris, 2005; Moreno et al., 2007). The cumulative literature illustrates
efforts not only to establish the etiology and nosology of EOBD, but also to develop treatment
interventions for the juvenile population.
Social workers are present throughout the healthcare system in hospital, outpatient, and
intensive treatment settings as an integral part of treatment approaches for individuals with
bipolar disorder and their families. Interventions incorporating the multitheoretical framework of
neurobiological, modified labeling, and developmental theories specific to the unique
phenomenology of EOBD are needed to improve treatment outcomes (Brown et al. 2008;
Corrigan, Powell & Rüsch, 2012). Limitations in the development and delivery of psychosocial
rehabilitation interventions targeted to issues of stigma, individual and family functioning, and
symptom management are emphasized throughout the literature (Camp, Finlay, & Lyons, 2002;
Cerit et al., 2012; Crowe et al., 2012; Davis, Kurzban, & Brekke, 2012; Heflinger & Hinshaw,
2010). Several researchers have identified the need to improve understanding of the
phenomenology of EOBD through qualitative research with adolescents and their families
(Moses, 2009; Sullivan & Miklowitz, 2010).
This study constitutes an important first step in improving conceptualization and
treatment of EOBD by providing a more accurate and thorough phenomenology of EOBD from
the perspective of emerging adults with history of EOBD diagnosis. The integration of multiple
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theoretical frameworks will create a comprehensive perspective from which to understand
EOBD. Study conclusions and implications will address gaps in existing research and better
inform the development of theory and therapeutic interventions for EOBD.
Definitions
Bipolar disorder. Bipolar disorder is a mental illness comprised of a longitudinal pattern
of depressive and manic or hypomanic episodes (APA, 2013). Bipolar I disorder consists of a
cyclical progression of manic and depressive episodes, while bipolar II disorder consists of a
similar progression of hypomanic and depressive episodes in the absence of manic symptoms
(APA, 2013).
A manic episode is defined by the presence of “abnormally and persistently elevated,
expansive, or irritable mood and abnormally and persistently increased goal-directed activity or
energy” (APA, 2013, p. 124). Manic episodes last a minimum of one week in duration and
include behavior changes such as grandiosity, decreased need for sleep, pressured speech, racing
thoughts and flight of ideas, distractibility, increase in psychomotor activity and agitation, and
excessive involvement in reckless activities with high potential for adverse consequences.
Symptoms must be severe enough to cause impairment of the individual’s normal functioning
and cannot be attributed solely to a medical condition or substance (APA, 2013).
A hypomanic episode is defined by the presence of manic symptoms at a lesser severity,
such that the individual’s ability to function is not as fully impaired as in a manic episode.
Additionally, the minimum duration of a hypomanic episode is 4 days, compared with the one
week minimum duration for a manic episode. Hypomanic episodes occur in both bipolar I and II
disorders and often are preceded or followed by depressive episodes (APA, 2013).

8
A depressive episode lasts for a minimum of two weeks and includes the following
symptoms: depressed mood (sadness, hopelessness, tearfulness), diminished interest or pleasure
in almost all activities, unintended weight gain or loss (5% or more of body weight within a onemonth period), insomnia or hypersomnia, psychomotor agitation or retardation, fatigue, feelings
of worthlessness or inappropriate guilt, diminished ability to think or concentrate, and recurrent
thoughts of death or suicidal ideation. Depressive episodes cause significant distress and
impairment in the individual’s ability to function and similarly cannot be solely caused by a
medical condition or substance. Bipolar disorder may additionally include atypical features such
as episodes with concurrent (“mixed”) manic and depressive features, rapid cycling, psychosis,
catatonia, and a seasonal presentation of symptoms (APA, 2013).
Early-onset bipolar disorder. Early-onset bipolar disorder (EOBD) is defined as the
presence of bipolar disorder symptomatology (depressive and manic or hypomanic episodes)
manifested in full prior to age 18 (APA, 2013). While each individual’s presentation of bipolar
symptoms and course of illness may vary (i.e., increased incidence of rapid cycling, episodes
with mixed manic-hypomanic and depressive symptoms, and increased risk of suicide in the
juvenile population), the diagnostic criteria for bipolar disorder, regardless of age of onset,
persists across the lifespan (Perlis et al., 2004). In the fifth edition of its Diagnostic and
Statistical Manual of Mental Disorders (DSM-5, 2013), the APA further emphasized the
longitudinal congruence of bipolar disorder with the introduction of Disruptive Mood
Dysregulation Disorder (DMDD, discussed below) to categorize disturbances in affect occurring
in childhood and adolescence that do not meet criteria for full bipolar symptomatology.
Stigma. Stigma is defined as stereotypes, discrimination, and devaluation associated with
a condition or trait perceived as negative (Corrigan, 2005). While stigma originates from external
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sources such as stereotypes and beliefs of the general population, self-stigma occurs when the
individual internalizes stigmatizing beliefs as self-directed criticism (Corrigan et al., 2012).
Through stigma, individuals are devalued due to their membership in an undesirable or defective
group with low social power. Stigma has been shown to increase the subjective burden of mental
illness while negatively affecting the help-seeking behaviors and functioning of both individuals
and families (Heflinger & Hinshaw, 2010; Perlick et al., 2008; Struening et al., 2001).
Emerging adulthood. Emerging adulthood is defined as a distinct developmental stage
occurring between ages 18-25 that spans the gap between adolescence and adulthood (Arnett,
1999). Emerging adulthood is a time of exploration of identity, interpersonal relationships, and
goal attainment occurring alongside increased independence and agency in decision-making
responsibilities (Arnett, 2006a, 2006b). As emerging adults, the participants’ experience of
bipolar disorder during adolescence will be recent; therefore, participants will be able to
accurately recall the adolescent experience of EOBD while providing the insight and cognitive
depth associated with emerging adulthood. The resulting phenomenological data will
significantly enrich and expand upon current understanding of the phenomenology of EOBD.
Delimitations
This study seeks to better understand the phenomenology of EOBD as defined above.
Several issues therefore fall outside the scope of this study. These issues are present across the
debate within the literature regarding nosology, differential diagnosis, and etiology of EOBD.
Phenotype controversy. Much of the literature on EOBD has reflected the nosological
debate between the narrow phenotype and broad phenotype definitions of bipolar disorder. The
narrow phenotype, preserved by the APA (2013) in DSM-5, specifies an episodic course of
illness comprised of distinct manic and depressive symptoms that differ significantly from the
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individual’s baseline functioning. The broad phenotype incorporates a more inclusive
presentation of a continuous, non-episodic course of persistent irritability and affective instability
that may be difficult to distinguish from the individual’s personality and functioning (Ghaemi &
Martin, 2007). This study adheres to the DSM-5 definition of bipolar disorder and does not
incorporate the more inclusive broad phenotype conceptualization of EOBD.
Disruptive mood dysregulation disorder. In the DSM-5, the APA (2013) introduced a
new diagnosis, Disruptive Mood Dysregulation Disorder (DMDD), as an alternative to a broad
phenotype diagnosis of EOBD. DMDD is included in DSM-5 solely as an alternative diagnosis
for the severe, non-episodic irritability and affective instability that has frequently been
misdiagnosed as EOBD. Whereas an adolescent with EOBD experiences manic and depressive
episodic mood states, an adolescent with DMDD experiences anger outbursts and continuous
irritability in the absence of the episodic bipolar mood states. The APA states a prevalence of
DMDD in 2-5% of children and adolescents, compared with EOBD prevalence of less than 1%
prior to age 18 (p. 157).
DMDD and EOBD are defined as mutually exclusively occurring disorders, and as such
cannot be diagnosed in the same individual (APA, 2013). This study explores the
phenomenology of EOBD; and as such, selected only participants with an EOBD diagnosis
during adolescence.
Heritability and genetic risk factors. The family system has been extensively
incorporated into bipolar disorder research. Much of this research, however, has focused on
heritability and genetic predisposition to bipolar disorder. This study does not address or explore
the presence or heritability of psychiatric symptomatology in family members.
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Chapter Two: Literature Review
This literature review will address two main areas related to the phenomenology of
EOBD. First, theoretical frameworks will be reviewed as they relate to EOBD among
adolescents and their caregivers. Second, pertinent domains such as the identity development and
perception of self, interactions with the healthcare system, and stigma will be examined. Gaps in
the literature will be discussed and research questions will be presented.
Theoretical Framework
This section reviews the neurobiological, modified labeling, and emerging adulthood
theoretical frameworks that guide and inform this study’s design.
Neurobiological theories. Neurobiological theories offer causal explanations for the
presence and development of bipolar disorder symptomatology. Neurobiological theories address
physical abnormalities of the brain, dysregulation of neurotransmitters, and dysfunction of brain
activity.
Structural brain irregularities. Research utilizing neurobiological testing indicates
several brain structural abnormalities are associated with bipolar disorder. Ahn et al. (2007)
reported an association between increased volume of nucleus accumbens (NA), a basal ganglia
(BG) structure, and EOBD diagnosis in participants age 6-16. Ahn et al. reported psychotropic
medications were negatively correlated with decreased structural abnormality, possibly
illustrating the effect of pharmacological interventions on bipolar disorder. Frazier et al. (2008)
reported findings indicating not only larger NA volumes in participants ages 6-17 with EOBD,
but also smaller left and right cerebral volumes. Bitter et al. (2011) reported abnormal
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development of the amygdala in participants age 12-17 following onset of EOBD
symptomatology. While amygdala volume was within normal limits at onset of EOBD
symptomatology, volume did not increase as expected during the first year with active
symptomatology. These findings are consistent with structural abnormalities of the prefrontal
cortex, BG, hippocampus, anterior cingulate, and amygdala associated with adult-onset bipolar
disorder (Miklowitz & Johnson, 2006).
Brain activity dysfunction. In addition to structural abnormalities, abnormal functioning
of brain activity is associated with bipolar disorder. Rich et al. (2007) reported significant
differences in the response to frustration in participants with EOBD that indicate executive
attention deficits and inability to modulate attention in the presence of increased emotional
demands.
Behavioral approach system (BAS) sensitivity, a type of brain activity dysfunction, is
highly correlated with EOBD and may predict the onset of symptomatology (Alloy et al.,
2012b). The BAS model is a biobehavioral system activated by goal- or reward-relevant stimuli.
Behavioral approach system (BAS) activation includes increased motor behavior, incentivereward motivation, and positive goal-striving emotions. Individuals with EOBD are likely to
have a BAS with greater sensitivity and response to environmental cues. Behavioral Approach
System (BAS) hyperactivation is associated with manic symptoms of bipolar disorder; increased
reward responsiveness and increased goal-striving may be predictors of onset of bipolar
symptoms. BAS hypoactivation is associated with depressive symptoms of bipolar disorder.
Adolescents with greater BAS hyperactivation and hypoactivation had greater incidence of
development of bipolar disorder. Alloy et al. (2012b) reported 42.1% of adolescent participants
with high to moderate BAS activity had first-episode onset of bipolar II disorder, while 10.5%
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experienced first-episode onset of bipolar I disorder within the 4.5 year follow-up period. BAS
hypersensitivity is therefore associated with vulnerability to onset of EOBD as well as course of
illness and may offer predictive properties regarding onset of illness.
Neurotransmitter dysregulation. Neurotransmitter dysregulation is a primary
contributing factor to bipolar disorder symptomatology. While manic and depressive symptoms
of bipolar disorder have been attributed to imbalances in transmission of the chemicals
dopamine, serotonin, and norepinephrine within the brain, current neurobiological theories focus
on the functioning of larger neurotransmitter systems. Miklowitz and Johnson (2006) point to the
interaction of dopamine and serotonin systems with other neurotransmitter systems (such as
gamma-Aminobutyric acid (GABA)) as causes of manic and depressive symptoms.
Manic symptoms such as hyperverbality, heightened mood, increased energy, and sleep
deprivation are associated with dopamine dysregulation (Miklowitz & Johnson, 2006).
Dopamine dysregulation is linked to brain functioning associated with reward motivation (i.e.,
BAS) and regions such as the NA (Ahn et al., 2007; Alloy et al., 2012; Frazier et al., 2008),
indicating an association between the increased sensitivity of dopaminergic pathways and the
subsequent onset of bipolar disorder symptomatology. While decreased sensitivity of serotonin
receptors has been associated with mood disorder symptomatology, including bipolar disorder,
the exact nature of serotonergic system dysregulation remains undefined (Miklowitz & Johnson).
Neurobiological theories offer an explanation for EOBD symptomatology and course of
illness comprised of a complex, interwoven pattern of dysfunction in the brain involving
neurotransmitters, structural irregularities, and activity disturbances within the brain’s interactive
systems. Neurobiological theories continue to strongly influence research and treatment of
EOBD and bipolar disorder.
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Modified labeling theory. Modified labeling theory asserts that individuals with and
without mental illnesses internalize role behaviors associated with mental illness. While
individuals with mental illnesses internalize ‘sick’ behaviors, individuals without mental
illnesses internalize the devaluation and discrimination of those with mental illness. Modified
labeling theory states that stigma is manifested through devaluation, in which the presence of
mental illness decreases the perceived value of the individual, and discrimination, in which the
individual is distanced and ostracized from larger society (Link, Cullen, Struening, Shrout, &
Dohrenwend, 1989).
Modified labeling theory can be used to explain the inception of stigma within the
healthcare system as well as society. Psychiatric diagnoses assigned by the healthcare profession
carry labels not only for the behaviors associated with mental illnesses, but also the expectations
and limitations regarding individual functioning and prognosis. Individuals with mental illnesses
internalize healthcare providers’ conceptualizations of mental illness. The provision of treatment
interventions that decrease symptomatology often incorporates labeling practices by healthcare
professionals that facilitate the inception and perpetuation of stigma. Labeling within the
healthcare system also produces devaluation and discrimination; the individual with mental
illness comes to expect rejection from others and subsequently adopts avoidance coping, in
which potential sources of stigma are avoided (Kroska & Harkness, 2006).
Longitudinal effects of stigma and labeling include negative connotation toward mental
illness, self-blame, social withdrawal, and secrecy that occur independently of the type of mental
disorder and length of treatment history. Furthermore, stigma may increase risk of relapse of
mental illness and failure of symptoms to remit, thus contributing to the identity as well as
mental health of the individual (Link et al., 1989).
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Labeling in adolescence. Stigma and labeling associated with mental illness occur with
adolescents as well as adults. In a study of adolescents with mental illness, Moses (2009) found
that 37% did not self-label or view themselves as mentally ill. These adolescents described
psychiatric symptoms and associated behaviors in terms of situational contexts and
manifestations of identity rather than symptomatic of mental illness. Approximately 42% of
adolescents reported ambivalence regarding labeling and self-labeling through the healthcare
system. These ambivalent adolescents identified psychiatric symptoms, yet expressed both
uncertainty and limited understanding of diagnostic issues and labels from healthcare
professionals. Ambivalent adolescents displayed a tendency to attribute symptoms and
psychiatric hospitalizations to identity and personal choices rather than the label of a mental
disorder. Approximately 20% of adolescents strongly endorsed diagnostic labels. The selflabeling group displayed a tendency to attach the possessive pronoun “my” to a diagnosis (i.e.,
“my bipolar disorder”), thereby fusing the disorder to their identity. The self-labeling adolescents
additionally displayed higher levels of self-awareness and insight regarding symptomatic
behaviors (Moses, 2009).
Moses (2009) concluded that adolescents vary regarding their endorsement and
application of labeling. Self-labeling adolescents reported experiencing more rejection, more
difficulties in social functioning, and more avoidance coping. Moses hypothesized that
adolescents’ ambivalence regarding self-labeling may be related to continuing psychological and
cognitive development, social context, or limited understanding of the phenomenology of mental
illness. Self-labeling among adolescents was correlated with higher self-stigma and depression.
Moses asserted that self-labeling in adolescents with mental illness may be demoralizing,
stigmatizing, and disempowering. While higher levels of public stigma, social rejection,
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devaluation, discrimination, and depression correlated with self-labeling, it is unknown whether
self-labeling is the causal factor or by-product of these processes. Depressive symptoms may be
symptomatic of mental illness as well as an outcome of social rejection and stigma. Furthermore,
Moses reported that younger age at onset of symptoms was associated with increased selflabeling; this could be due to increased experience with labeling of the healthcare system, public
stigma, devaluation, discrimination, or social rejection. While the nature of the relationship
between labeling and self-labeling in adolescents remains largely undefined, the process of
labeling and self-labeling is an integral part of the phenomenology of adolescent mental illness.
Theory of emerging adulthood. Theory of emerging adulthood asserts that the period
between ages 18 and 25 is a distinct stage occurring between adolescence and adulthood in
which increased independence and exploration facilitate growth and development across multiple
domains. Emerging adulthood encompasses five main features: 1) identity exploration, 2)
instability regarding life circumstances and decisions; 3) focus on self; 4) feeling ‘in between’
adolescence and adulthood; and 5) possibility and optimism of the emerging adults in response to
increased ability to effect change on their lives (Arnett, 1999; Arnett, 2006a). Factors influencing
identity development and exploration include life events such as moving out of the family home,
the formation of new relationships, and choice of occupation; as well as environmental
influences, the individual’s collective social support, and belief system. (Bynner, 2005;
Schwartz, Côté, & Arnett, 2005). Emerging adulthood inherently incorporates a perceived sense
of uncertainty regarding adult tasks such as marriage, beginning a family, and creating a career
path; and the associated decision-making to attain these goals that requires an established sense
of identity (Arnett, 2006a). Emerging identity varies culturally and is subjectively defined.
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Emerging adulthood is considered complete once the individual feels adult goals have been
attained, thereby completing the transition to adulthood (Arnett, 1999).
Emerging adulthood and psychosocial development. Psychosocial development in
emerging adulthood is characterized by a sense of opportunity and possibilities that include
changes and developments in family, social, and romantic relationships. During emerging
adulthood, the relationship between the emerging adult and the parent changes toward a
relationship comprised of two adults, rather than a parent and dependent child. This change in
the parental relationship requires the parent’s acknowledgement of their child as an emerging
adult in terms of status, independence, and agency. While patterns of parent-child interaction and
family dynamic during childhood and adolescence influence the parent-child relationship during
adulthood, this influence weakens as the emerging adult moves further into adulthood. Affection,
open communication, and mutual respect in family relationships influence identity development
and exploration in emerging adulthood (Aquilino, 2006). Increased independence in emerging
adulthood allows emerging adults to detach from unhealthy family relationships and establish
strong bonds in both peer and romantic relationships (Arnett, 2006b; Aquilino, 2006; Collins &
van Dulmen, 2006).
Emerging adulthood and stigma. Emerging adults remain susceptible to stigma and
self-stigma, particularly regarding identity development. Components of stigma such as viewing
oneself self as “less than” others without mental illness, avoidance, and coping methods present
in adolescence continue through emerging adulthood and present as a challenge to identity
development. Moreover, emerging adults with mental illness reported difficulty disclosing the
mental illness, which carries significant implications for relationship building during emerging
adulthood (Elkington et al. 2012).
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Support from relationships in emerging adulthood may be the greatest protective factor
against stigma and self-stigma. Appraisal support, which encourages the individual to reframe
situations in a more positive light, is particularly associated with decreased stigma among
emerging adults with mental illness (Dahl, 2004; Doherty & MacGeorge, 2012).
Emerging adulthood and EOBD. Emerging adults with a diagnosis of bipolar disorder
are more likely to have received the diagnosis in recent years; the majority of cases have onset of
symptoms and diagnosis between ages 18-25 (Dahl, 2004; McGorry, Purcell, Goldstone, &
Amminger, 2011). Furthermore, emerging adults’ family and social support, relationship
building, and efforts to cope with stigma are processes that began during adolescence (Aquilino,
2006; Elkington et al., 2012).
Paradoxically, a positive correlation occurs between mental illness and wellness during
emerging adulthood; while psychopathology of mental illness increases during emerging
adulthood, well-being and self-esteem increase as well (Arnett, 2006b; Galambos, Barker, &
Krahn, 2006; Schulenberg & Zarrett, 2006). Processes that occur in emerging adulthood such as
increase in social support, commitment to education and goal attainment, and greater sense of
meaning are associated with increased well-being (Galambos et al., 2006; Schulenberg & Zarrett,
2006; Steger, Oishi, & Kashdan, 2009). Thus, while emerging adults may encounter the
difficulties associated with experiencing symptomatology of mental illness, the developmental
processes occurring during emerging adulthood may provide protective properties and facilitate
development of healthy identity and relationships (Arnett, 1994; Elkington et al., 2012;
Schulenberg & Zarrett, 2006). This study’s sample is comprised of emerging adults who offer
both the recent experience of EOBD symptomatology and the insights of emerging adulthood.
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Interpersonal functioning and social support. Social support in bipolar disorder is an
important component toward maintaining wellness, as it is associated with decreased
vulnerability to bipolar depressive episodes and a shorter recovery time following symptomatic
episodes (Johnson et al., 1999). Individuals with bipolar disorder report increased difficulty in
social activities and interpersonal relationships, including social and family interactions
(Calabrese et al., 2003). During symptomatic episodes, deficits in interpersonal functioning
increase; while during periods of symptomatic recovery interpersonal functioning has been
shown to improve (Weinstock, Keitner, Ryan, Solomon, & Miller, 2006). Furthermore, deficits
in social cognition and functioning in adults with bipolar disorder are also present in EOBD and
believed to persist across the lifespan throughout the course of illness (McClure et al., 2005).
Social functioning and relationships therefore have significant implications for the course of
bipolar disorder.
Interpersonal social rhythm therapy. Social functioning is a core concept in
interpersonal social rhythm therapy (IPSRT), a therapeutic intervention for bipolar disorder that
seeks to stabilize symptomatic episodes through achieving lifestyle balance. IPSRT integrates
behavioral, interpersonal, and psychoeducational models to alleviate severity and frequency of
symptomatic episodes of bipolar disorder. IPSRT focuses on stabilizing circadian rhythms and
sleep-wake patterns, as well as the social cues that affect these patterns. Personal relationships
and their social demands are viewed as mediators between biological and psychological
vulnerabilities for symptomatic episodes of bipolar disorder (Frank, Swartz, & Kupfer, 2000).
Family-focused treatment. For families affected by bipolar disorder, impairment in
family functioning is associated with course of illness and persists even in the absence of
symptomatic episodes (Weinstock et al., 2006). Therefore, it is important that therapeutic
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approaches to bipolar disorder also focus on interpersonal functioning within the family. FamilyFocused Treatment (FFT) is a therapeutic approach that focuses on the balancing patterns of
interpersonal communication and expressed emotion (EE) within the family system. Greater
levels of EE within the family are associated with high levels of criticism, hostility, and
emotional over-involvement as well as risk of symptomatic relapse for the individual with
bipolar disorder (Miklowitz, 2008; Morris, Miklowitz, & Waxmonsky, 2007). FFT aims to
stabilize bipolar disorder by balancing protective and risk factors in family and social
environments. FFT interventions address interpersonal functioning within the family through
psychoeducation, relapse prevention, communication enhancement, and problem-solving with
family members (Miklowitz, 2008). When used with EOBD, FFT addresses age-appropriate
developmental tasks, the family experience of EOBD, and works to reduce negative high EE
family behaviors such as criticism and hostility (Morris et al., 2007).
Extant Knowledge on EOBD
The phenomenology of EOBD is explored across five domains within the literature: a)
scope of the illness; b) the adolescent perception of self; c) interactions with the healthcare
system; d) the family system; e) stigma. When viewed collectively, the research across these
domains provides a comprehensive understanding of existing knowledge of EOBD.
Scope of EOBD. Prevalence data and course of bipolar disorder illness are discussed
across the lifespan, with consideration and implications for EOBD. Information presented for
bipolar disorder is inclusive to both early- and adult-onset presentations in accordance with the
DSM-5 conceptualization of bipolar disorder (APA, 2013).
Prevalence. Bipolar disorder occurs in 1-2% of the adult population. While EOBD
prevalence is consistent with adult-onset prevalence at 0 – 2% of adolescents in community
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samples and 6.0 - 6.9% of adolescents in clinical samples, it has been diagnosed in up to 13% of
the adolescent and child population across community and clinical samples (APA, 2013; Harris,
2005; Miklowitz & Johnson, 2006). The discrepancy between EOBD prevalence and diagnostic
rates is not rooted in whether bipolar disorder symptomatology can manifest prior to age 18, but
in whether EOBD is conceptualized and operationalized consistently with adult-onset bipolar
disorder (Miklowitz & Johnson, 2006). The trending conceptualization of EOBD as a chronic
and continuous state of irritability, tearfulness, and psychomotor agitation with prolonged temper
outbursts, rather than as an episodic illness with distinct manic and depressive states has
impacted treatment interventions, prognosis, course of EOBD illness, and the psychological
development of adolescents with EOBD (Biederman, 1995; Biederman et al., 1995; Faedda et
al., 1995; Wozniak et al., 1995).
Bipolar disorder is the sixth cause of disability worldwide, and its functional impairment
occurs even in the absence of full symptomatic episodes (Cerit et al., 2012; Judd et al., 2002).
Psychotropic medications may decrease the severity and frequency of both subthreshold and full
symptomatic episodes, but management of bipolar disorder remains challenging. In a study of
five guideline-concordant psychotropic medications, only 58-63% of participants’ symptoms
responded partially or in full to the prescribed medications (Garnham et al., 2007). Furthermore,
up to 30% of individuals with bipolar I disorder and 15% of those with bipolar II disorder
experience impairment in functioning in the absence of symptomatic episodes. As many as 20%
of individuals with bipolar disorder transition between symptomatic episodes without periods of
symptom-free recovery (APA, 2013).
Course of illness. The average age of onset of bipolar I disorder is 18 years and for
bipolar II disorder occurs in the mid-20s (APA, 2013). However, the literature indicates onset of
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symptoms occurs an average of ten years prior to a diagnosis (Berk et al., 2009; Torrey &
Knable, 2002). Within the literature, varying estimates indicate a significant portion of
individuals with bipolar disorder report onset of symptoms in their youth. Torrey and Knable
stated 20-40% of individuals with bipolar disorder report onset of symptoms in childhood, while
Perlis et al. (2004) reported onset of symptoms prior to age 13 in 28% of individuals with
bipolar disorder and onset of symptoms prior to age 18 in 66% of individuals.
The onset of bipolar disorder often occurs over with symptomatology progressively
increasing to its full diagnostic presentation over the course of several years. In a clinical sample,
45% of participants age 7-17 progressed from subthreshold symptoms to bipolar I or II disorders
over a period of 5 years. Twenty-three percent of participants developed bipolar I disorder, 9 of
which first progressed to bipolar II disorder within the sample timeframe. Twenty-two
participants met criteria for bipolar II disorder (not including the 9 participants who eventually
met criteria for bipolar I disorder) by conclusion of the study. Furthermore, hypomanic
symptoms were present in 85% of participants within one month prior to onset of bipolar I or II
symptomatologies (Axelson et al., 2011).
The polarity (i.e., manic or depressive) of the first episode at onset of bipolar disorder
may contain important clues for the prognosis and course of illness. Approximately two-thirds of
adults with bipolar disorder (67%) reported first episode was depressive in nature, and 75% of
these adults with depressive onset reported a course of illness dominated by depressive episodes.
In comparison, only 27.9% of participants with manic episode at onset of illness experienced
course of illness dominated by depressive episodes. Improved identification of episode polarity
at onset of bipolar disorder may facilitate improved intervention and course of illness (Daban et
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al., 2006). Additionally, successful treatment early in the course of illness is associated with an
improved prognosis (McGorry, 2010).
Determining first episode polarity in adolescents with emerging mood symptomatology
can be challenging for the clinician due to factors such as differential diagnosis between bipolar
disorder subtypes (i.e., type I, II, or unspecified; APA, 2013). Furthermore, clinicians face the
often-nuanced nosological diagnostic challenges of distinguishing between mood swings and
mood episodes, continuous irritability and episodic course of illness, and rage outbursts in
contrast to true manic symptoms in order to make an accurate EOBD diagnosis. Co-occurring
conditions such as psychotic features, substance abuse, atypical depression, and ADHD further
complicate the clinician’s ability to accurately diagnose EOBD. Additional factors include
consideration of the adolescent’s age and cognitive and normative development, the clinician’s
adherence to either broad or narrow conceptualization of EOBD, the reliability of child and
parent report of symptoms, and utility of family history in making a diagnosis (Carlson, 2012).
EOBD and adolescent perception of self. Neuroplasticity and neurobiological changes
are a critical component in the onset of EOBD and have significant implications for emotional
and social development, including normative processes of cognitive and psychosocial
development, achieving symptomatic and syndromic recovery, and identity development that
begin during adolescence and continue through emerging adulthood (Dahl, 2004).
Adolescent cognitive development. Adolescence is a developmental period frequently
defined as occurring between ages 11 – 22 in which significant changes occur in biological,
cognitive, emotional, and social functioning (Gutsegell & Payne, 2004). Cognitive, emotional,
and social development each occur at differing rates as influenced by biological pubertal
changes, rather than as a uniform process occurring consistently throughout adolescence
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(Steinberg, 2005). Cognitive improvements in reasoning, information processing, self-regulation,
self-evaluation, and coordination of affect and cognition occur alongside growth in the prefrontal
cortex region in the brain (Steinberg, 2005). Adolescents progress from operating based on
conceptualizations of concrete rules and ideals to independent reasoning based on deductive
hypotheses and logic (Piaget, 1964). Adolescents may begin to use reasoning and logic in early
adolescence but continue to refine this process of formal operations (Piaget, 1964; Steinberg,
2005). Cognitive development is influenced by social context and emotion, and in turn
influences social and emotional development. Self-regulation, comprised of the coordination of
emotional, intellectual, and behavioral processes, is the desired outcome of adolescent cognitive
development (Steinberg, 2005).
Adolescent moral and psychosocial development. While an EOBD diagnosis can affect
the adolescent’s self-concept and psychosocial development, the symptomatic course of EOBD
illness can impact normal, emotional, cognitive, and social development (Birmaher et al., 2006;
Parry & Levin, 2012). During adolescence, a process of moralization occurs alongside cognitive
development, in which the interaction between the adolescent and social environment transforms
both the adolescent’s attitudes and conceptualizations of their environment (Kohlberg, 1963).
Between ages 10-16, adolescents typically progress from conventional morality to postconventional morality according to Kohlberg’s stages of moral development; obedience to
authority is replaced with abstract conceptualizations of justice and the value of individual rights
may override adherence to rules. Moral development during adolescence reflects patterns of
interaction between the adolescent, social environment, and peer groups (Kohlberg, 1963).
Peer relationships and social functioning in adolescence have significant implications for
the course of EOBD illness and identity development. Peer rejection and subsequent loneliness
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are associated with a trajectory of illness that consists of more depressive symptoms (Pederson,
Vitaro, Barker, & Borge, 2007). Challenges to social functioning such as romantic interests,
increased self-consciousness, and social anxiety occur concurrent to biological and behavioral
changes associated with adolescence (Forbes & Dahl, 2010). Peer relationships may influence
self-regulatory skills both negatively and positively, while self-regulatory skills can influence the
quality and quantity of peer relationships (Farley & Kim-Spoon, 2014). The development of a
personal identity is an essential task during adolescence. Social relationships serve as a
mediating factor through which a strong sense of self can be developed, as opposed to persistent
role confusion and identity diffusion (Erikson, 1997).
Early-onset bipolar disorder (EOBD) symptomatology can negatively affect adolescent
progress toward developmental tasks pertaining to identity, relationships, academic functioning,
and psychological autonomy (Miklowitz & Johnson, 2006). While psychiatric and therapeutic
treatment interventions can potentially decrease the symptomatic effect on adolescent
development, adolescents remain vulnerable to stigmatizing messages through healthcare
systems and society that impact normative processes of identity development (Alreja et al., 2009;
Miklowitz & Johnson, 2006).
Effect on psychosocial development. The diagnosis and treatment of EOBD are
influential to the adolescent’s physical and psychosocial development. As a result of an
overreliance on neurobiological theories, comprehensive and multidisciplinary treatment
approaches have frequently been reduced solely to pharmacotherapy; and the significance of
contributing factors such as the family system and impact of environmental triggers has been
minimized. Pharmacological interventions carry the potential for both positive and negative
outcomes in child and adolescent populations. While psychotropic medications have
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demonstrated similar benefits in the adult and juvenile population bipolar populations, these
medications carry significant health risks for the juvenile population, such as health
complications (i.e., weight gain; metabolic syndrome; tardive dyskinesia; polycystic ovarian
syndrome; thyroid and parathyroid function; and hyperprolactinemia associated with changes in
estrogen levels) and documented fatalities (Correll & Carlson, 2006; Parry & Levin, 2012). The
long-term effects of pharmacotherapy on the adolescent’s physical health remain largely
unknown; and impact on self-concept, psychological development, and family communication
have been questioned as well (Parry & Levin, 2012).
Defining recovery. While treatment interventions for bipolar disorder have primarily
focused on the reduction and management of bipolar symptomatology, research is increasingly
exploring the concept of recovery. Conus et al. (2006) identified three types of recovery:
syndromic, symptomatic, and functional. Syndromic recovery consists of a clinically significant
reduction (> 50%) in severity of bipolar symptomatology to the extent that diagnostic criteria are
no longer met; however, mild residual manic or depressive symptoms may persist (McMurrich et
al., 2012; Sachs & Rush, 2003; Stotland, Mattson, & Bergeson, 2008). Symptomatic recovery
refers to an improvement in the magnitude of symptoms while diagnostic criteria remain
significant (McMurrich et al., 2012; Stotland, Mattson, & Bergeson, 2008). Functional recovery
incorporates a return to previous level of functioning and psychosocial activity (McMurrich et
al., 2012; Zarate, Tohen, Land, & Cavanagh, 2000). Functional recovery consists of
improvements in social functioning, occupational functioning, and independent living, and
therefore addresses impairments and life stressors associated with bipolar symptomatology,
medication side effects, and societal stigma (Stotland et al., 2008).
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Within the literature, complete syndromic and symptomatic recovery from bipolar
disorder are viewed as potentially unattainable. Bipolar disorder has a chronic course of illness
that worsens over time without proper treatment, and is characterized by high recurrence of
symptomatic episodes as well as chronic and unremitting residual symptoms that occur between
symptomatic episodes (Angst & Sellaro, 2000; Frank et al., 2000; McMurrich et al., 2012). A
permanent cure, or complete remission of bipolar disorder symptomatology, is considered to be
nonexistent due to the course of illness—as many as 90% of individuals who have experience
one manic episode will experience another throughout their lifetime (Sachs & Rush, 2003).
Furthermore, subsyndromal and residual symptoms persist even in the absence of full
symptomatic episodes and are associated with profound psychosocial impairments (Zaretsky,
2003). Bipolar disorder is considered in to be partial remission if symptomatic recovery was
achieved for a two-month period, and in full remission if syndromic recovery was achieved for a
two-month period (APA, 2013; Perlis et al., 2009; Sachs & Rush, 2003).
Inquiries across the interdisciplinary literature regarding longitudinal aspects of EOBD
recovery are limited. As compared to adult-onset bipolar disorder, EOBD course of illness is
associated with poorer treatment outcomes and course of illness; includes higher incidence of
rapid cycling without asymptomatic periods of recovery between symptomatic episodes; and is
associated with greater stressful live events, poorer quality of life, and increased risk of
impairment in social functioning (Elgie & Morselli, 2007; Findling et al., 2001; Paykal, 2001;
Perlis et al., 2009). Other aspects of recovery such as the developmental impact of EOBD,
resilience factors, functional impairment, and maturation effects on episode recovery, recurrence,
subsyndromal and residual symptoms also remain under researched (Strober et al., 2006).
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EOBD course of illness is affected by both risk and protective factors that influence
treatment outcomes. Identified risk factors include lower perceived social support, stressful life
events, disruption in social and circadian rhythms, and medication noncompliance (Cohen,
Hammen, Henry, & Daley, 2004; Frank et al., 2000). Protective factors include high levels of
social support, psychotherapy and psychosocial interventions, higher level of education, being
married, and short duration of illness (Johnson et al., 1999; Sachs, 2008; Wingo, Baldessarini,
Holtzheimer, & Harvey, 2010).
Identity development and stigma. Individuals with bipolar disorder report concern
regarding not only the effects and experience with psychotropic medication, but also the effect of
bipolar disorder itself on their identity. In a phenomenological study of adult patients after
receiving a diagnosis of bipolar disorder, participants reported ambivalence and hesitation
regarding psychotropic medications specifically due to concern regarding side effects such as
decreased cognitive functioning, weight gain, decreased energy, and decreased creativity. The
trial-and-error approach of trying multiple medications was reported as frustrating, but some
participants reported willingness to tolerate side effects if symptom reduction was deemed
beneficial (Proudfoot et al., 2009).
Participants identified symptom management as one of their greater concerns associated
with receiving a diagnosis of bipolar disorder. Some participants reported “terrifying” fear of
symptomatic episodes due to perceived loss of control over their lives. While some participants
reported feeling relief after receiving the diagnosis of bipolar disorder following years of
experiencing symptoms, some participants reported denial, anger, disbelief, and shock.
Participants discussed attempts to come to terms with their ‘new’ identity and merge ‘old’ and
‘new’ identities. Participants reported difficulty regarding trusting their thoughts, emotions,
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impulses, and reality-testing ability. Additionally, participants reported questioning course of
illness, ability to function, and ability to have a ‘normal life’ regarding social, family, and work
relationships (Proudfoot et al., 2009).
Proudfoot et al. (2009) reported individuals with bipolar disorder may experience a loss
of self following a diagnosis of bipolar disorder, and reported stigma was also of significant
concern. Participants reported fearing they would lose relationships if people found out about the
bipolar disorder diagnosis and worried about how to disclose the diagnosis to others. Participants
reported that stigma increased the isolation of bipolar disorder, specifically when support people
were unsure how to help. Proudfoot et al. identified the need for psychoeducation for friends,
family, and the larger community, to increase support for individuals with bipolar disorder.
EOBD and interaction with the healthcare system. Treatment for EOBD occurs within
the healthcare system and includes psychiatric, pharmacological, and therapeutic interventions
designed to alleviate bipolar disorder symptomatology and improve both individual and family
functioning. This section reviews stigma and treatment as experienced through the healthcare
system. Inception of stigma, loss of autonomy, and psychiatric, pharmacological, and therapeutic
interventions are discussed.
Inception of stigma. Labeling and stigma associated with mental illness often originate
within the healthcare system. Stigmatizing practices such as labeling and referring to the youth
by their diagnosis (i.e., “that bipolar boy” or “that boy is bipolar”), focusing treatment and
assessment on deficits indicated by the medical model, and treatment planning without the youth
or family present commonly occur within the healthcare system. Treatment models often focus
exclusively on symptomatology rather than a holistic and strengths-based approach incorporating
protective family and environmental factors. Individuals and families often experience a
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dichotomous relationship between the ‘expert’ healthcare professional and ‘ignorant’ patient,
rather than a collaborative relationship in which the youth and family are experts as well.
Stigmatizing practices within the healthcare system may negatively affect the recovery of
individuals with bipolar disorder and influence families to avoid contact with the healthcare
system (Browne, Hemsley, & St. John, 2008; Heflinger & Hinshaw, 2010). Families, as well as
individuals, are subject to stigma through the healthcare system, which may lead to reduced
contact with the healthcare system to avoid stigmatizing services (Heflinger & Hinshaw, 2010).
Recovery-oriented interventions that enhance functional recovery and minimize stigma are more
successful in facilitating the individual’s recovery (Stotland, Mattson, & Bergeson, 2008).
Loss of autonomy. Stigmatization and labeling experienced through the healthcare
system negatively affect individuals’ self-esteem, and result in loss of identity and loss of
confidence (Browne et al., 2008). In a qualitative study of adults with bipolar disorder the core
theme from participants was feeling out of control regarding the illness and over their lives
(Crowe et al., 2012). Participants reported difficulty managing symptoms, and stated the onset of
symptoms created a significant change in their lives. Participants reported their self-identity was
affected by their experience of bipolar symptoms as well as the responses of others to their
symptoms. Participants reported feeling flawed, powerless, and incapacitated by symptomatic
episodes. Psychotropic medications were associated with loss of autonomy, defectiveness, and
identity; in turn, loss of autonomy was associated with interaction with healthcare professionals.
Participants reported the need to take medication indicated they were not normal and were not
who they wanted to be. Participants reported believing they were different in negative ways,
even in the absence of these beliefs from others; this indicated the internalization and
endorsement of stigmatizing beliefs (Crowe et al., 2012).
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Therapeutic interventions. Therapeutic interventions have significant implications for
the long-term course of bipolar illness. Therapeutic interventions for EOBD include individual,
group, and family modalities. While data on EOBD remains limited, the literature on adult-onset
bipolar disorder indicates the combination of psychotherapy, and pharmacotherapy is effective in
reducing rates of symptomatic relapse by 30 – 40% over a 12 to 30 month period. Benefits such
as symptom reduction, improved interpersonal and daily functioning, and medication adherence
were present for one or more years following termination of therapy services (Miklowitz, 2008).
Informal support. Community-based peer supports provide recovery-oriented,
complimentary approaches to clinical interventions for bipolar disorder and EOBD. Perceived
social support can be both a risk and protective factor for individuals with bipolar disorder.
DeVylder and Gearing (2013) identified declining social support occurring in adolescents prior
to psychiatric hospitalization, and advocated for social interventions to indirectly improve
symptomatology. Peer support is associated with enhancing individual’s sense of empowerment,
reducing stigma, improving self-esteem, decrease symptomatology, and decrease risk of
symptomatic relapse (Corrigan, Powell, & Rusch, 2012; Davis et al., 2012). Perlick et al. (2004)
reported a correlation between stigma and intentional reduction in social functioning, and
advocated for recovery-based peer support to inoculate against the effects of stigma. While peer
supports do not directly address symptomatology as clinical interventions do, participants in peer
support groups report a simultaneous decrease in symptomatology and increase in hope and
empowerment (Brown et al., 2008; Fukui, Davidson, Holter, & Rapp, 2010).
EOBD and the Family. The family system is an important mediating variable in the
comprehensive management and course of illness of bipolar disorder. This section discusses
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family burden and stigma, family functioning, and the family’s experience of bipolar disorder
symptomatology.
Family functioning. Family functioning and cohesion are each affected by bipolar
disorder. During both symptomatic and symptom-free episodes families appear to operate in a
more cohesive, adaptive manner, while during prodromal and recovery periods, families
experience less cohesion, ability to adapt, and more conflict. Family functioning may also be
affected by relationship stress and conflict common during symptomatic episodes of bipolar
disorder (Sullivan & Miklowitz, 2010).
Conversely, family functioning may influence the severity of bipolar disorder
symptomatology. Living with an intact biological family and enhancing family relationships are
protective factors toward alleviating symptomatic episodes and improving course of illness,
while family hostility, stigma, misunderstanding, and low maternal warmth are risk factors
associated with increased symptomatic episodes (Elgie & Morselli, 2007; Geller et al., 2002).
Adolescents with EOBD in families with greater conflict experienced more severe manic
symptoms over a two-year period, while adolescents in families with greater cohesion
experienced decreased severity of depressive symptoms (Sullivan, Judd, Axelson, & Miklowitz,
2012). While family functioning has important implications for the treatment and course of
bipolar disorder, the cumulative literature has not explored the possibility of positive family
outcomes due to EOBD. Family cohesion has been identified as a protective factor to reduce
bipolar symptomatology and incorporated into Family Focused Treatment (FFT) intervention
(Miklowitz, 2008; Sullivan & Miklowitz, 2010; Sullivan et al., 2012); however, family cohesion
has not been studied as a positive outcome of EOBD.
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EOBD and Stigma. Stigma has been discussed in the context of the perception of self,
the healthcare system, and the family. In this section, stigma is reviewed in more detail regarding
its relationship to symptomatology, social and occupational functioning and predictive ability of
functioning.
Symptomatology and stigma. As explained by modified labeling theory, societal views
contribute to the stigma associated with mental illness. In bipolar disorder, societal stigma and
labeling may differ according to each symptomatic episode. In a sample of college students, 40%
described manic symptoms as voluntarily aggressive, dangerous, and unpredictable with a lack
of self-control, and expressed irritability, lack of understanding, and the desire to withdraw from
the individual. In contrast, participants reacted to depressive symptoms with pity and desire to
help the individual (Wolkenstein & Meyer, 2008). While stigma research specific to the
fluctuations in bipolar mood states is limited, this study suggests varying societal attitudes
relative to manic and depressive symptoms.
While symptomatology may influence societal stigma, stigma appears to affect bipolar
symptomatology as well. Cerit et al. (2012) identified three predictors of functioning in
individuals with bipolar disorder: severity of depression, perceived social support, and
internalized stigmatization. Severity of depression emerged as the strongest predictor of poor
functioning; recurrent mild depressive symptoms in particular were negatively associated with
functional recovery in bipolar disorder. Stigma directly predicted functioning as well as
predicted pathways for other predictors of functioning. Cerit et al. (2012) suggested a
bidirectional relationship exists between bipolar disorder and stigma, in which stigma can
exacerbate bipolar symptomatology; and in turn, symptoms perpetuate stigma beliefs. Therefore,
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treatment interventions for bipolar disorder that address stigma may have important implications
for symptom reduction.
Social functioning and stigma. Sensitivity and concern regarding stigma may impair
social functioning. In a clinical sample of adults with bipolar disorder and their caregivers,
participants that reported greater concern regarding stigma displayed greater impairment in
social functioning. Stigma was associated with increased avoidance coping, including increased
psychosocial isolation, but not with decrease in family functioning. Participants who reported
concern regarding stigmatization experienced poorer social adjustment at the seven-month
follow up (Perlick et al, 2004). Stigma appears to negatively affect social functioning and
recovery in individuals with bipolar disorder.
Limitations of Previous Studies
At present there are no published studies investigating the experience of EOBD by
adolescents or emerging adults with a history of EOBD diagnosis. The cumulative literature
predominantly adheres to the medical model, with a quantitative focus on establishing
neurobiological markers for EOBD and effectiveness of pharmacological interventions used to
treat adult bipolar disorder. With a few exceptions (i.e., Moses, 2009), there is an overwhelming
absence of qualitative inquiries into the experience of adolescent mental illness. Research and
treatment for EOBD have largely been conducted in the absence of the self-report of the
adolescents affected by bipolar illness as a primary data source (Heflinger & Hinshaw, 2010).
Emerging adulthood has been similarly overlooked as a source of information and reflection of
past experience of EOBD in adolescence.
Various authors have recognized these limitations within the literature and addressed the
need for qualitative, family- and adolescent-focused research to better understand the
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phenomenology of EOBD. Sullivan and Miklowitz (2010) stated the need for qualitative
research to better understand family experience and functioning during symptomatic episodes of
bipolar disorder. Miklowitz (2008) identified the need for increased research to improve
pharmacological and therapeutic interventions for EOBD, including greater inquiry into the
adolescent experience of EOBD. Miklowitz, Biuckians, and Richards (2006) called for research
to investigate EOBD adolescent physiological and symptomatic responses to family conflict.
Heflinger and Hinshaw (2010) questioned the application of theoretical frameworks from the
adult to the juvenile population as well as the absence of theory specific to the juvenile
population. In summary, the first-person experience of adolescents with EOBD has been largely
peripheral in research, despite the acknowledgement within existing research of the need for the
phenomenological data.
Aims of Present Study
To address limitations of previous studies, the present study will explore EOBD in a
sample of emerging adults ages 18-25 with a history of EOBD diagnosis. Many existing studies
have utilized quantitative methodologies, relying on the scoring of standardized measures to
approximate an understanding of the phenomenology of EOBD. While past inquiries have
included quantitative investigations into neurobiological malfunctioning, pharmacological
approaches, and family functioning, the present study will utilize qualitative methodology to
explore the full phenomenology of EOBD.
While the literature on bipolar disorder has incorporated self-report from adults with
bipolar disorder, adolescents and emerging adults have been underutilized as primary informants
and sources of data in EOBD research. The present study utilizes the reflection of emerging
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adults to reconstruct their experience of EOBD in adolescence to increase understanding of the
phenomenology of EOBD with implications for current functioning.
Previous studies have explored EOBD through various theoretical perspectives; however,
our understanding of the phenomenology of EOBD remains limited. The present study proposes
the integration of neurobiological, modified labeling theories with the theory of emerging
adulthood as the foundation for a more complete and multidimensional understanding of the
phenomenology of EOBD.
Summary of the Study
This qualitative study will explore the phenomenology of EOBD among emerging adults
by addressing the following research questions:
1) How do emerging adults (ages 18-25) describe the experience of EOBD during
adolescence (ages 13-17) in terms of experience of symptoms; changes in individual,
social, and family functioning caused by course of illness; and the experience and
perception of stigma and self-stigma?
2) How do emerging adults (ages 18-25) characterize the cumulative influence of
interactions with healthcare systems and treatment interventions on their experience of
EOBD?
3) What are the characteristics of the relationship between EOBD, social and family
relationships and the developmental transition to adulthood according to emerging
adults?
4) How have stigma and self-stigma associated with EOBD affected the social, emotional,
and cognitive development of emerging adults ages 18-25?
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Chapter 3: Methodology
To obtain an understanding of the lived experience of EOBD and best address research
questions, this study incorporated a transcendental phenomenological design. This chapter
reviews transcendental phenomenology and its application to study design, including sampling,
data collection, and data analysis.
Transcendental Phenomenology
Phenomenology is the philosophy and study of pure phenomena through human
consciousness (Husserl, 1965, 2012; Moustakas, 1994). Derived from the Greek word
phaenesthai, ‘phenomenon’ means ‘to bring to light’ or ‘show itself completely’ (Moustakas,
1994). A phenomenon is a reality contained within the human experience. Phenomenological
data is obtained through the individual’s subjective report of the experience (Groenewald, 2004).
In transcendental phenomenology, the researcher sets aside all previous habits of thought and
breaks down the barriers or biases generated by these habits in order to uncover the pure essence
of the phenomenon (Groenewald, 2004; Husserl, 2012). The goal of phenomenology is a return
to things as they truly are, rather than how they are perceived and judged (Groenewald, 1994;
Moustakas, 1994).
Transcendental phenomenology seeks to uncover the essence of human experience
through a transcendental, or pure, ego free of prejudgment and presupposition. To accomplish
this, transcendental phenomenology asks two questions: a) what is the essence of the experience
of the phenomenon; and b) in what context(s) did the experience occur (Moustakas, 1994)?
Through transcendental phenomenology, an accurate description of the phenomenon is obtained
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through explication and synthesis of the subjective experiences of the phenomenon (Groenewald,
2004; Moerer-Urdahl & Creswell, 2004).
Transcendental phenomenology utilizes qualitative methods to obtain the lived
experiences of the phenomenon of study through the individuals’ self-report. The philosophical
assumptions of transcendental phenomenology uniquely focus on eliciting the experience of the
phenomenon, as opposed to similar methodologies such as ethnography, in which the
phenomenon is observed by the clinician, and narrative approaches such as oral history, in which
the focus is on narration. Qualitative interviews are interactive and semi-structured, relying on
the two core transcendental phenomenological questions as stated in the previous paragraph to
guide the interview while incorporating flexibility, allowing for the full revelation of the
experience as directed by the individual rather than the researcher (Moustakas, 1994).
Phenomenological interviews are iterative in nature, as the researcher continuously reflects on
the relationship between the individual’s self-report and core research questions, often diverging
from intended questions to allow the individual to guide the interview and capture the essence of
the phenomenon as he or she experienced it. The goal of the phenomenological interview is for
the individual to share as much of the experience as authentically and unselfconsciously as
possible in his or her own words (DiDicco-Bloom & Crabtree, 2006).
Epoche, intentionality, noema, and noesis. Several concepts are central to the design
and implementation of transcendental phenomenology. Here, these concepts are discussed here
in brief, with further application in data analysis.
Epoche. In transcendental phenomenology, a transcendental state incorporates “a
readiness to see in an unfettered way, not threatened by the customs, beliefs, and prejudices of
normal science, by the habits of the natural world or by knowledge based on unreflected
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everyday experience” (Moustakas, 1994, p. 41). The absence of bias is accomplished through a
process called epoche (from the Greek έποχή) in which all judgment is suspended in order to
view the phenomenon as it is.
Epoche is regarded both as a philosophical concept and a component of data analysis.
Epoche is the first step in the phenomenological reduction process, in which the experience is
conceptualized according to recurrent themes and textural descriptions present in interview data;
phenomenological reduction is discussed further in discussion of data analysis. While pure
epoche is difficult to achieve, even its approximation reduces researcher bias and maximizes the
credibility of the study (Moerer-Urdahl & Creswell, 2004; Moustakas, 1994). Through epoche,
the researcher gains the ability to collect, describe, and analyze the phenomenon of study as
accurately as possible without the influence of his or her own experiences.
Intentionality. Intentionality is the awareness, or perception, of the phenomenon.
Intentionality is not the phenomenon itself, but rather the subjective lived experience of the
phenomenon and includes judgment, interpretation, and value of the phenomenon (Moustakas,
1994). Intentional experiences contain the essence of the experience of the phenomenon, and are
therefore sought out through phenomenological interviews as representative of the phenomenon
of study (Husserl, 2012). The essence of the phenomenon is constructed through a compilation of
multiple intentional experiences.
Noema and noesis. Each intentionality is comprised of a noema and noesis. In its most
simple definition, noema refers to the phenomenon itself, the object of the experience, and noesis
is how the phenomenon is experienced. Noema represents the sensory experience of the
phenomenon, while noesis contains the meaning of the experience through perception, emotion,
memory, and judgment. Through reflecting on the noema the noesis is uncovered, and with it the
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essence of the phenomenon. Transcendental phenomenology seeks to discover both noema and
noesis of each intentional experience of the phenomenon, and it is through this process that the
phenomenon can be truly understood (Moustakas, 1994).
Participants
Transcendental phenomenology utilizes a homogenous sample of individuals who have
experienced the phenomenon of study. This study utilized purposive sampling to recruit
emerging adults ages 18-25 with history of diagnosis of EOBD between the ages 13-17 per selfreport. Participant eligibility and recruitment are discussed below.
Participant eligibility. Participants were eligible to take part in this study if they met the
following inclusion criteria: a) between 18 and 25 years of age; b) diagnosed with bipolar
disorder between the ages of 13 and 18; c) spoke English fluently; d) did not have an active
substance abuse or substance dependence disorder, drug-induced mood disorder, pervasive or
intellectual developmental disorder, unremitting psychosis or psychotic disorder, posttraumatic
stress disorder, or a life-threatening eating disorder (adapted from Sullivan & Miklowitz, 2010);
e)did not display imminent danger to self or others.
Recruitment of sample. The researcher coordinated with clinical sites and community
support groups in Tampa, Florida and Orlando, Florida areas and also recruited participants via
online advertising, summarized in Table 1. Sample sites were provided with study flyers and
were asked to display and/or distribute flyers to potential eligible participants. A study flyer is
included in Appendix A.
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Table 1. Study Recruitment Sources

Clinical sites

Community
support

Tampa
USF Counseling Center
USF Psychological
Services Center
USF Student Health
Services
USF Psychiatry Clinic
DBSA Tampa Bay
MHA Tampa Bay
NAMI Hillsborough

Orlando
UCF Counseling and
Psychological Services
UCF Student Health Services
Aspire Health Partners
18 Clinicians in private practice
Greater Orlando Bipolar Support
MHA Orlando
NAMI Greater Orlando

Internet
WeSearchTogether.org
DBSA.org online listing
DBSA.org online
support group listing
Facebook page and
advertisement

Response and enrollment. The researcher was contacted by 26 potential participants.
Five were excluded due to not meeting study criteria for current age or age of EOBD diagnosis.
Eleven potential participants reported meeting study criteria but did not follow through or
maintain communication with the researcher. Two potential participants were scheduled for
interviews but “no-showed” (confirmed interview but never responded to phone or email contact
attempts at scheduled time).
Eight participants consented and were enrolled in the study between May and December
2016. The sample consisted of 7 females and 1 male between ages 18 – 25 (M = 21.75; SD =
2.31); participants reported receiving EOBD diagnosis between ages 13 and 17 (M = 15.56; SD =
1.50). Table 2 summarizes the sample recruitment.
As part of the iterative process of phenomenological research, the researcher reviewed
interview recordings and transcripts in October 2016. The researcher observed then that content
and description was similar across participant interviews, creating a consistent and detailed
portrait of participants’ experience of EOBD. As a result, the researcher noted that the study
sample was approaching saturation in terms of data as well as size for a phenomenological
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design (Creswell, 2007; Dukes, 1984; Edward, 2005; Smith, 2004). By the end of December
2016, eight participants were enrolled and recruitment concluded.

Table 2. Sample Recruitment
Category
Excluded (Criteria)
Never scheduled
No-Show
Drop-Out
Enrolled
Total

N
5
11
2
0
8
26

Obtaining informed consent. Data collection was facilitated through telephone
interviews. Following initial phone or email contact, the researcher emailed the USF Institutional
Review Board (IRB) Verbal Consent form (see Appendix B) to participants for review. At the
beginning of the scheduled interview telephone call, the researcher reviewed and obtained verbal
informed consent. Participants additionally were asked for permission to audio record interviews;
all participants consented to have their interviews recorded by the researcher.
Ethical Considerations
DiCicco-Bloom and Crabtree (2006) propose four ethical issues pertaining to participant
involvement in qualitative research: a) reducing the risk of unanticipated harm; b) protecting the
participant’s information; c) effectively informing participants about the nature of the study; and
d) reducing the risk of exploitation. These considerations are addressed in the IRB protocol and
are discussed here in brief.
Risk of unanticipated harm to participants. The first ethical issue addresses the risk of
unanticipated harm to participants. The qualitative interviews address the phenomenon of EOBD
as experienced by emerging adults ages 18-25. The phenomenon of EOBD may be a sensitive

43
issue to participants, and while the researcher is a licensed clinician and therapist, it is not
appropriate for the researcher to provide clinical services to study participants. To address this
possibility, participants were provided with information for follow-up care if needed. As part of
obtaining verbal informed consent, the researcher advised each participant that the interview
could be stopped, paused, or discontinued at any time at the participants’ discretion (i.e., due to
emotional distress or discomfort). Per IRB, if any participant displayed indications of significant
emotional distress during or following the interview that necessitate immediate intervention, the
researcher would contact emergency medical services with the physical address provided by the
participant at time of interview. This did not occur, but was designed to address care and safety
of participants throughout data collection.
Protection of participant data and identifying information. The second ethical issue
involves the protection of participant data and identifying information. Audio recordings,
transcripts, and identifying information of participants were stored by the researcher in two
locations: a locked cabinet and a secure storage drive in the researcher’s office. Participants
were informed that referral sites would not be informed of their participation in the study and no
identifying information or data would be released to referral sources.
Nature of the study. The third ethical issue addresses informing participants of the
nature of the study
The researcher obtained verbal informed consent via telephone per IRB policy. Informed
consent addressed the extent and nature of the study. Participants were informed that the purpose
of the study was solely to collect data and that no treatment interventions would be provided. Per
IRB, participants were additionally informed that while the study was considered minimal risk,
the content of interview questions could potentially result in emotional distress. The researcher
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provided participants with information on follow-up mental health care and informed
participants they had the right to withdraw from the study at any time.
To facilitate participants’ understanding of the nature of the study, the researcher sent the
verbal informed consent form, interview questions, a detailed overview of the study, and followup care information to participants via email prior to the telephone interview for their review.
The researcher reviewed each of these documents prior to obtaining informed consent and
proceeding with the research interview.
Participant exploitation. The fourth ethical issue addresses the risk of participant
exploitation. Participants were not exploited for personal gain or for the sake of the study.
Participants were each compensated for their time and participation with a $20 gift card
following completion of the interview.
Data Collection
Qualitative interviews. Phenomenological studies utilize qualitative, semi-structured
interviews to collect data from participants (DiDicco-Bloom & Crabtree, 2006).
Phenomenological interviews contain pre-determined, open-ended questions generated by the
study’s research questions; yet during the interview these questions may be modified in whole or
in part, omitted, or expanded upon according to the participants’ self-report of the experience of
the phenomenon of study (DiCicco-Bloom & Crabtree, 2006; Moustakas, 1994).
The researcher’s flexibility and reflexivity throughout the interview establishes rapport
with the participant and facilitated obtaining the full essence of the participant’s experience.
Table 3 displays the semi-structured interview questions organized by research question and
theory. Appendix C contains the semi-structured interview schedule as delivered during
participant interviews.
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Participant interviews were conducted via telephone, audio recorded, and transcribed by
the researcher. Interviews were 45 – 75 minutes in length. While participants agreed to
participate in a second interview for clarification or expansion of qualitative data if needed, no
second interviews were conducted. No clarification or expansion of data was needed during data
analysis, as participant accounts provided rich description that led to achievement of thematic
saturation. Additionally, participants reported during member checking (discussed further below)
that their individual and composite descriptions were accurate with no missing or incorrect
information, and stated that no additional interviews were needed. Using the steps in
phenomenological data analysis described below, interview transcripts were then analyzed to
construct individual and composite descriptions of the phenomenology of EOBD.
Data Analysis
Analysis of phenomenological data includes the processes of epoche, phenomenological
reduction, and imaginative variation. In contrast to quantitative data analysis, the goal of
phenomenological reduction is the explication of data, rather than explanation of data—the
phenomenon is exposed and described using the participants’ own words, rather than explained
and interpreted by the researcher (Van Kaam, 1969). This study used Moustakas’ (1994)
transcendental modification of the Van Kaam anthropological method of analysis of
phenomenological data (Van Kaam, 1969). Moustakas adapts Van Kaam’s method to
transcendental phenomenology, thus altering the data source from observed behavior to
participant self-report via semi-structured interviews. Table 4 summarizes Moustakas’
modification of Van Kaam’s phenomenological data analysis as applied in this study.
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Table 3. Interview Questions Arranged by Research Question
Variable
Theory
Question
Q1. How do emerging adults (ages 18-25) describe the experience of EOBD during adolescence (ages 13-17)
in terms of experience of symptoms; changes in individual, social, and family functioning caused by course
of illness; and the experience and perception of stigma and self-stigma?
EOBD

Neurobiological

How old were you when you were diagnosed with bipolar
disorder? How old are you now?
What was it like to receive the diagnosis of bipolar disorder?
What did the illness mean to you at that time?
How would you describe your experience of bipolar symptoms
during your teenage years? What were your manic episodes like?
Your depressive episodes?
Did you feel that other people (friends, family, healthcare
providers) understood your experience of bipolar disorder?
Q2. How do emerging adults (ages 18-25) characterize the cumulative influence of interactions with
healthcare systems and treatment interventions on their experience of EOBD?
EOBD
Neurobiological;
Who diagnosed you with bipolar disorder? In what treatment
Modified labeling
setting (inpatient, outpatient)?
theory
What events led up to the diagnosis?
Did you have a psychiatrist? A therapist? What was your
experience with them?
Have you ever been hospitalized due to bipolar disorder? If so,
what was that like?
Were you prescribed medication for bipolar disorder during this
time? How would you describe your experience with medication?
Did you feel that the treatment you received was helpful?
[Whether yes or no:] In what way?
Did your experience of bipolar disorder change during or after
receiving treatment? If so, in what way?
Q3. What are the characteristics of the relationship between EOBD, social and family relationships and the
developmental transition to adulthood according to emerging adults?
Interpersonal
Emerging
After the onset of bipolar symptoms but prior to diagnosis, do you
Support and
Adulthood;
remember whether any changes occurred in relationships with
Relationships;
Modified
your family or with friends during this time?
Transition to
Labeling
After receiving the diagnosis of bipolar disorder, do you
Adulthood
remember any changes occurring in relationships with your
family or friends during this time?
What were your greatest supports during this time? What were
your greatest challenges?
How did these changes affect you as you moved from
adolescence into young adulthood?
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Table 3 (Continued)
Variable
Theory
Question
Q4. How have stigma and self-stigma associated with EOBD affected the social, emotional, and cognitive
development of emerging adults ages 18-25?
Stigma; Social,
Modified labeling;
Did you experience self-stigma, in which you label or judge
emotional, cognitive
Emerging
yourself, during this time? If so, what was that like?
development/identity
Adulthood
Do you feel that any of the changes you experienced in your
support system or related to stigma or sense of self had an effect
on your bipolar disorder and mental health during this time?
Do you feel that your sense of self (sense of identity) changed due
to your experience of bipolar disorder during this time? If so, in
what way?
Did you feel that you understood the changes in your life that
were occurring due to bipolar disorder?

Epoche. Establishing and maintaining epoche allowed the researcher to analyze findings
in terms of participants’ experiences of the phenomenon, rather than the researcher’s
interpretation through preexisting bias. To facilitate epoche, the researcher maintained a
reflexive journal throughout the study; this is discussed further under implementation of
strategies for rigor, below.
Phenomenological reduction. Phenomenological reduction includes the processes of
horizonalization, reduction and elimination, clustering, and validation of themes. These
processes are reviewed in terms of application in this study.
Horizonalization. Horizonalization consists of identifying and listing every relevant
expression of the experience; these expressions or moments of the experience are also referred to
as intentionalities. Intentionalities include both sensory components of the experience (noema)
and the perceptions, emotions, and meaning attached to the experience (noesis).
The researcher read each interview transcript three times to obtain not only an overall
understanding of participants’ experiences, but also to identify and compile written descriptions
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of units of meaning of participants’ descriptions. After reviewing all interviews three times, the
researcher had a compilation of intentionalities, or units of the essences of participants’
experiences.

Table 4. Modification of Van Kaam’s Phenomenological Method of Data Analysis
Step
1) Listing and Preliminary
Grouping (Horizonalization)

Process
List every expression relevant to the experience.

2) Reduction and Elimination

Review descriptions and keep only those that describe a unit of
the essence of the experience (invariant constituents). Merge and
eliminate descriptions as needed to remove overlapping, vague,
and repetitive descriptions.

3) Clustering and Thematizing
the Invariant Constituents

Organize related invariant constituents (codes) into themes and
sub-themes.

4) Final Identification of the
Invariant Constituents and
Themes by Application:
Validation

Review codes, sub-themes, and themes to verify they accurately
represent participants’ collective experiences. Discard any themes
that are not compatible or relevant.

5) Individual Textural
Description

Using codes, sub-themes, and themes, create a description for
each participants’ experience of the phenomenon.

6) Individual Structural
Description

Using codes, sub-themes, and themes, create a description for
each participants’ description of the meaning and associated
thoughts and emotions experienced as part of the phenomenon.

7) Textual-Structural Description

8) Composite Description

Combine the textural and structural descriptions for each
participant to create complete individual descriptions of
participants’ full experience of the phenomenon.
From the individual textural-structural descriptions, develop a
composite description of the meanings and essences of the
experience, representing the group as a whole

Note: Adapted from Phenomenological Research Methods by C. Moustakas, 1994 and Existential
Foundations of Psychology by A. Van Kaam, 1969.
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Reduction and elimination. The researcher then reviewed the compiled list of
intentionalities according to two criteria:
1) Does it contain an essential moment of the experience?
2) If yes, can this intentionality be described abstractly and labeled?
Expressions that did not meet both criteria, that overlapped, were repetitive, or nondescriptive were discarded. The labeled intentionalities that remained represented the invariant
constituents (codes), or elements of the participants’ experiences.
Clustering and thematizing the invariant constituents. The researcher next organized
the invariant constituents into visual clusters according to participants’ descriptions. The
researcher re-read interview transcripts and reviewed the clusters both separately and
comparatively to ensure the notes were grouped in a way that accurately represented the
participants’ experiences. The researcher then created a label for each cluster.
The resulting product was a visual series of seven clusters of invariant constituents:
family, experience of illness, identity, impact of illness, peer relationships, stigma, and
management of illness. The researcher compiled the visual code-mapping into a preliminary
codebook that contained the seven clusters (families) and a total of 115 codes.
Final identification of invariant constituents and validation of themes by application.
The researcher then reviewed transcribed interviews from participants A, E, and H, and coded
each interview with the preliminary codebook. Each code was then reviewed three times against
the following criteria:
1) Is the code expressed equally throughout each individual transcription, as well as
among transcriptions A, E, and H?
2) Are codes explicitly stated and compatible?
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Through this process, the invariant constituents (codes) were validated, or confirmed,
through application to interviews A, E, and H. Codes that were not consistently present
throughout the data, or were not explicitly stated or compatible were removed from the
codebook. The final codebook includes 54 codes and is included as Appendix D.
Imaginative Variation. Through imaginative variation, the data is explicated to expose
the essential structures of the phenomenon and establish the participants’ experience.
Imaginative variation answers the two core phenomenological questions: a) what is the essence
of the experience of the phenomenon; and b) in what context(s) did the experience occur
(Moustakas, 1994)?
The completed output from imaginative variation includes four components: an
individual textural description; an individual structural description; an individual combined
textural-structural description; and a composite description for all participants.
Use of qualitative software in data analysis. The researcher utilized ATLAS.ti software
during steps 4 through 8 illustrated in the phenomenological data analysis process presented in
Table 4. While the initial identification of invariant constituents and codes were developed by
hand, the researcher used ATLAS.ti was used validate codes, code each interview, and
incorporate code reports in synthesis of themes and sub-themes used to create the individual and
composite descriptions. The codebook was revised and finalized through consensus coding and
review of each interview. Following verification of codes, the researcher entered the final
codebook into ATLAS.ti. Using ATLAS.ti, each interview transcript was analyzed and coded
with the final study codebook. Once interviews were coded, the researcher created code reports
that guided the grouping and consolidation of codes into themes and sub-themes. Code reports
were created for individual interviews as well as for the project (Hermeneutic Unit, or HU).
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Individual descriptions. Imaginative variation begins with analysis of the individual
participant’s experiences. Using ATLAS.ti software, the researcher coded participant interviews
and created an individual code report linking each code with the participant’s quotations. From
the code report, the researcher created the individual textural and structural descriptions
incorporating participants’ wording to capture the full essence of participants’ descriptions
Textural description (noema). A textural description was completed for each participant
to describe their experience of EOBD, including onset of symptoms, diagnosis, and course of
illness. In analysis, this emerged as the code family for the experience of the illness itself (i.e.,
symptomatology).
Structural description (noesis). A structural description was completed for each
participant to describe their experience of the impact of EOBD, including perception, thought,
emotion, and coping reactions. Participants described their experience of identity, the healthcare
system, interpersonal relationships, labeling, and mediating factors associated with EOBD during
adolescence.
Textural-structural description. The researcher constructed a merged description for each
participant that included their experience of EOBD, the illness itself, as well as their experience
with the impact and effects of EOBD on their sense of self, relationships, and coping behaviors
during adolescence. The individual textural-descriptions are included in a companion volume to
this manuscript.
Emerging adulthood. While the interviews elicited retrospective data, throughout the
course of the interviews the participants discussed related components of their experience with
bipolar disorder during emerging adulthood. Participants’ accounts of emerging adulthood
yielded distinct and separate invariant constituents and themes as compared to participants’
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accounts of adolescence. As this study’s purpose and research questions address participants’
experiences of EOBD between ages 13 -17, the presentation of findings include only the themes
encompassed by the study research questions that pertain to adolescence. Additionally,
participants’ experiences of bipolar disorder after the age of 17 no longer fit within the scope of
the study, as EOBD is defined as occurring with the ages of 13 – 17. The data on emerging
adulthood is therefore not included in the composite description and phenomenology of EOBD;
however, this data is included in the audit trail and within the individual descriptions for each
participant.
Composite textural-structural description. In the final step of phenomenological
analysis, the researcher creates a combined textural-structural description that incorporates the
invariant constituents and themes of participants’ combined experiences into a composite
description, or explication, of the phenomenon of study. This final step embodies the essence of
the experience of the phenomenon.
Following completion of the individual textural-structural descriptions, the researcher
constructed the composite textural-structural description. Using the process outlined above, the
researcher used ATLAS.ti to synthesize codes into sub-themes and themes that represented
participants’ complete experience of EOBD. The composite textural-structural description is
presented in Chapter 4.
Strategies to Maximize Rigor
This section reviews strategies to maximize trustworthiness and enhance the rigor and
validity of the study. Reflexivity of the researcher, member checking, peer examination, audit
trail, and thick description are discussed with applications for this study.

53
Reflexivity of the researcher. Strategies for enhancing rigor must be built into the study
design, rather than solely during post-hoc evaluation (Morse et al., 2002). Similar to construct
validity in quantitative research, reflexivity refers to the researcher’s attitude and mindfulness
regarding how his or her preconceptions affect the research (Thomas & Magilvy, 2011).
Reflexivity of the researcher affects the methodological coherence of a study. Considerations of
sampling strategies and composition, data collection and saturation, and data analysis must be
congruent to the research questions and methodology. These considerations are established
during study design but are confirmed and modified throughout the execution of the study
through the reflexivity of the researcher (Morse et al., 2002).
In this study, reflexivity of the researcher was employed through continuous iteration—
implementation, reflection, and evaluation of the phenomenological research design—throughout
data collection and analysis. The researcher’s reflexivity facilitated maintaining mindfulness and
adherence with study measures designed to maximize trustworthiness, such as reflexive journal,
audit trail, consensus coding, and member checking.
Reflexive Journal. Through the study, the researcher used a reflexive journal to record,
express, and ventilate not only preexisting bias but also the researcher’s reactions and responses
to participant data during data collection and analysis. The journal was used in a raw and honest
matter; entries chronicle the researcher’s reflexivity and iteration in designing and implementing
the study, responses to planned and unanticipated events, and the researcher’s candid and
sometimes emotional reactions to participant data; as a result, the researcher maintained the
ability to remain ‘in the moment’ with minimal bias.
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Peer review and reliability. To ensure dependability and reliability, the researcher
utilized two qualitative approaches: consensus coding (interrater reliability) and stability
reliability. Table 5 summarizes reliability in coding of participant interviews.

Table 5. Summary of Reliability in Interview Coding
Interview
Agreements
Participant A
76
Participant B
60
Participant C
98
Participant D
40
Participant E
68
Participant F
50
Participant G
49
Participant H
68
Total Consensus
509
Stability reliability consensus (A, B, C, E) = .865
Interrater reliability consensus (D, F, G, H) = .8625

Disagreements
5
11
16
8
15
10
6
9
80

Consensus
.938
.845
.860
.833
.819
.833
.907
.883
.864

Consensus coding. Four of the eight transcribed interviews (D, F, G, H) were coded and
compared through consensus coding with a peer reviewer. Two peer reviewers assisted in this
study: a classmate provided consensus coding for the first interview with the initial codebook,
which included identification and validation of codes by application. The second peer reviewer
was the researcher’s major professor, who also provided consensus coding and validation of
codes by application for four interviews.
Reliability coefficient. To establish dependability and reliability of data analysis, an
interrater reliability ratio of .70 was used for each of the four interviews in consensus coding
(Hays & Singh, 2012).
Stability reliability. To maximize dependability of individual coding, the researcher
independently coded interviews A, B, C, and E; and recoded the interviews two days later. As
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with comparison coding, the researcher compared both codings for each interview and created a
merged consensus coding using the same interrater reliability ratio of .70. The same codebook
was used to code all eight interviews.
Peer examination. An external review can enhance the study’s credibility (Creswell &
Miller, 2000). Collaboration between the external reviewer and the researcher occurring
throughout the study can produce an exchange of feedback, criticism, and examination of study
method and processes. To maximize credibility, the researcher maintained communication and
collaboration with her major professor throughout design, implementation, and review of the
study. The major professor provided feedback on implementation of study methods, with
suggestions for improvement and review.
Audit trail. The researcher maintained an audit trail throughout the study, beginning with
the dissertation proposal defense in 2014. The audit trail is presented as a companion volume to
this manuscript and includes the following components: a) an explicit statement of purpose; b)
rationale for sampling strategy and selection; c) detailed descriptions of the process of data
collection and length of time required; d) thorough explanation of data analysis, including
thematic reduction; e) discussion of the interpretation and presentation of findings; and f)
verification strategies to establish credibility of study conclusions (Thomas & Magilvy, 2011).
The audit trail allows for external review and feedback to confirm that study findings are
grounded in data, inferences are logical, methodology is justifiable and appropriate, extent of
researcher bias, and use of verification strategies were used to enhance rigor and credibility
(Creswell & Miller, 2000).
Thick description. Rich descriptions of the setting, participants, and themes further
establish the credibility of the study (Creswell & Miller, 2000). Thick descriptions allow the
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reader to feel the experience of the phenomenon being investigated. In contrast with descriptions
simply reporting facts or conclusions, thick descriptions employ a constructivist perspective and
provide as much detail as possible regarding interaction with participants, participants’ language
and perhaps body language, and examples of interaction and experience with the participants. In
this study, thick description consisted of direct quotations and wording of participants to describe
their experiences of living with EOBD.
Member checking. Member checking is the most crucial technique for establishing
credibility (Lincoln & Guba, 1985). Study participants present as a lens through which to
establish study validity (Creswell & Miller, 2000). From the constructivist perspective,
participants’ self-report is reality. Therefore, verifying the accuracy of the study’s representation
of participant data is essential to establishing the rigor of the study. Through member checking,
participants review both data and interpretation (data analysis) for confirmation and verification.
After completing participants’ individual textural-structural descriptions, the researcher
contacted the eight participants to request engagement in member checking. Four participants
replied that they would participate, while one participant replied that she did not wish to
participate and entrusted the researcher with the analysis. Three participants did not reply to
multiple series of communication from the researcher.
The four participants who agreed (A, B, F and H) to participate in member checking were
sent their individual textural-structural descriptions and a summary of themes from the
composite description. Participants were asked to address a) if themes and study conclusions in
both their individual and composite descriptions were accurate; b) whether any elements of their
missing were inaccurate or needed adjustment; c) whether any elements of their experience were
missing and needed to be included; and d) to provide any additional information or feedback on
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their descriptions. Participants A, B, F and H each replied that they found the individual and
composite descriptions to be accurate, but did not offer any additional comments or request a
second interview. Appendix E includes a summary of the themes sent to participants for member
checking of composite description.
In summary, four of eight participants (50%) participants responded to member checking
and verified their individual description as accurate, while 4 of 8 participants (50%) responded
and verified the composite description as accurate.
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Chapter 4: Findings
The purpose of the present qualitative study is to explore the experience of EOBD
through semi-structured interviews of emerging adults with a history of EOBD diagnosis. Data
analysis yielded a construction of participants’ experience of EOBD as an interconnected web of
five main themes and fifteen sub-themes that characterized participants’ experience of EOBD.
When describing themes and sub-themes, participants consistently depicted themes as
experienced in relation to or in conjunction with other themes. Figure 1 displays the
interconnectivity of participant themes.

Figure 1. Thematic Illustration of the Phenomenology of EOBD

Study findings are therefore presented in two sections. First, the composite texturalstructural description of participants’ experiences is presented in relation to the purpose of the
study. Table 6 presents the five themes and sub-themes that comprise the composite textural-
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structural description. Second, themes and sub-themes are discussed according to study research
questions. Table 7 displays the themes and sub-themes characterizing participants’ experience of
EOBD as organized by research question.
Composite Textural-Structural Description of the Phenomenology of EOBD
Participants described their experience of EOBD across five main themes: managing and
coping with EOBD, effect on relationships, change and uncertainty, impact on identity, and
experience of stigma and labeling. Each theme and its associated subthemes are presented below.

Table 6. Summary of Themes and Sub-Themes
Managing &
Coping with
EOBD

Effect on
Relationships

Experience of
Illness

Seeking and
receiving support

Treatment and
engagement with
healthcare system
Perceptions of
healthcare and
treatment
Knowledge and
understanding of
illness

Difficulty
maintaining social
functioning

Change and
Uncertainty
Change in illness

Change in identity
and sense of self
Change in
relationships

Impact on Identity
Adaptation &
integration
Emotional
adjustment
Secrecy & selective
disclosure of illness

Experience of
Stigma &
Labeling
Labeling

Self-labeling
Challenging and
rejecting
labeling

Life changes

Use of coping skills

Managing and Coping with EOBD
Participants described their efforts to manage and cope with EOBD symptoms and course
of illness. Sub-themes include participants’ experience of illness, perceptions of healthcare and
treatment, treatment and engagement with the healthcare system, knowledge and understanding
of illness, and use of coping skills.
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Experience of Illness. Participants described their experience of EOBD as characterized
by manic and depressive symptoms, changes in illness, and comorbid symptoms such as anxiety
and self-injury. Participants’ age at the time of EOBD diagnosis varied from 13 to 17 years old
(M = 15.56, SD = 1.50). Participants reported age at onset of EOBD symptoms between 7 and 17
years old (M = 12.88, SD = 2.66). Three participants reported polarity at onset of symptoms as
manic, while four reported polarity at onset of symptoms as depressive. Participants’ experiences
of EOBD symptomatology and course of illness are explored here.
Manic and hypomanic symptoms. Three participants described the polarity of their first
episode as manic, and all eight participants described experiencing manic or hypomanic
symptoms during adolescence. Participants described their experience of mania in terms of
increased energy and productivity, impulsivity, decrease in rational decision-making, increase in
risky behavior, increased social activity, increased energy and hyperactivity, racing thoughts,
decreased sleep, euphoria and elation, agitation and aggression, delusional thoughts, grandiosity,
and hallucinations.
Participant H described his first manic episode:
…and I would say my manic episode probably started sometime right
around when high school started, like the beginning of the year. But it was
definitely a lot of classic symptoms of bipolar mania[pause] it was like
delusional thoughts, hard to relate to people in social situations, grandeur
thoughts, grandiosity [pause] towards the end was I was being
hospitalized there were some hallucinations going on [pause] just kind of
out of touch, having that out of touch feeling…feeling like you’re on top of
the world, you can get anything done [pause] just having really elated
thoughts, elated emotions that were blown out of proportion. And just like
overly emotional in situations, like no control over.
Participant D similarly described her experience with mania:
When I was younger it would kind of be like I would study nonstop, I
would read everything, I would do, like, everyone’s homework…I would
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do so much. I would literally be running up and down my hallway, like
screaming and studying, and I would get so hyper. Then, like a lot of
racing thoughts that I would get just kind of made me a good student and
at the time there was [sic] no depressive symptoms so everyone just told
me that I was smart and hyper. And so I thought it was normal. But it
wasn’t really that normal. I had a bit of a hard time sleeping. I would just
do a little too much than most normal people would…
Two participants reported experiencing dysphoric symptoms, including agitation and
aggression. Participant G described her manic symptoms in this manner:
I would get aggressive with my parents. They would even have to call the
police sometimes, and they would have me take a walk and get me to calm
down because it would go on for hours at a time. Aggravation, a lot of
yelling and arguing.
Depressive symptoms. Five participants described their first episode as
depressive, and all eight participants described experiencing symptoms of depression
during adolescence. Participants characterized depression as low mood, sadness, social
isolation, decreased focus and clarity of thought, decreased motivation, decreased ability
to do things, crying, and spending a great deal of time in bed.
Participant C described feeling “numb” and “defeated,” and elaborated further:
And I knew it was depression, but either way [pause] I was lack of myself.
I was lack of life. I was basically black and white. Everything was just
nothing.
Participant B described her experience with depression:
When I was depressed I remember laying in bed for months just watching
TV, just showering was hard, anything like that. I played thoughts in my
head over and over, like I wasn’t good enough, like no one cared about
me, and just stuff like that. I would cry a lot, so sometimes I would fall
asleep crying and wake up crying.
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Participant H described experiencing significant changes in cognition and social
impairment:
And my depressive symptoms [pause] I’ve never been [pause] I’ve not
usually been suicidal. I’ve never attempted suicide. But just really low
motivation, low social desire, low desire to get out or do anything, low
drive to accomplish anything, your thoughts are a little cloudier, and your
cognitive function I think is affected slightly since you just are not
interested in anything. You’re not really—your brain doesn’t really get
going. It doesn’t really get your gears going about anything…[it] renders
me not wanting to do anything for anywhere of period of a few weeks to a
few months.
Comorbid symptoms. Seven of the eight participants described experiencing symptoms
or diagnoses of other mental health conditions, including anxiety, self-injury, eating disorders,
and substance abuse. Only one participant described experiencing exclusively manic and
depressive symptoms throughout adolescence.
Six participants described experiencing symptoms of anxiety, including excessive worry,
panic and panic attacks, and ritualistic behavior to alleviate anxiety. Participants described
anxiety as emerging from other stressors, as well as stressors associated with EOBD itself.
Participants D and F described experiencing anxiety as a result of the illness and stressors
associated with seeking treatment. Participant G described being treated for anxiety prior to
EOBD diagnosis.
Participant C described her experience of having a panic attack:
I do get a lot of anxiety episodes, and a lot of them are really random. No
reason to happen. But I could be driving to Home Depot and next thing
you know I’m having a full-blown panic attack and I’m having to pull off
the side of the road.
Three participants described engaging in self-injury during adolescence concurrent to
bipolar symptomatology. For participants, self-injury was consistently described while
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discussing anxiety, interpersonal stressors, and lack of control over situations or bipolar
symptomatology. Methods of self-injury included cutting, burning, and hitting oneself.
Participant B described self-injury as a component of her experience of depressive
symptoms:
I would kind of like make decisions, like just to stay in my room, and I
don’t know, like hit things and stuff. But then I also cut myself and would
burn myself. Stuff like that. I hit myself sometimes.
Participant D described self-injury as related to depression and suicidality:
I think that I was 13 turning 14 or something like that, and I basically
started cutting myself when I was 11 [pause] so it progressed over the
years and when I was 13 turning 14 I was cutting a lot more and I cut
very, very deeply so I had to go to [pause] I was feeling suicidal and I
wanted to practice cutting myself so that I could commit suicide. I don’t
know what I was thinking. I was young. Um, anyways. So during this
episode of cutting I had slit my wrists too deep and my brother saw it, so
they took me to the hospital.
Two participants described being diagnosed with attention-deficit disorder. Participant H
described ADHD as an additional challenge during adolescence:
I was getting tested because I thought I had ADHD. And I eventually got
diagnosed and medicated for ADHD, and it felt like the right thing to do
because I was really struggling to focus on my schoolwork, but I only
stayed on medication for about 3 years [pause] just getting on the meds
itself was a challenge. And dealing with a dual diagnosis, another
diagnosis, ADHD, in addition to bipolar disorder…
One participant described comorbid substance use during adolescence. Participant E
described marijuana and alcohol use that coincided with onset of her first manic episode.
Participant E described her substance use as a trigger that obscured the onset of symptoms.
I started smoking and drinking, and then after that it was just like… you
know sometimes with drugs it makes things more uh [pause] amplified I
guess. Like they really bring out the symptoms. And when I was at school,
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I would smoke a lot and I would drink a lot. And I remember one night I
started hallucinating, and I was like ‘yo, like I’m seein’ shit’—excuse my
language. I curse a lot—‘I’m seein’ shit, like what is going on?’ And my
roommates were looking at me like, ‘what? Like, are you that high?’ At
first it was cool that I was smoking, that I could put everything on a drug
and just be like ‘oh I was high. That’s some strong weed!’ and people
obviously didn’t really know that I was like having a breakdown.
Participants B and C described having an eating disorder during adolescence. Participant
C stated her eating disorder began following a significant reduction in appetite due to ADHD
medication, while Participant B described her eating disorder as associated with self-esteem,
self-judgment, and self-labeling.
Suicidality. Two participants reported experiencing suicidal ideation with suicide
attempt.
Participant D described her suicidal thought processes:
…at the time I felt like, ‘oh well I should [commit suicide] [pause] if this is
who I am, like, I should just kill myself.’ I was like, if I’m sick why am I
going through this, or whatever [pause] and for some reason I didn’t
[commit suicide]. I don’t know why.
Participant C described feeling defeated as a part of depression, and associated defeat
with suicidal ideation:
And I always kind of knew I was kind of defeated and I wanted to defeat
myself, I wanted to hurt myself, I wanted to end my life. I did several
suicide attempts to try to do that. And all the suicide attempts that I have
done have failed.
Two participants described suicide attempt in addition to ideation. Participant C
recounted her experience with a failed suicide attempt:
And I actually attempted suicide. I had a belt that I was trying to hang
myself with, but it broke. And it took a lot for me to build up to do that,
and when it failed I didn’t really have—I couldn’t build myself up to do it
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again. I guess I was just scared of what would happen. I wasn’t scared of
dying, I was just more scared of what would happen after I went. You
know, what would my parents say about me?
Treatment and engagement with healthcare and treatment. As part of symptom
management and treatment for EOBD, participants described their experiences with the
healthcare system. All participants described accessing healthcare at varying levels of acuity
ranging from psychiatric hospitalization to outpatient treatment. Participants described subthemes that included their perceptions of healthcare, as well as ease or difficulty of access to
services.
Accessibility of healthcare. All participants described utilization of healthcare services
throughout adolescence. All participants described seeing a psychiatrist and taking psychotropic
medication following receipt of EOBD diagnosis, while five participants described additionally
seeing a therapist. Five participants reported history of psychiatric hospitalization due to bipolar
disorder. Two participants were diagnosed in hospital settings, while six were diagnosed in an
outpatient setting by a psychiatrist or therapist. Two participants described initially accessing
healthcare and treatment involuntarily through law enforcement, while six participants described
voluntarily seeking treatment. Accessing healthcare did not necessarily coincide with onset of
symptoms or receipt of EOBD diagnosis. While four participants described receiving EOBD
diagnosis and treatment upon first accessing healthcare, the other four participants described
initially seeking and receiving treatment and non-EOBD diagnosis such as depression or anxiety.
Participant H described entering the healthcare system through hospitalization during his
first manic episode after a prolonged experience of untreated symptoms:
So at 14 when I first got diagnosed, that was probably the worst manic
episode I’ve ever had. And it was the first time I ever experienced the
symptoms of my bipolar disorder. And it was probably as bad as it was
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because I was unmedicated. My parents never thought about treating me
for a mental illness or going to see a psychiatrist for any of my issues that
I had…and I would say my manic episode probably started sometime right
around when high school started, like the beginning of the year. And it
only took me 6 to 8 weeks into high school to have full-blown manic
feelings and to have my mom realize ‘okay, you need to go to the hospital.’
All participants described continuing healthcare and treatment for EOBD in some form
throughout adolescence. Six participants described maintaining continuous psychiatric care and
psychotropic medications, while two participants described receiving only psychiatric care, one
participant described receiving only therapeutic care, and two participants described inconsistent
compliance with treatment of any kind. Participants ascribed their decisions to maintain
engagement in healthcare as related to their perceptions of treatment, discussed further.
Psychotropic medication. Psychotropic medication was a core component of all eight
participants’ treatment for EOBD, and was described as profoundly impacting their experience
of EOBD throughout adolescence. All participants reported taking medication throughout
adolescence. Five participants described an improvement in symptoms with medication and
maintained compliance with psychiatric treatment, while two participants reported that
medications at times appeared to exacerbate symptoms and reported intermittently discontinuing
medication as a result. One participant described resistance to psychotropic medication
throughout adolescence and stated she did not begin taking medication until age 19.
All participants described having multiple healthcare providers during adolescence and
taking several medications before finding a medication that worked with tolerable side effects.
Of the seven participants who were prescribed psychotropic medication during adolescence, all
identified medication side effects as a significant challenge.
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Participant H described experiencing significant side effects from medication that
included sedation, cognitive dulling, and weight gain, and described being “like a zombie.”
Over the course of my adolescence I probably gained 75 pounds or
something, and some of it might be due just to growing—I mean not
growing height-wise, but just growing, everything filling in—some of it
was definitely due to the medication and weight gain. And then from 18 to
23, with the different medications I’ve been on, I’ve gained an additional
100 pounds. And I’m not even that fat of a person, I’m like 6’ 3” and
weigh 270 right now. But the fact that being on medications caused me to
gain almost 200 pounds in the course of my lifetime is just crazy.
All seven participants who reported taking medication during adolescence described
being prescribed stronger medication during and immediately following symptomatic episodes,
with adjustments in medication strength occurring as symptoms stabilized.
Participants C and G described reported mixed benefit from medication and stated at
times their symptoms appeared to worsen with medication. Participant G described experiencing
increased agitation, suicidality, and sedation due to medication, while Participant C described
experiencing cognitive changes:

I had a very terrible effect with that medication. I was driving to work and
I felt like I was detached—I felt like I was a puppet on strings and it just
felt like when I stood up or did anything, it just felt like the strings got cut.
So it really felt like I just couldn’t move myself. Someone just took—it felt
like they just took my soul away. It really just—all of me they just kind of
removed. All my personality they just removed. And I only took it once, a
very low dose too…Either way, I was driving and I had a bad reaction to
it and I almost got into a car accident. It just wasn’t a good medication.

Participant H described medication as beneficial, but also addressed the challenge of
medication for differing manic and depressive episodic states. Participant H described the
desired outcome of balance and remission of symptoms as difficult to attain.
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And it [EOBD] sometimes can get helped with the medication, but
sometimes the medication can only help so much without them wanting to
induce a manic episode. So I think that’s the toughest part of bipolar
disorder—you need to stay in the middle and that’s not how medications
work all the time.

While participants described the challenges associated with psychotropic medication,
they also acknowledged its benefits. Six of the seven participants who were prescribed
medication in adolescence described psychotropic medication as the catalyst for their
symptomatic improvement. Participant A described medication as effective and the key factor to
her stability:
I don’t know if I would be able to effectively handle it if I had just had
counseling. I just know that since I started taking the medication my life
has improved immensely. And there has not been a point where I have
gone off my medication and had issues. So I think that is—that has to be
what is helping.
Participant B described both the benefit and uncertainty associated with psychotropic
medication:
You know, I think medicine has helped me so much. I really do think it’s
helped save my life. And it’s still really difficult. It’s really hard when the
medicine stops working and you have to try a new one. You don’t know
what it will do. And the side effects [pause] it’s really difficult. But I want
to do everything I can to help myself, so I think medicine is a good thing.

Psychoeducation. Participants described psychoeducation as helpful in understanding
EOBD and their experience of symptoms during adolescence. Participants described obtaining
psychoeducation from providers as well as through their own self-education. Participants
described psychoeducation being provided to family members as well.
Participant G described psychoeducation she received at time of diagnosis:
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They said it was a mood disorder mostly. Nothing to do with physical or
real bad mental issues, but they said I would need to take medicine for it,
come back for treatment, and basically get it in check to see if everything
was okay.
Participant H described receiving psychoeducation from providers, but stated his own
research and self-education were beneficial in understanding EOBD:
I still think that [psychoeducation from providers] got me halfway there.
And the other halfway was me reading online about bipolar disorder and
learning about it myself.
While participants described the value of psychoeducation, they did not describe a
change in stigma, acceptance of denial of illness, or interpersonal relationships concurrent to
psychoeducation. Additionally, knowledge and understanding of illness was described as
separate and unrelated to provision or receipt of psychoeducation. Psychoeducation, therefore,
emerged as the transmission of information rather than the absorption, incorporation, or
understanding of the information.
Perceptions of healthcare and treatment. Participants described their perception of
healthcare and treatment for EOBD as both beneficial and non-beneficial. Participants
additionally described the healthcare system as potentially difficult to navigate. Participants also
expressed avoidance and ambivalence toward healthcare and treatment for EOBD.
Healthcare is beneficial. All participants described healthcare and treatment for EOBD
as beneficial. Psychotropic medication and psychotherapy were identified as particularly
beneficial to participants.
Participants who described psychotherapy as beneficial identified validation,
psychoeducation and normalization of their experience, unconditional regard from healthcare
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providers, and ability for self-expression were as specific components of their experience that
were beneficial.
Participant G additionally described her therapist as beneficial due to validation, selfexpression, and gaining an understanding of her experience:
And my therapist, talking to them [therapist] actually helped me out a lot,
being able to get stuff off my chest that I wasn’t able to with my own
family. But being able to talk the situation out with somebody else that
actually had somewhat of an understanding of what I was feeling made the
situation a lot better.
Participant B described therapy as beneficial because it “served as an escape” from
stressors and symptoms. Participant B also described therapy as beneficial when it was
individualized and incorporated her use of art as a coping skill.
Participants also described the combined treatment approach of psychiatric care and
psychotropic medication as beneficial. Participant A described seeing several therapists during
adolescence, but stated it was upon seeing a psychiatrist and beginning medication that EOBD
symptoms began to improve, while Participant E described healthcare and treatment as beneficial
in helping “taming” the illness and stabilizing symptoms.
Participant F described her experience with therapy and medication as an influential part
of her adolescent experience:
Yeah looking back—well the therapy that I had when I was a teenager was
so important. And she was a really good therapist and helped me through.
But yeah, the psychiatry too, because I wouldn’t have had my medication
corrected with the mood stabilizer and would probably be a very different
person or in a very different place if I hadn’t been put on it.
Healthcare is not beneficial. Six participants described aspects of their experiences with
psychotherapy, medication, and hospitalization as not beneficial. Participants identified lack of
knowledge and understanding of illness as the factor that determined whether healthcare and
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treatment were beneficial. Lack of knowledge and understanding of illness emerged as the most
common code across all participants and is discussed further below.
Several participants described therapy as non-beneficial due to lack of rapport and
therapist understanding of their experience. When asked about whether her experience with
therapy was beneficial, Participant D replied:
The therapy no because…the therapy, especially no, because she would
just scribble things in her notebook and ask one question, sit there ten
minutes in silence. So therapy, no.
Participant H described experiencing therapists’ lack of knowledge and understanding:
In understanding what I was going through and also, as a therapist it’s
your responsibility to help people get through what issues they need to
work on, and I just don’t feel like they were able to provide that especially
in the context of having bipolar disorder.
Participants described psychiatric hospitalization as a negative experience with limited
benefit. Overall, hospitalization was described in terms of lack of understanding by staff and
providers, as well as lack of control over admission, discharge, and treatment. Participant D
described her experience with psychiatric hospitalization in terms of lack of knowledge and
understanding by hospital staff and providers:
So they don’t know [pause] there’s different levels of illness I want to say
in the hospital setting, or mental health setting, medical setting…so it’s
like, they stick us all—these different levels. And it’s like this one person
might be very hostile…I mean, in the hospital this girl was throwing a
chair at me, and like threatening to kill me, and they didn’t know what to
do about it. And I told them—before it even happened—this girl is
harassing me, I know it’s going to get worse; can you do something? They
would just tell me that I’m being paranoid, that with my disorder making
me think things that aren’t true. And, so just like…I don’t know. There’s a
lot of things. It’s like the fact that they think you should just do whatever
because you have a disorder and not take care of you. It’s negligence. And
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the setting itself is just [pause] a lot of things about it. I don’t even know
how to get into it, so I’m just going to leave it there.
Avoidance of healthcare. Several participants described avoidance of psychiatric
treatment and psychotropic medication during adolescence. Participant F described seeing a
therapist while declining medication until she noticed EOBD symptoms were not improving.
Participant A described beginning therapy in eighth grade, but stated she did not see a
psychiatrist or begin medication until age 17; at which point she was diagnosed with EOBD
when symptoms had not improved.
Participant B stated that while she received multiple EOBD diagnoses by psychiatrists at
age 16, she refused to return for psychiatric treatment and medication until age 19. Participant B
described her decision in terms of avoidance to preserve autonomy and self-sufficiency:
I just wanted to be able to do it by myself instead of having something to
help me. Because I didn’t like taking them [medications] every day and
like, I just didn’t like being on meds. I don’t know why I was really so
against it as a teenager.
Participants C and G described self-discontinuing a medication regimen for several years
due to negative experiences with medication effects and side effects. Participants D, E, and H
also described efforts to prevent and avoid psychiatric hospitalization following negative
experiences.
Difficulty navigating the healthcare system. Three participants described difficulty
accessing healthcare due to issues with insurance or ability to afford services, finding available
providers, getting medication on time, and coordinating between providers. Participant G
described difficulty finding providers due to insurance, and stated she continued to see
ineffective providers for years due to lack of alternate options:
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At times it was hard to find a provider, be able to get different help,
because a lot of the providers didn’t accept the insurance that I was
getting, and they wouldn’t accept it for therapists and psychiatrists. So it
was a lot of moments where I felt like I was not able to get help for myself,
but I went back to the same provider for those 4 years because I wasn’t
able to get the help that I needed at the time.
Participant F described difficulty coordinating between providers, specifically between
psychiatrists and pharmacies to ensure they received psychotropic medication regularly. This
participant also described incidents of having to forego medication temporarily due to difficulty
navigating coordination between providers:
Ambivalence toward healthcare. One participant described ambivalence and uncertainty
regarding treatment interventions and providers associated with lack of trust and loss of
autonomy. Participant H described his ambivalence toward healthcare providers:
Like, they’re [healthcare providers] the people you’re supposed to trust,
and they’re the people you rely on for your medication. Like if I went off
my medication I would go bipolar again. And I can’t have that. And so it’s
really hard…you’re put in a really tough spot where it’s like you’re forced
to trust them, they have no—like, you have no cards in your hand and the
cards are all in their hand.
Knowledge and understanding of illness. Knowledge and understanding of
EOBD, as well as lack of knowledge and understanding of EOBD also emerged as core
components of participants’ experiences. While six participants described knowledge and
understanding of EOBD as part of their experience, lack of knowledge and understanding
of illness was endorsed by all eight participants and was the most common invariant
constituent throughout all interviews. Participants described not only their own lack of
knowledge and understanding, but that of their families, peers, and healthcare providers.
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Lack of knowledge and understanding of illness. Participants described
experiencing confusion and lack of understanding of emerging symptoms. Participants
described having a limited understanding of EOBD at the time of diagnosis.
Participant D described her own confusion and lack of understanding of EOBD
symptoms:
It’s still hard because my brain isn’t even fully developed yet, nor was it
when I was at that age. With my emotions and everything, it was like
really hard. I didn’t understand any of it. Like, when I was younger I
literally didn’t understand what was going on, why I couldn’t focus or why
I was having strange thoughts that I couldn’t really explain. And it just
kind of felt like [pause] I don’t know. It was confusing.
Participants described their families’ lack of knowledge and understanding of EOBD
throughout adolescence. While some family members lacked understanding of specific
components of EOBD, others viewed EOBD as an ‘excuse’ for unstable and symptomatic
behavior. Participants A and F described their parents as understanding components of EOBD,
specifically depression, without understanding the full scope and nature of EOBD and need for
psychiatric treatment.
Participant F stated her parents did not fully understand bipolar disorder
symptomatology:
…they just don’t always seem to get what’s happening because—or they
see it still as depression rather than bipolar. Because they don’t really
understand the manic part of it, and that my mom has had bouts of
depression in her life, so they don’t really understand the manic part of it
at all.
Participants C and G described their families’ lack of understanding of EOBD and stated
their families viewed the illness as attempts to justify behavior disturbances. Participant C
described her mother’s lack of knowledge and understanding:
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My mom basically had to deal with me and all my appointments and my
bipolar symptoms. She was there to, like, see it all, but yet she didn’t
understand. So she would come home and get upset, why didn’t you do the
dishes, why didn’t you do this, why didn’t you do that. Like, it’s almost
kind of like every parent says that. So this would go on for weeks. I
wouldn’t get out of bed. She didn’t really understand it.
Participant A attributed her family’s lack of understanding in part to the difficulty
distinguishing between normative adolescent mood swings and EOBD symptomatology:
I think that people generally expect teenagers to be super moody and
fluctuate in terms of how they feel all the time, and so I think that being a
teenager with bipolar disorder is extremely hard because you have to
communicate that what you’re feeling is not within the normal range.
When people expect that kind of depressive symptoms. And I think that
was the hardest thing with my family, with trying to convince my mom that
she was wrong to think that what I was experiencing was normal. So I
think that’s the biggest challenge. Because once you get older, I think if
you have symptoms of bipolar disorder people generally tend to think that
they are abnormal and you get help faster but as a teenager they’re
introducing so many things that people can’t look into how difficult it is
for you in comparison to others.

Knowledge and understanding of illness. Participants described attaining their
own understanding of the illness and discussed the knowledge and understanding of
illness of their support system as well as healthcare providers. All participants described
knowledge as part of receiving the EOBD diagnosis and attaining an understanding of the
symptoms, course of illness, and treatment implications for EOBD. Seven participants
described receiving the EOBD diagnosis as a confirmation of the problematic symptoms
they had been experiencing.
Participant D described her reaction to receiving the EOBD diagnosis:
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…but it did also provide me some sort of feeling of understanding of what
I was going through, like the sixth sense. Like there’s a pattern here, you
know?
Participant F described gaining an understanding of her experience:
…because I’m a really upbeat person, so depression never seemed right.
Because I would have manic episodes and not really get how that fit into
it, so having the diagnosis of bipolar just made so much more sense as to
what was going on with me personally.
Denial of illness. While participants described knowledge and lack of knowledge
and understanding of illness, six participants additionally described experiencing denial
of illness, in which the knowledge and understanding of EOBD was present but
simultaneously refuted. Participants described their own denial as well as that of their
support systems. Participants described difficulty accepting EOBD diagnosis as
influencing engagement in treatment and interpersonal relationships; as well as related to
participants’ sense of self.
Participant H described EOBD diagnosis as difficult to accept. Participant B described
being “in denial a little bit,” getting three EOBD diagnoses by multiple providers (the initial
diagnosis as well as a second and third opinion), and avoiding seeing a psychiatrist or taking
medication for several years.
Participant E described experiencing denial during onset of symptoms and for several
years following diagnosis. Participant E described compliance with treatment out of fear of
relapse, but stated she continued to hope the diagnosis was wrong:
…it’s like yes, I understood it but I was in denial for I would say…I was in
denial for about 4 years or so. So I knew it, like I would go to a
psychiatrist and get medicine and stuff like that. But I was still kind of
hoping that, in the back of my mind I was always hoping that I really
wasn’t bipolar and really it was just like the drugs that were doing
something.
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Five participants described their family’s denial of illness and need for treatment.
Participants described others’ denial of illness as unaffected by interactions with healthcare
providers and psychoeducation.
Participant A described recognizing and accepting EOBD symptoms; however, described
her mother’s denial:
And my mom was also very adamant about the fact that she didn’t want to
have a child with mental illness, and thought that it would reflect on her
as a parent if I did, and so she was also very invested in making sure that
she mitigated my symptoms and basically just dismissed them.
Participant E described denial of illness within community and cultural context that
shaped her experience of EOBD:
I want to say I’m African-American, first of all. A black woman. So I think
mental illness especially in the black community is—how do I say this—
it’s something that black people, like, deny. Because black people for so
long have always tried to be so strong and, you know, it’s just something
that…for example, one of my friends was depressed and her father was
like ‘only white people get depressed.’ You know, get over it, toughen up
and keep going.
Use of coping skills. In addition to treatment interventions, five participants described
their own coping efforts and use of coping skills to alleviate symptoms and stressors.
Participant G described writing poetry, listening to music, and talking to others as helpful
with agitation, anxiety, and depression. Participant B described art as both helpful and
therapeutic.
Participant E described reading success stories of others with mental illness as inspiration
and a source of strength.
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I would read stuff about people who were bipolar. Or I would look at
celebrities or other people that were famous and living their life
wonderfully, that were bipolar. Like, I forgot…what’s his name? Robert
Downey, Jr or something? That guy, Iron Man. He has mental disorders.
And I know there’s some other woman that’s, like, gorgeous that has
bipolar disorder. So that’s basically what I did, is I didn’t let it get me
down. Obviously I propelled my life into something else.
Effect on relationships
A second theme of participants’ experience of EOBD was the changes that
occurred in interpersonal relationships. Participants described their efforts navigating
normative adolescent changes in peer and family relationships as well as the added
element of changes prompted by the presence and course of EOBD illness, stigma, and
engagement with the healthcare system.
Difficulty maintaining social functioning. Participants described difficulty
maintaining peer and family relationships due to decline in social functioning, isolation,
and conflict. While participants noted change as a normative part of adolescence, the
difficulties noted below were attributed specifically to the impact of EOBD.
Family relationships. All participants described change and conflict in family
relationships, ranging from lack of understanding to fighting and aggression. Participant
G described experiencing frequent family conflict she associated with EOBD, including
yelling, arguing, and fighting with family members’ and identified rebuilding family
relationships as her greater challenge during adolescence
Participant E described an intense argument with her sister that occurred when living
with her sister following diagnosis:
I lived with her [sister] when I transferred back and went to a different
school. And one time she and I had an argument. She got really pissed off.
I don’t remember what we’d argued about. And she told me—she’s like,
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‘you know what…you are so annoying. I’m just going to take all your
medicine and I’m just going to flush it down the toilet so you don’t have
any medicine.’ And she was like ‘and then you’ll just have an episode
again.’ And when she said that to me, I was like, wow. And it took me
years to forgive her for saying that, because I was like, you’re my f***ing
sister…how dare you, in the heat of an argument, use my mental disorder
and threaten the argument on throwing away my medicine so that you’ll
affect me.
Peer relationships. Six participants also described experiencing difficulty and
conflict in peer relationships. Participants described difficulty making and maintaining
friendships due to the presence of EOBD symptoms and resulting changes in behavior.
Participant C associated difficulty maintaining friendships in high school with peers’ lack
of knowledge and understanding of EOBD:
I lost every single one of my friends in high school. People just saw me as
a freak. They didn’t like--they didn’t like that I was just unstable. And I
can see from their point of view. Who wants a friend, you know, who’s
going through a hard time? and they try to help and nothing they do helps.
So basically a lot of friends would give up on me or people would just
walk out immediately. They just don’t want to deal with it, or they don’t
like it.
Following hospitalization and beginning treatment, Participant H stated his parents
transferred him to a different high school. Participant H then described the difficulties associated
with social functioning while receiving treatment for EOBD:
I knew I had to make friends all over again after losing all my friends, and
I don’t know [pause] it was really rough with relationships with friends
because I was zonked out on really heavy sedating meds that hadn’t gotten
phased out yet since being in the hospital. So just kind of now, instead of
dealing with having a manic episode while adjusting to going to a brand
new high school, I was dealing with bipolar disorder diagnosis and
medication while going to a brand new high school and that was just as
rough in my opinion.
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Isolation. Four participants described an increase in isolation associated with
onset and experience of EOBD symptomatology, including withdrawal from social
situations, pushing others away, and selectively leaving their ‘safe space’ (e.g., bedroom).
Participants described isolation occurring in conjunction with symptoms of depression
and anxiety, as well as part of efforts to cope with EOBD symptomatology.
Participant B described isolation and a disruption in relationships associated with EOBD
symptomatology:
So [I] just became a lot more isolated. I guess because I was just crying
all the time and I just would go by my feelings with friends. I think a lot of
it was on my part, with my change in relationships just because I became
more isolated. I would get attached to certain people but then detach and
[pause] I would just go by my feelings and moods with people.
Participant A described an association between isolation and increase in
symptomatology:
I think that feeling socially isolated just makes everyone’s symptoms
worse. That was a pretty big piece. And I don’t think I’ve felt as socially
isolated as I did during my senior year at any other point in my life.
Seeking and receiving support. Participants described seeking and receiving
support from others as a key component of their experience of EOBD throughout
adolescence. Seven participants described having a support system, while two
participants described a lack of support during adolescence. Participants also described
seeking help and support upon noticing EOBD symptoms and receiving support from
family, peers, and healthcare providers.
Support. Seven participants described their family and peers as supportive during
adolescence. Participants described support as separate from knowledge and understanding and
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involvement in treatment. Support was described as listening, attempting to understand, and
trying to help unconditionally.
Participants B and H described their parents’ support in the process of coping with
emerging symptoms, seeking help, and receiving the EOBD diagnosis.
Participant B described approaching her mother upon noticing prodromal symptoms:
I struggled a lot before that [EOBD diagnosis]. I came out to my mom and
told her I had been having a lot of the mood swings, which she noticed.
And I told her about all my suicidal thoughts, the trouble I’d been having.
I opened up a lot. And she helped me get a therapist and stuff.
Participants also described receiving support from friends and peers. Participant A
described her friends as having an active role in advocating for her to seek treatment due
to emerging symptoms:
There were a couple people who I was friends with who I didn’t see in
person, so some long-distance friendships. People who just saw my
emotional patterns and were trying to persuade me to get a diagnosis
because I wasn’t seeing anyone… I think that getting the bipolar diagnosis
definitely confirmed what they had suspected, that there was something
more significant going on than depression and they were much more
vigilant in trying to help me.
Involvement of others in treatment. Six participants reported that family
members provided referrals or facilitated treatment, coordinated with healthcare
providers, participated in treatment sessions, and administered participants’ medication.
Involvement of others in treatment was described as separate from support and lack of
support, and was perceived as both beneficial and not beneficial.
Participant G stated her mother would attend therapy sessions with her and would at
times receive progress reports from providers. Participant B described her mother’s involvement
as helpful in conveying emerging symptoms to the psychiatrist. Participant A stated her mother
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recommended and paid for her to see a psychiatrist at age 17 when symptoms had not improved
through therapy.
For some participants, family involvement was not a positive experience. Participant C
described her mother’s involvement in treatment as having a negative effect on therapeutic
rapport:
I was trying different medications and my mom only had to take me to
therapy sessions. The therapist would eventually try to tell her what my
mood disorders are and what are the actual symptoms and my mom would
fight it. And eventually the therapist would get so tired of fighting with my
mom they would—the therapist would say ‘your mom’s being right. You’re
being lazy, so you need to step up or you need to help out your mom.’ It
just felt—I changed therapists shortly after, but with that it didn’t feel like
I actually had a therapist.
Loss of autonomy due to healthcare. Participants C, D, E, G, and H described
incidents in which they felt excluded from their treatment team and experienced a loss of
autonomy. Each of these participants described incidents when healthcare providers
spoke only to their parents and they were not involved in treatment sessions or decisions.
Additionally, participants D and H stated they were not able to administer their own
medications for significant periods of time. Participants described feeling invalidated and
frustrated, and associated the lack of inclusion and autonomy with their age.
Participant H described loss of autonomy:
And so…from ages 14 to 16 I didn’t administer my own meds. My dad was
the one who gave them to me every night, and he kept them locked up. And
I don’t know if it was a lack of trust or what [pause] and my dad would
frequently come to my psychiatrist appointments and there were times,
especially if I was really depressed, he would just talk to the psychiatrist
instead of me. And that made me feel really not included in my own
treatment plan. So it definitely was less trust and more careful treatment.
And it’s kind of weird because I didn’t cause myself to have bipolar
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disorder, so why they thought that they needed to do that was [pause] I
don’t know, maybe it was their own m.o .
Lack of support. Participants A and C described having limited support during
adolescence. Participant A described peer support as indicated above, but described an absence
of family support characterized by her mother’s denial of illness.
…and so I really didn’t feel support sometimes. I really didn’t feel support
from family, and still don’t really feel support from family.
Participant C described a lack of family and peer support, as well as limited support
during her pregnancy at age 15. Participants A and C both described feeling alone and having
‘no one there’ for support.
Seeking help and support. Four participants described seeking treatment and support
from others voluntarily upon noticing emerging symptoms. Each participant described reaching
out to their parents for assistance accessing healthcare and for support in managing symptoms.
Participant B described reaching out to her mother first for help seeking a psychiatrist,
but also described seeking support from friends and church leaders in her support system.
Participant B described receiving limited support and stigmatizing responses from friends
and church leaders; this is discussed more fully as part of the theme of stigma.
Change and Uncertainty
Participants’ overall experiences of EOBD were characterized by change and
uncertainty. All eight participants described their adolescence as a period of continuous
changes in symptomatic states and course of illness, identity and sense of self, and
relationships. Participants also described life changes that affected their experience
during adolescence.
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Change in illness. While each of the participants described experiencing
depressive, manic, and comorbid symptoms, each of the 8 participants characterized their
overall experience of EOBD as dominated by change, uncertainty, and instability of
symptoms. Duration of episodes varied from days to weeks or months; the severity and
frequency of symptoms similarly varied. The severity of manic and depressive episodes
was described as ranging from disruptive to debilitating. While some participants
described an experience dominated by depressive episodes, others described that manic
episodes were more disruptive to their lives in adolescence.
Participant G described her experience of changes in duration and type of episodic states
I experienced depression for weeks at a time. It would come and go. And
then I have moments of anxiety, aggravation, and irritability. And I was
really becoming passive-aggressive towards everybody around me.
Participant B described experiencing instability in the type of symptoms as well as course
of illness:
I’ve heard of this thing called rapid cycling. I’m not sure what that is, but
they [symptoms] would shift a lot. But there would be times where I’d
have a long depression, like where I had it for a couple months. And there
would be weeks of hypomania. But a lot of it was throughout the day,
even.
All participants also described a change in the type of episodes they experienced
throughout adolescence. . Participants E and H experienced manic polarity at onset of illness,
and described a pattern in which manic symptoms largely subsided, while depressive episodes
had become more dominant. Participants A and F described the inverse: a course of illness
initially dominated by depressive episodes, and more recently characterized by manic episodes.
Participant F also described experiencing more depression when younger. Participants C and G
additionally described experiencing persistent symptoms of anxiety, irritability, and emotion
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dysregulation. Participants described ideation for self-injury and suicide as overall decreasing
throughout adolescence as well.
Change in identity and sense of self. Each of the eight participants described
experiencing changes in sense of self. Six participants described experiencing a change in
identity that consisted of viewing themselves as different or defective as a result of
EOBD. Three participants described a change in their thoughts, beliefs about themselves,
and behavior occurring as a result of EOBD.
View of self as different or defective. Six participants described experiencing a
change in identity in which they came to view themselves as defective, damaged, or
different from others due to EOBD—a sense of liminality and ‘otherness.’ Participants
described themselves as flawed, abnormal, worthless, and weak. Participants described
feeling that there was something ‘wrong’ with them, that they were an outcast, and that
others would not care for them if they became symptomatic.
Participant A described her experiencing a change in identity due to the implications of
an EOBD diagnosis, as opposed to her previous diagnosis of depression.
I went from thinking that I was basically experiencing something that a lot
of people go through to thinking that I was just having depression and
when I was older like my siblings I would be able to get out of it from
having that diagnosis and having the psychiatrist tell me this [bipolar
disorder] is a lifelong thing that I’m going to have to manage that really
shifted my sense of self.
Participant B described feeling worthless and not ‘good enough:’
I was very judgmental. I had this self-esteem thing going on as well as the
bipolar, so I did go through a lot…just thinking I’m worthless and trying
to be better looking. Like I had an eating disorder as well at 18. Um. I just
didn’t think I was a good person. I just thought I wasn’t worth it, I guess.
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Changes in decision-making. Three participants described experiencing significant
changes in their identity in the form of changes in thought patterns, perceptions, beliefs about
themselves, and behavior. Participants described engaging in unhealthy behaviors, choosing not
to pursue goals, and changes in coping patterns following EOBD diagnosis.
Participant E described change in social behavior and viewing herself as flawed due to
emerging EOBD symptoms:
I knew there was something wrong, and because of that I thought I was
flawed and I didn’t want to hang out with anybody.
Participant G described changes in her thoughts, perspective, and behavior following
EOBD diagnosis. Participant G described feeling that she had lost sight of her future and that her
life was falling apart
I got into really bad habits. I started drinking at parties, and smoking, and
getting into a lot of bad habits and getting in trouble a lot. And I felt like
before the [EOBD] diagnosis I had good grades and everything, and then
it all started to decline rapidly.
Changes in relationships. All eight participants described experiencing significant
changes in family and peer relationships during adolescence. Participants described changes as
occurring independently of EOBD as well as in response to EOBD.
Participant D described the loss of her older brother as a significant change unrelated to
EOBD that impacted other interpersonal relationships throughout adolescence:
So yeah, around 11 or so, or 12 or so, my oldest brother was with my
father. He took care of us at 28. He came out of the closet, and he decided
to leave the house a week before telling me and my brother. So that was
very depressing to me, because to me it felt like [pause] it felt like I lost
him. It almost felt like a grieving session for death or something. That’s
what it felt like. And relationship-wise, my family did start, kind of, turning
different. And so I also behaved differently. A lot of my early relationships
did fall apart at that time. That’s one thing that kind of triggered the
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depression symptoms, but afterwards I did carry that and it kind of did
ruin a lot of other relationships I had [pause] teacher-student
relationships, whether friends, friend to me relationships, or motherdaughter relationship…
Participant H described experiencing a change in his relationship with his parents
following hospitalization and diagnosis of EOBD:
But as far as family goes, yeah, my parents definitely treated me
differently from after I got diagnosed. They were less likely to allow me to
do risky things or to stay out late with friends, which kind of sucked,
because—I mean, I’m just talking as an angsty teen here—but it kind of
sucked because I was already trying really hard to make new friends and
then they’re not letting me do things with these people who could become
my friends.
All participants also described experiencing changes in peer relationships
associated with EOBD. Participants attributed changes in peer relationships to
symptomatic states, changes in illness, and peers’ limited ability to understand and
provide support. Participants additionally acknowledged changes in their own behavior
that placed strain on peer relationships; Participant E described deliberately creating
conflict with others, and Participant F described her symptomatic behavior as “high
maintenance” and off-putting to her friends.
Participant G described experiencing changes in peer relationships she associated with
feeling ostracized, self-isolation, and lack of understanding:
… nothing was working. Nobody understood what I was going through,
even before the diagnosis. And I didn’t really know what was going on,
and everybody was pushing me away, it felt like, and I was pushing them
away. Nobody wanted to be near me. That’s what it felt like.
Life changes. Participants described experiencing significant life changes associated with
onset and experience of EOBD, such as moving and beginning a new school. Participant H
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described onset of symptoms coinciding with beginning high school, while Participant A
described onset of symptoms beginning with moving to attend a new school in a different state.
Participant E described onset of symptoms beginning shortly before she graduated high
school, and described exacerbation and experiencing her first full manic episode at age 17 while
at college in a different state.
…just from the stress of graduating and leaving the state that I was used
to just triggered it [EOBD]. And all that stress and smoking was just too
much for my body and it was just like [pause] it just triggered it.
Participant C stated she became a mother at age 15. Participant C described her
pregnancy and motherhood as a significant life change and additional challenge in managing
EOBD:
I mean, it’s a lot of [pause] you’ve got a lot of responsibilities once a child
is born and you’ve got to really step up your game. When the baby is
awake and hungry you need to go feed the baby, otherwise you’re just
neglecting a child. And it was a real big struggle for me. It’s not my
intention to neglect my son but it was really hard for me to just fight
[depression] and not get frustrated and get mad at my son and especially
with his age and so I was really trying to struggle with being a mom and
going through post-partum depression is the depression I’ve always had
anyway…
Impact on Identity
A fourth theme identified by participants was the impact that EOBD had on their
identity. Participants described an experience in which the process of normative
adolescent cognitive, moral, and psychosocial identity development was altered due to
the impact and implications of EOBD on their identity and sense of self. Participants
described sub-themes of secrecy and selective disclosure of illness, difficulty trusting
self, maintaining sense of self, and integration of illness into identity.
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Secrecy and selective disclosure of illness. Participants described a sense of
secrecy associated with ‘hiding’ not only the illness but a portion of their identity from
others. Secrecy was described in conjunction with isolation and disclosure of illness, but
also with self-protection and vulnerability—that with EOBD the participants now had a
defective portion of their identity that needed to be hidden.
While Participant F described disclosing EOBD diagnosis to those she trusted, she
described hiding the onset of symptoms from those she did not trust:
I don’t think [they knew], of my high school friends. I don’t think they
ever had any idea because I pretty much hid it from people that I wasn’t
comfortable talking about it with.
Participants additionally described secrecy as related to judgment and fear of others
finding out. Participant C described hiding symptoms out of fear of judgment and rejection:
A lot of people—I never tried to show the symptoms to people that I feel
like they might judge me [pause] But basically I’ve always been afraid to
be judged.
Participant E further described bipolar disorder as “very, very private” and described her
efforts to prevent others from finding out:
I’ve always kept my mental health apart from everything else. I will seek a
psychiatrist or a therapist somewhere super far away, like one I went to in
[city], they were an hour and a half away where I knew nobody would see
me. And I would pick up my medicine at a drugstore or a pharmacy super
far away where the chances or odds of me running into somebody I know
is very slim. I think that has a lot to do with the fact that I don’t want
anybody to know…Even now I will go somewhere that’s a little bit further
just for the sake of not running into anybody I know, or not having
anybody know me. Seriously. It’s very, very private.
Related to participants’ description of secrecy was their discussion of disclosure
of illness. While some participants described open disclosure of illness, those who
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strongly endorsed secrecy described selectively disclosing EOBD to others. Selective
disclosure was described as a means to maintain secrecy.
Participant A stated that at the time of interview, she had never disclosed EOBD
diagnosis to her siblings:
I actually have never told my siblings that I have been diagnosed with
bipolar disorder just because I don’t really trust them to understand so
they just think that I have depression.
Participant E described a very selective pattern of disclosure, stating that she told few of
EOBD diagnosis:
So no, I didn’t tell my friends, and ‘til today I only think maybe two of my
ex-boyfriends know [and] one of my other friends. Not a lot of people
know. Like I haven’t told that many people, actually. So no, they don’t
know.
Participants also described selective disclosure of illness by family members. Participant
F stated she and her family have not disclosed or discussed bipolar disorder diagnosis with
extended family:
Not anyone in my family besides my parents knows, just because we have
a very bizarre family dynamic and it would just—it just doesn’t feel like
the time or the space to let them know about it.
In contrast, participants described a more open disclosure of illness with those
they associated with lower risk of judgment and rejection.
Participant F described disclosing her symptoms to her parents in adolescence, and
described an open disclosure with friends to her:
Probably over 20 [people know]—most of the people I’m friends with
know about it. Especially because—I’m an only child, so I’m pretty good
at being independent, and I don’t mind being alone—but I’m really open
when I’m a depressive or manic state, that I need to be around other
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people. So I feel like I just let people know. Like all my roommates have
always known. Pretty much everyone close to me has always known.
Participant C described open disclosure with her fiancé:
But when I comes to my fiancé now, I’ll let everything shine through. He’s
seen everything.
Participant H described an open pattern of disclosure of illness beginning in adolescence:
I’d say ages 13 to 17, I would disclose—it was my choice to disclose it to
people, if I felt I could trust you I would disclose it to you. From ages 18
to now, 23, I feel like I would tell pretty much anyone as long as they
weren’t malicious about it. And I don’t bring it up, but if someone asks or
if it’s relevant I might tell them.
Adaptation and integration. Participants described the sub-theme of adaptation
to EOBD as part of their identity, including preserving portions of their sense of self
while integrating the illness.
Participants described maintaining or exceeding levels of functioning throughout
adolescence while experiencing EOBD symptomatology. Participants primarily referred to
maintaining academic functioning.
Participant F described depressive symptoms as a “really big problem” her senior year of
high school, yet she performed well academically and was accepted to college. Similarly,
Participant B described maintaining her academic performance through use of coping skills:
Participant C described experiencing significant sedation from psychotropic medication
during high school, but described continuing to pass her classes:
I would sleep all the time in class, but mostly due to the medications I was
on. I think the biggest one that took effect was Seroquel, and basically I
wasn’t awake at all at any time of day. And that really kind of ticked my
parents off that I was sleeping all the time, and they get calls that I’m
sleeping in the class. But I was still passing my classes, but to this day I
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don’t even know how. I would do all the tests, I would do everything. It’s
almost as if I learned in my sleep.
Participants described efforts to maintain sense of self and integrate EOBD as disruptive
and a struggle. Participant F described struggling with identity throughout adolescence due to
EOBD:
I struggled with self-identity and self-image for a pretty long time in
middle school. So when I was 12 to about 16, I feel like I kind of got the
hang of who I was. And I’ve pretty much had the same self-identity since
being 16, but it was—yeah, it definitely just disrupted my self-worth and
who I thought I was for a long time.
Participant E described adaptation and integration of EOBD as her greatest challenge
during adolescence:
I think my biggest challenge [during adolescence] was really just
accepting this [EOBD] and honestly figuring out how to make this fit with
my life, and how to still enjoy life and explore it, as well as live with it
responsibly and not have another breakdown. So that was my biggest
challenge, just trying to enjoy life. And that was my biggest challenge
then.
While some participants described achieving a sense of self, others described a
loss of self due to the presence and impact of EOBD.
Participant G described feeling as if she lost identity with the onset of symptoms:
Before I was able to be friends with everybody. I was doing good [sic] in
school. I went to school every day. I was getting along with all my friends
and teachers and all my siblings. But after a while depression started to
set in and I didn’t feel like doing anything anymore. I felt like I lost who I
was before, and things started to change around me. And I started to push
everybody away and was more aggravated when people tried to talk to
me.
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Participant C described the process of searching how to find a sense of self:
Basically I had a hard time trying to figure out who I was. I was changing
myself a lot, whether it was like a physical appearance or I was changing
my attitude toward a lot of things. Every single time. I didn’t know
basically who I was. I didn’t know how to define myself because I couldn’t
be true [pause] I mean, I was around a bunch of people all the time—I
was around my parents, I was around people at school [pause] I mean, I
was afraid that when I found my true self nobody was going to like me.
Emotional adjustment. All eight participants described experiencing an internal
struggle and emotional adjustment to receiving the diagnosis of EOBD and throughout
course of illness. Emotional adjustment included participants’ emotional reactions to the
illness itself as well as fear related to what the illness meant for their lives and what it
represented in terms of their identities. Participants described feeling out of control,
having difficulty trusting their own thoughts and emotions, and fear of EOBD.
Emotional response to illness. All participants described experiencing strong
emotional responses to the EOBD diagnosis and symptoms as well as to the implications
EOBD had for their identity.
Participants A and D described EOBD as fear provoking. Participant D also described
experiencing confusion and sadness:
It was confusing and kind of heartbreaking. Especially the prognosis.
Being told by a psychiatrist you’re going to have to take meds your whole
life. And you might die. They’re both kind of scary.
Participant E described feeling frustrated and blaming herself for what she perceived as a
“flaw”:
It [receiving the EOBD diagnosis] kind of made me frustrated, because it
was just like, damn I have a flaw now. That’s what it was like. I was upset.
That made me feel kind of weak, because I was upset that I could let
something like that happen even though obviously you know it’s genetic,

94
and sometimes different environments and stuff like that [pause] but I was
kind of upset that it happened to me. But I was kind of like, ‘well it is what
it is.’
Feeling out of control. Five participants further described a sense of feeling out
of control and a fear of losing control over their thoughts, emotions, behaviors, and their
lives due to EOBD. Participants described feeling that EOBD was in control or worrying
that the course of illness would take control over their lives, and expressed a fear of
losing their identities and autonomy in the future.
Participant A described feeling out of control over her emotions:
I think that it [EOBD] meant that I was basically just emotionally unstable
and that I like wasn’t able to have control over any of my emotions and
that I was just constantly fluctuating between extreme emotional states.
Difficulty trusting self. Participants ultimately described the result of fear and
feeling out of control in terms of distinguishing normative and authentic thoughts,
emotions, and perceptions from symptomatic experiences. Participants described
difficulty trusting themselves and differentiating their identity from EOBDEOBD
symptoms.
Participant A similarly described the inclination to merge her identity with symptoms:
Feeling like if I just started getting into a mindset that was depressed I
would immediately—and this might be part of the symptoms of
depression—would immediately think that I was worthless or that I was
letting the disorder control me. I think that’s definitely a huge piece. And
there’s been other times where I join a bunch of activities or connect to a
lot of things and people tell me that I’m overcommitting myself and that
I’m crazy and that I do too much, to which I usually respond ‘yeah you’re
right. I’m clinically insane.’ Which is not true. But I do sometimes identify
myself as being those things when other people point out my abnormal
behaviors.
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Participant E described the process of differentiating between bipolar symptoms and
normative emotional and situational responses:
And even if, let’s say I go through something today, and I’m crying. And
I’m just like ‘why am I crying so much? Like, obviously maybe I need to
take more medicine,’ or something. And sometimes I don’t give myself the
credit I need. Like maybe I’m crying because I really am going through
something and I need to let out these tears. Because crying is an emotion
that every human has the right to feel. So something I think that I’ve just
desensitized my emotions [pause] and sometimes I think I’ve given too
much power to being bipolar and saying like ‘the reason I feel this way is
because I’m bipolar so I need to try to get this under control. I don’t need
to cry because maybe I’m overreacting.’ So I think that I do it to myself
sometimes subconsciously and I don’t realize it. And then I have to go
back and think about it and say ‘okay, maybe I was feeling that way on
purpose.’ So it’s a constant battle and I think I’ll probably face that for
the rest of my life [pause] knowing when it is my disorder and knowing
when it is “normal.” Whatever normal is.
Experience of Stigma and Labeling
All eight participants described stigma, self-stigma, and labeling as part of their
experience of EOBD. Participants described stigma concurrent to diagnostic labeling within the
healthcare system, as well as through family and peer relationships. Participants described stigma
occurring in the absence of knowledge and understanding of illness, while having significant
implications for identity development. Participants described internalizing stigma and diagnostic
labeling, as well as efforts to challenge and reject stigmatizing messages.
Notably, each participant used the word ‘crazy’ multiple times throughout their interview
across all themes in reference to themselves as well as symptomatic states. Six participants used
the word ‘crazy’ as a component of stigma and three participants referred to themselves as
‘crazy’ when describing self-labeling and internalizing stigma
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Labeling. All eight participants described experiencing stigma beginning at diagnosis
and continuing throughout adolescence. Participants described family, peers, community, and the
healthcare system as sources of stigma. Participants described stigma as unrelated to knowledge
of illness, stating that stigmatizing beliefs occurred even in individuals who possessed
knowledge of EOBD. Participants described an awareness that stigma associated with EOBD
could be used against them to discredit them and devalue them.
Participant E described stigma as isolating and addressed the importance of addressing
stigma through psychoeducation:
I think mental illness is something that is very stigmatized and very much
needs to be talked about…The way I look at it is that I don’t think that
mental illness is fairly treated compared to other diseases…when it comes
to something like mental illness, it’s like “Ewwww, that crazy person! I
hope it’s not schizophrenia and I hope they’re not trying to kill me!’…So
just because it’s not physical, I think that people should understand mental
illness and stuff that you can feel, that’s emotional, should receive just as
much attention and just as much, you know, praise and recognition to help
people to get through it as other illnesses and diseases do. So I think
stigma is definitely something that isolates people.
As previously introduced, Participant B sought help and support from friends and church
leaders due to emerging EOBD symptoms. Participant B described experiencing stigma rather
than support:
I did try telling several friends and leaders in my life, and a lot of them
just had their own opinions so I got different reactions. Like some people
saying ‘you’re going to be healed; you just need to pray it away’ to people
giving me advice that wasn’t needed, I guess. And I had people try to
diagnose me—like I had a person say ‘oh you’re schizophrenic, you’re
probably not just bipolar.’ Just people thinking you’re crazy, you’re crazy.
Not even understanding the disorder.
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Participants described an association between stigma, secrecy, and selective disclosure.
Participants specifically mentioned incorporating secrecy and selective disclosure of illness, as
described earlier, to avoid experiencing discrimination and devaluation associated with stigma.
Participant A described being “undercover” to minimize her experience of stigma:
I feel the effects of stigma when I overhear people talking about people
with mental illness and how difficult it is to interact with people who have
mental illness so I feel like when I’m undercover and people don’t know,
then I feel kind of stigmatized. But not like people directly telling me how
they think bipolar disorder is after revealing that I have it.
Self-labeling. In addition to experiencing devaluation and discrimination from others,
seven participants described internalizing stigmatizing messages that resulted in self-judgment
and self-criticism.
Participant C described the process of internalizing stigma:
…they would say stuff like ‘bipolar people just are very, just like, they
need medication and their emotions are completely out of whack.’ And I
started to believe that kind of stigma of ‘oh, you’re emotions are just out
of whack,’ and I started to believe that’s actually okay for emotions to be
out of whack, because I had bipolar disorder. I was like ‘well I have this
excuse to be moody anytime I want just because I’m diagnosed with
bipolar disorder.’ And it allowed me to get frustrated over anything.
Participants additionally described an association between self-stigma, sense of self, and
symptomatic improvement. Participant A described self-stigma as having a negative impact on
symptomatic functioning:
…it’s got to be true that experiencing stigma worsens symptoms. Certainly
identifying myself as crazy was not helpful in trying to recover. And also
trying to think that—well, buying into stigma puts you in a deeper hole in
trying to recover and trying to see that you can be something other than
an image, to something other than an unstable kind of person. Um, yeah I
think that stigma just makes it harder to change, so that would make the
symptoms harder.
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Challenging labeling. Five participants described efforts to challenge or reject
stigma and self-stigma. Participants described their resistance toward stigmatizing beliefs
as an ongoing struggle. Participants described challenging labeling and stigma from
external sources such as community, social media, and peers; however, diagnostic
labeling and stigma from the healthcare system were not mentioned.
Participant H described accepting EOBD while not defining himself by the illness:
I tried really hard not to identify myself as bipolar, but just to have it be a
part of me but not who I am, if that makes sense.
Participant E described used the Olympics as an analogy when describing her efforts to
challenge stigma:
I feel like obviously life is a race. Everybody’s competing for something.
Whether it’s a good job, or finding love and getting married and having
kids--everybody’s competing for something. And it’s funny that the
Olympics are on right now, because I compare it to the Olympics or a
race. And I say that I don’t feel like I’m in like the Special Olympics for
people who have a mental disorder. I don’t put myself in that category of
saying that I’m different from other people. I’ve always looked at myself
like I’m still the exact same, like I’m still the same person. And I’m gonna
finish this race and win and beat everybody else, and be in the normal
race, and not put myself in a special race. So I kind of gave myself
strength in not making myself seem different from other people, but finding
people that were doing normal things and living their life, and I just— you
know, you just change and adapt to it.
Presentation of Themes According to Research Questions
The phenomenology of EOBD is additionally presented as thematic responses to study
research questions. While the research questions were developed to elicit participants’
experiences of distinct components of EOBD as identified by theoretical framework and the
literature review, analysis of findings revealed that the phenomenology of EOBD consisted
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instead of an interconnected web of themes as illustrated in Figure 1. Participants did not
experience EOBD, relationships, identity development, or labeling independently, but rather in a
combined pattern that was consistent across all participants.
For each research question, themes and subthemes endorsed by five or more participants
are presented as representative of the sample and overall experience of EOBD. Table 7 displays
the themes and sub-themes characterizing participants’ experience of EOBD as organized by
research question.
Research Question 1: How do emerging adults describe the experience of EOBD
during adolescence in terms of experience of symptoms; changes in individual, social, and
family functioning caused by course of illness; and the experience and perception of stigma
and self-stigma? Participants described their experience of EOBD across five themes: managing
and coping with EOBD; effect on relationships, change and uncertainty; impact on identity; and
experience of labeling.
Managing and coping with EOBD. Participants described their experiences of the
illness itself. All eight participants described experiencing both manic and depressive symptoms.
While seven participants described experiencing comorbid symptoms such as anxiety self-injury,
eating disorders, and ADHD, only four endorsed comorbid symptoms in response to the first
research question. Six participants described their experience with utilizing treatment and
accessing the healthcare system, including psychiatric and therapeutic services, psychotropic
medication, and provision of psychoeducation. Five participants described their own denial of
illness as well as their family members’ denial of EOBD diagnosis. Participants unanimously
endorsed a pervasive lack of knowledge and understanding of EOBD—acknowledging their own
confusion and lack of psychoeducation at onset of illness as well as deficits in knowledge and
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Table 7. Presentation of Themes According to Research Question
Research Question

Themes

Sub-themes
Experience of illness

1) How do emerging adults (ages
18-25) describe the experience of
EOBD during adolescence (ages
13-17) in terms of experience of
symptoms; changes in
individual, social, and family
functioning caused by course of
illness; and the experience and
perception of stigma and selfstigma?

2) How do emerging adults (ages 1825) characterize the cumulative
influence of interactions with
healthcare systems and treatment
interventions on their experience
of EOBD?

Treatment and engagement with
Managing & Coping with EOBD

healthcare system
Knowledge and understanding of
illness

Effect on Relationships

Seeking and receiving support

Change and Uncertainty

Change in illness

Impact on Identity

Emotional adjustment

Experience of Stigma and Labeling

Labeling
Experience of Illness
Treatment and engagement with

Managing & Coping with EOBD

healthcare system
Perceptions of healthcare and
treatment
Knowledge & understanding of

Managing & Coping with EOBD

illness
Use of coping skills

3) What are the characteristics of the
relationship between EOBD,
social and family relationships
and the developmental transition
to adulthood according to
emerging adults?

Difficulty maintaining social
Effect on relationships

functioning
Seeking & receiving support

Change and Uncertainty

Changes in relationships
Adaptation & integration

Impact on Identity

Secrecy & Selective Disclosure of
Illness
Knowledge & understanding of

Managing & Coping with EOBD
4) How have stigma and self-stigma
associated with EOBD affected
the social, emotional, and
cognitive development of
emerging adults ages 18-25?

illness
Difficulty maintaining social

Effect on relationships
Change and Uncertainty

functioning
Change in identity
Labeling

Experience of Stigma and Labeling

Self-labeling
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understanding from family, peers, and healthcare providers. Five participants described attaining
an understanding of EOBD throughout adolescence as well as treatment by healthcare providers
with knowledge of EOBD; however, participants described denial of illness persisting despite
psychoeducation and knowledge of EOBD.
Effect on relationships. Five participants described seeking help and support in response
to EOBD symptoms from family and peers. Five participants described experiencing support
during adolescence, while four participants endorsed experiencing isolation and difficulty
maintaining social relationships.
Change and uncertainty. Six participants characterized their experience of EOBD as a
prolonged series of changes between symptomatic states. Participants described a lack of
predictability and certainty in the duration and frequency of symptomatic episodes, time between
episodes, and the nature of symptomatic episodes.
Impact on identity. Seven participants described experiencing an emotional response to
receiving the EOBD diagnosis and to EOBD symptoms throughout adolescence. Participants
described experiencing a wide range of emotions such as sadness, blame, anger, and fear, as well
as feeling out of control over the illness and subsequently having difficulty differentiating
between their sense of self and EOBD.
Experience of stigma and labeling. Participants unanimously described experiencing
labeling and stigma associated with EOBD; this occurred in the form of diagnostic labeling as
well as devaluation and discrimination from others associated with stigma.
Research Question 2: How do emerging adults characterize the cumulative influence
of interactions with healthcare systems and treatment interventions on their experience of
EOBD? All eight participants characterized the influence of healthcare and treatment with one
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theme: managing and coping with EOBD. Participants described three sub-themes: experience of
illness; treatment and engagement with the healthcare system, and perceptions of healthcare and
treatment.
Five participants described their experiences of manic, depressive, and comorbid
symptoms as a part of their experience with the healthcare system. All eight participants
described accessing various levels and types of healthcare and treatment interventions for
EOBD. Seven participants were prescribed psychotropic medication for EOBD during
adolescence. Participants described beneficial aspects of medication, such as alleviating
symptoms; as well as non-beneficial aspects such as exacerbating symptoms and disruptive or
unpleasant side effects. Six participants described their perception of healthcare and treatment as
beneficial, referring specifically to psychotropic medications that were considered effective and
healthcare providers who were knowledgeable of EOBD. Six participants described their
experience of healthcare and treatment as non-beneficial referring to medications that were
ineffective, psychiatric hospitalization, and healthcare providers who did not understand EOBD.
Four participants described healthcare and treatment of EOBD as both beneficial and nonbeneficial; these participants described choosing to continue aspects of treatment that were
effective (i.e., medication) while modifying or discontinuing aspects of treatment that were
ineffective (i.e., changing providers). Participants’ perceptions of healthcare influenced their
decisions to maintain or avoid treatment for EOBD.s’ experiences.
Research Question 3: What are the characteristics of the relationship between
EOBD, social and family relationships and the developmental transition to adulthood
according to emerging adults? Participants described the relationship between EOBD and
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interpersonal relationships across four themes: managing and coping with EOBD; effect on
relationships; change and uncertainty; and impact on identity.
Managing and coping with EOBD. Participants identified knowledge and understanding
of EOBD as an important factor in interpersonal relationships throughout adolescence. All eight
participants described feeling that their interpersonal relationships were affected by their own
limited knowledge of EOBD and the lack of knowledge and understanding of EOBD by family
members and peers. Three participants described denial of illness within their support system.
Two participants described feeling that their family or peers understood their experience with
EOBD during adolescence. Participants differentiated between knowledge of illness and support;
and as discussed below, participants described feeling support from family and peers who did not
understand EOBD. Five participants described employing the use of coping skills in the absence
of direction and understanding of their support system.
Effect on relationships. While all participants described their interpersonal relationships
as lacking knowledge and understanding of EOBD, each participant also endorsed receiving
support from family and peers during adolescence. While this may appear paradoxical,
participants indicated collectively that their family and friends often did not understand EOBD
symptoms or course of illness yet remained largely supportive and helped to the best of their
abilities. Two participants described a lack of support from family with greater support from
peers and friends.
All participants additionally described experiencing difficulty in interpersonal
relationships. Six participants described difficulty making and maintaining friendships and
experienced relationships as a stressor, while four participants described experiencing isolation
and avoidance of those who they felt did not support them.
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Impact on identity. Six participants described EOBD as significantly impacting their
identity and developmental transition into adulthood. Five participants described EOBD as a
barrier and obstacle in interpersonal relationships and goal attainment throughout adolescence.
Change and uncertainty. Participants characterized their experience of EOBD and
interpersonal relationships in terms of change. Participants described a bidirectional pattern in
which changes and conflict in relationships were described as catalysts for changes in illness, as
well as byproducts of changes in illness. All eight participants described changes occurring in
interpersonal relationships as a mixture of normative adolescent life changes and changes
occurring due to the onset of EOBD and course of illness. Five participants stated that their
relationships did not change following EOBD diagnosis, as the changes had previously occurred
intrinsically along with the onset of EOBD. Three participants described experiencing changes in
symptoms associated with changes in relationships, such as increases in isolation and conflict as
symptoms increase in severity.
Research Question 4: How have stigma and self-stigma associated with EOBD
affected the social, emotional, and cognitive development of emerging adults ages 18-25?
Participants described their experience with stigma and EOBD across four themes: managing and
coping with EOBD, effect on relationships, change and uncertainty; and experience of stigma
and labeling.
Managing and coping with EOBD. Four participants associated lack of knowledge of
EOBD and understanding of the adolescence experience with stigma and self-stigma, and stated
a need for psychoeducation. However, two participants described experiencing stigma and
labeling from healthcare providers and others who did possess knowledge of EOBD.
Additionally, two participants described experiencing stigma in conjunction with denial of
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illness; this included the experience of devaluation discrimination due to EOBD associated with
cultural beliefs.
Effect on relationships. Six participants described difficulty maintaining social
functioning due to stigma and self-stigma. Of the six participants, three described difficulty
making and maintaining relationships, while three described isolating themselves from others in
efforts to avoid judgment, rejection, and stigma.
Change and uncertainty. Six participants described experiencing change in identity
associated with stigma and self-stigma. Four participants described experiencing a change in
sense of self and viewing themselves as different or defective due to stigma associated with
EOBD. Two participants described experiencing changes in thought, perspective, and behavior
associated with internalizing stigma, such as choosing not to pursue goals and having a
foreshortened sense of future.
Additionally, participants moderately endorsed experiencing a change in illness
associated with labeling. Four participants described increases in depressive symptoms, isolation,
and anxiety in response to experiencing and internalizing stigma.
Impact on identity. Four participants moderately endorsed stigma and self-stigma as
affecting their identity and sense of self. Three participants described having difficulty trusting
their own thoughts, emotions, reactions, and reality-testing in response to exposure to stigma,
and described difficulty differentiating between EOBD and their own identities. One participant
described internalizing stigma and feeling out of control over the illness and herself.
Labeling. All eight participants described experiencing diagnostic labeling and stigma;
and six participants described internalizing stigma and endorsing labeling (i.e., “I am bipolar”).
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All participants described experiencing devaluation and discrimination from family, peers,
society, and healthcare associated with stigma and EOBD.
Summary of findings. Study findings are presented here in two parts. First, the
composite textural-structural description of participants’ experience is presented as the
phenomenology of EOBD. Second, findings are presented in accordance with study research
questions. Participants described EOBD as an interconnected experience in which
symptomatology, interpersonal relationships, identity, and stigma were changing singularly and
in multi-directional relationships; and ultimately, the interaction between EOBD and normative
adolescent developmental processes.
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Chapter 5: Discussion
In this chapter, study findings are reviewed concurrent to the study’s theoretical
framework, research questions, and the existing knowledge base as presented in Chapter 2.
The purpose of this study was to increase understanding of the experience of early-onset
bipolar disorder (EOBD). To explore the lived experience of EOBD, the study employed a
transcendental phenomenological design constructed around two questions: a) what is the
essence of the experience of the phenomenon; and b) in what context(s) did the experience occur
(Moustakas, 1994)? Semi-structured interviews were conducted with eight participants ages 18 –
25 who received a diagnosis of EOBD during adolescence (between ages 13 – 17). Interviews
collected retrospective data regarding their experience of EOBD. While not built into the study
design or research questions, participants discussed elements of their current experience of
bipolar disorder in emerging adulthood during the course of their interviews. As previously
indicated, this data was also transcribed and analyzed as a separate theme, emerging adulthood;
and is included in a companion volume to this manuscript.
As previously discussed, analysis of participant data identified five themes of
participants’ experience of EOBD during adolescence: managing and coping with EOBD; effect
on relationships; impact on identity development; experience of stigma and labeling; and change
and uncertainty. These five themes and fifteen sub-themes were constructed and synthesized
from raw codes and code families using ATLAS.ti output. Together, these five themes create the
participants’ collective lived experience of EOBD during adolescence: a period in which
participants struggled to balance normative development with onset of illness, inception of
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stigma, and changes in sense of self and interpersonal relationships. Each of the five themes was
endorsed by all eight participants, indicating saturation of data.
While thematic findings of participants’ experiences of bipolar disorder during emerging
adulthood fall outside the scope of this study, the researcher has maintained the data due to its
value and potential for inclusion in additional research.
Integration of Theoretical Framework and the Phenomenology of EOBD
The phenomenology of EOBD is supported by a multi-theoretical framework consisting
of neurobiological theories, modified labeling theory, and theory of emerging adulthood.
Integration of these theories provided a comprehensive perspective that was endorsed by
participant data and study findings.
Neurobiological theories. Neurobiological theories provide etiological and biological
explanations for the onset of EOBD symptoms and course of illness. Participants described their
experiences of the illness, including age of onset of symptoms; age of diagnosis; manic and
depressive symptoms; suicidality; length, duration, and frequency of episodes, and longitudinal
course of illness. Five participants described a progression of illness that included onset of
depressive symptoms and diagnosis of depression in early adolescence (ages 12-14), with onset
of manic or hypomanic symptoms and diagnosis of EOBD between ages 14-17.
Seven participants described experiencing comorbid symptoms such as anxiety, selfinjury, ADHD, and eating disorders. All participants viewed EOBD as a byproduct of
neurotransmitter dysregulation (“a chemical imbalance”) consisting of fluctuations in mood,
energy, and emotion. Participants’ understanding of basic components of neurobiological
theories of EOBD appeared to serve as a foundation for understanding and treating the illness.
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While causal explanations, genetic considerations, and etiology of EOBD were not
addressed in interview questions, three participants reported presence of mental illness such as
bipolar disorder and depression in first-degree relatives.
Modified labeling theory. Modified labeling theory explains the inception of stigma as
an interactive process in which behaviors and beliefs associated with diagnostic labels are
internalized. Individuals with the illness adopt behaviors associated with illness and impairment,
while individuals without the illness adopt behaviors associated with discrimination and
devaluation.
Participants’ experience of EOBD reflected a pattern of labeling, stigma, and self-stigma
consistent with modified labeling theory. All participants described experiencing discrimination
and devaluation associated with EOBD labeling through interaction with interpersonal
relationships (i.e., family and peers), society, and exchanges with the healthcare system and
healthcare providers.
Seven out of eight participants described internalizing beliefs and behaviors associated
with illness in the form of self-labeling and endorsing stigma. Participants described self-labeling
as a process originating with reception of stigma; and additionally described self-labeling in
conjunction with changes in identity (viewing self as different or defective) and interpersonal
relationships (isolation and secrecy), as well as fear of judgment.
Theory of emerging adulthood. All eight participants described changes in their
experience of bipolar disorder occurring as they transitioned into emerging adulthood. Within the
theme of emerging adulthood, focusing on self and self-sufficiency was endorsed by all
participants. Consistent with Arnett (2006a), all participants described experiencing changes in
work, relationships, and behavior patterns that focused on increasing independence and self-
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sufficiency. Participants described attaining an increase in knowledge of bipolar disorder and
how to manage the symptoms to improve course of illness. Consistent with Arnett (2006b), each
participant described experiencing varying degrees of recurrent symptomatology while
experiencing increased self-esteem and sense of well-being. Participants described feeling
empowered with greater ability to initiate life changes such as seeking out support and pursuing
life goals. Participants’ focus on self and self-sufficiency appeared as a contrast to descriptions
of feeling out of control and confused during adolescence.
Four participants additionally described increased interest in enacting systemic change to
improve the experience of bipolar disorder for others. These participants explained their interest
in this study as prompted by their hope of participating in a movement for change. Participants
described the need for increased understanding of EOBD and the adolescence experience to
improve healthcare and treatment interventions.
Participants described additional changes occurring in emerging adulthood. All
participants described experiencing normative changes associated with adulthood, including
moving away from home, attending college, and pursuing a career. One participant strongly
endorsed additional changes in in identity and identity development occurring in emerging
adulthood that included increased confidence and ability to reject stigmatizing messages. While
all participants described a change in perspective associated with emerging adulthood, one
participant described a sense of optimism “and hope for my adulthood” that they described was
not present during their adolescence
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Integration of Findings and Knowledge Base
This section compares study findings with the existing literature on EOBD. Study
findings relevant to scope of EOBD, adolescent development, interactions with the healthcare
system, interpersonal relationships, and stigma are presented.
Scope of EOBD. Participant descriptions of EOBD course of illness were consistent with
current knowledge within the literature. Participants described experiencing onset of symptoms
between 7 and 17 years of age (M = 12.88; SD = 2.66) and receiving EOBD diagnosis between
ages 13 and 17 (M = 15.56; SD = 1.50). Five participants described polarity of first episode as
depressive, while three participants described polarity of first episode as manic. Participants with
manic onset were diagnosed and treated during psychiatric hospitalization and reported no prior
symptoms of any kind. Participants with depressive onset describing receiving diagnosis from an
outpatient provider and onset of symptoms prior to diagnosis.
Study participants described varying courses of illness, including differing duration and
frequency of episodes. Study participants described seeking and receiving treatment within an
average of three years of onset of symptoms (M = 2.69, SD = 2.27), as compared with ten years
for adult-onset bipolar disorder (Torrey & Knable, 2002). Several participants reported receiving
an initial diagnosis of depressive or anxiety disorder prior to EOBD diagnosis; this is consistent
with a progressive onset of bipolar disorder illness in adolescents (Axelson et al., 2011); however
due to small sample size no conclusions can be made.
Participants described an overall course of illness in contrast to that of McGorry (2010).
Instead of a course of illness consistent with polarity of first episode, participants in this study
with manic symptom onset described depressive symptoms as more disruptive to functioning
over time; and conversely, several participants who described depressive symptoms at onset
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identified manic episodes as more severe. Furthermore, participants did not describe an
association between earlier age of diagnosis and improved course of illness.
Consistent with the findings of McMurrich et al. (2012), participants in this study
described varying degrees of syndromic, symptomatic, and functional recovery in emerging
adulthood (McMurrich et al., 2012). While some participants described an improved course of
illness, others described continuing to experience persistent symptoms and challenges in
treatment of bipolar disorder.
EOBD and adolescent development. Study participant descriptions of identity and
social development between ages 13 – 17 were consistent with cognitive and psychosocial
development as established within the literature (Kohlberg, 1963; Piaget, 1964; Steinberg, 2005).
Participants in this study described their sense of identity and social functioning as significantly
altered, and in some cases impaired, by the presence of EOBD symptomatology as proposed by
multiple authors (e.g., Alreja et al., 2009; Birmaher et al., 2006; Miklowitz & Johnson, 2006).
Consistent with findings of Farley and Kim-Spoon (2011) and Pederson et al. (2007), study
participants described experiencing depressive symptoms in conjunction with peer rejection,
isolation, and decreased self-regulation.
EOBD and interaction with the healthcare system.
Psychotropic medication. Consistent with multiple authors (e.g., Cerit et al., 2012;
Garnham et al., 2007; Judd et al., 2013), participants in this study described taking psychotropic
mediation with varying results. While some participants described improvement in course of
illness and reduction in symptoms they attributed to medication, other participants described
continuing to experience symptomatic and functional impairment despite compliance with
prescribed medications.
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Therapeutic interactions. As previously stated, participants described responses to
therapeutic interventions as both beneficial and non-beneficial. Participants who felt validated
and supported by a provider that understood EOBD described a beneficial relationship; while
other participants described the therapist as judgmental or lacking knowledge of EOBD and
therefore described therapy as non-beneficial. While some participants described an improved
sense of well-being, this study did not investigate improvement in treatment outcomes or
symptomatology as identified by Miklowitz (2008).
EOBD and interpersonal relationships.
Informal and peer support. Study participants described peer relationships as a core
component of their experience of EOBD. Participants described social functioning as influential
to symptomatic functioning; and additionally described social relationship as impacted by EOBD
symptomatology. The impact of peer and community support on empowerment, and role in
stigma reduction, self-esteem, and risk of relapse (Brown et al., 2008; Corrigan et al., 2012;
Davis, Kurzban & Brekke, 2012; Perlick et al., 2004) were not explored by participants; these
are discussed as implications for future research, below.
Family support. Participants from the current study described family relationships as part
of the construct of interpersonal relationships. As with informal and peer support, dimensions of
family support such as family stress and conflict, family cohesion, and family functioning were
not explored in relation to influence on EOBD symptomatology. Participant accounts are
descriptive and include the meaning associated with family relationships and dynamic.
EOBD and stigma. Participants from the current study described their experiences with
diagnostic labeling, stigma, and self-stigma. Consistent with Cerit et al. (2012), study
participants described their experience of EOBD as both influencing and influenced by stigma
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and self-stigma. As asserted by Crowe et al. (2012), study participants described feeling a loss of
control over their lives, self-blame, and viewing ability to manage symptoms as part of their
sense of self; .
Results are additionally consistent with findings by Moses (2009) and Camp, Finlay, and
Lyons (2002). Participants in this study described experiencing rejection and difficulties in
social functioning associated with stigma. In describing their efforts to reduce the impact of
stigma, participants described adopting patterns of avoidance coping, including secrecy,
isolation, and selective disclosure of illness.
Implications for Social Work Practice
The healthcare system is a gatekeeper for adolescents with EOBD. Providers assess and
generate EOBD diagnoses and provide treatment. As the course of illness is indefinite and
requires lifelong care, the role of healthcare remains pivotal throughout the lifespan in mediating
the course of bipolar disorder. However, the healthcare system is often the site of origin of
labeling and stigma, and therefore carries important implications for identity development and
social functioning across the lifespan as well. Social workers are present throughout medical and
mental healthcare settings, and therefore have a unique influence over the range of treatment for
EOBD.
Lack of knowledge and understanding of EOBD emerged as the most frequently
occurring invariant constituent (code) across all participants’ experience of EOBD. Participants
described lack of knowledge and understanding as a determinant in whether healthcare was
beneficial, as influential within interpersonal relationships, and as a buffer against stigma and
self-stigma. This carries powerful implications for providers; increasing individual and family
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psychoeducation as well as provider education would greatly benefit adolescents as well as their
support system.
Participants identified labeling and stigma as carrying significant implications for their
developing sense of self and social functioning. Providers can minimize diagnostic labeling and
inception of stigma through use of a collaborative method with the adolescent and parents that
incorporates a strengths-based approach, as compared to traditional deficit-based medical
models. Providers can additionally focus on integrating illness management with normative
adolescent cognitive, emotional, and identity development. Participants described cognitive
reframing—learning to reframe EOBD as an external experience that was not part of their
identity and something they could learn to manage—as an important component of recovery, and
one which they often accomplished with little support. Some participants additionally described
providers as the primary or sole source of support.
The interconnectivity of themes present in participants’ experience of EOBD necessitates
clinical approaches that address and incorporate each of these themes in treatment approaches.
Providing psychiatric treatment and medication without therapeutic treatment is insufficient and
does not address the scope and needs of EOBD. Additionally, providing therapeutic services that
do not include family or do not address interpersonal functioning or identity development are
similarly insufficient. The incorporation of multiple treatment and theoretical frameworks, along
with a treatment model that addresses the neurobiological and developmental components of
EOBD are needed to accurately and effectively treat EOBD.
As a further consideration, due to the early age of onset many participants did not have a
‘before’ and ‘after’ diagnosis that are often incorporated into treatment of adult-onset bipolar
disorder when reframing the illness, combating stigma, and preserving a sense of identity.
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Instead, participants described one uniform, linear experience in which having bipolar disorder
consumes much of their identity—leaving them with little else to identify with.
Finally, participants were eager to be informed of their illness, understand treatment
options, and be an active part of treatment decisions; however, participants described being
excluded from treatment team and decisions due to their age. Including adolescents in treatment
decisions and explaining interventions can increase empowerment. Participants described
seeking help upon noticing symptoms and described consistent coping efforts to improve wellbeing; allowing adolescents a more active role could facilitate greater improvement.
Social Work Education and Policy
According to the National Association of Social Workers and the Council on Social
Work Education, social work best practices address the concerns presented above. The NASW
Code of Ethics (2008) directs social workers to work with interdisciplinary teams when available
(e.g., with healthcare providers such as psychiatrists and therapists), to maintain continuing
education, maintain currency with research and emerging knowledge, engage in evidence-based
practice, and refer out clients who they lack the specialization to treat. The CSWE Educational
Policy and Accreditation Standards (EPAS; 2015) that informs and regulates social work
education similarly instructs social workers to employ interdisciplinary knowledge and practice
rooted in research and evidence-based practice. Educational content includes psychopathology
and practice with individuals and families. Many social workers engage in clinical practice and
hold state licenses. Licensure for clinical social work varies by state, but generally requires
periodic continuing education and demonstration of advanced clinical skill.
The requirements for social work education, practice, and licensure address
psychopathology and clinical practice at a broad level (NASW, 2006). At a micro level, agency
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policies may enforce practice standards and require training specific to EOBD. However, the
research and knowledge base for EOBD remain limited, and as such social workers’ knowledge
base and practice abilities are similarly limited. Within the health disciplines, other therapists and
psychiatrists similarly may be lacking the specialized knowledge needed to treat EOBD.
The opportunity and responsibility, then, may rest with the production and dissemination
of research of EOBD. Increased research and dissemination of findings would increase the
availability and exposure of healthcare providers to current and emerging knowledge; which
would then be incorporated into practice and improve treatment and care for EOBD. Ultimately,
EOBD remains underresearched. This study presents an increased understanding of EOBD with
the intent to inform future research, and ultimately direct practice.
Future Research
While previous studies have explored the etiology and treatment options for EOBD,
much remains to be known about the impact of illness on developing identity and social
functioning. The constructs of stigma and self-stigma in particular emerged from participant data
with significant implications for the effects on identity development, social functioning, and
inception within the healthcare system.
Stigma, self-stigma, and identity emerged as separate constructs with participants’
experiences however, participants frequently identified changes in identity associated with
diagnostic labeling, stigma, and self-stigma. Viewing oneself as different or defective has
significant implications for social functioning in the form of avoidance coping such as isolation
and secrecy. Furthermore, participants described experiencing changes in illness that
accompanied stigma, self-stigma, and changes in identity. Cerit et al. (2012) asserted a
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bidirectional relationship between stigma and increase in symptomatology in adults with bipolar
disorder; however, this remains unexplored in the adolescent population.
Exploration of the influence of stigma in EOBD should include the identification of risk
and protective factors for the development of self-stigma. Self-labeling in adolescence is
associated with greater social, symptomatic, and functional impairment (Moses, 2009); yet also
remains underresearched. Furthermore, participants’ additional discussion of emerging adulthood
indicated adolescent experiences of stigma and changes in identity and social functioning
significantly affected the transition to adulthood. Additional research is needed to identify risk
and protective factors as well as the nature of the relationship between diagnostic labeling,
stigma, and identity development in EOBD.
Participants described experiencing stigma from within the healthcare system. While
discrimination and devaluation associated with stigma are separate constructs than mere
diagnostic labeling, participants often discussed them interchangeably. Furthermore, the
inception of discrimination and devaluation within the healthcare system is troubling in and of
itself, and carries the potential of powerful negative consequences for identity and social
development adolescents with EOBD. Research studies of healthcare professionals’ perspectives
and practices with EOBD population could elicit a better understanding of the process of
diagnostic labeling and inception of stigma; and in turn offer implications to improve healthcare
services.
Additional prospects for further research that were not explored within this study include
outcomes of EOBD on the family system; how social impairment associated with EOBD in turn
affects normative adolescent cognitive development; and the concept of resilience in adolescence
using ecological systems theory with implications for emerging adulthood . In summary, due to
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the exploratory nature of this study and the volume of data collected, there are many avenues for
continued research to improve conceptualization and treatment of EOBD.
Strengths and Limitations
Phenomenological study design facilitated exploration of participants’ lived experiences.
Semi-structured interview format provided participants with the ability to expand upon issues
they wanted to emphasize. Data analysis allowed for participants’ experiences to be captured
authentically in their own wording to obtain the essence of their experiences. Each participant
that reviewed his/her their narrative noted the accuracy in how their stories were told, and felt
satisfied that they had been heard.
While eight participants yielded saturation of data, a larger sample size of 10 – 15
participants was desired. Challenges in recruitment resulted in a sample generated entirely
through online advertising on a support group (DBSA) website and interviews completed via
telephone. While it is uncertain if participants would have been as candid and open if the
interviews were conducted in person, a face-to-face format would have been preferred.
Additionally, the study’s original design included partnering with a clinical agency to
serve as a referral source, sample site, and would provide follow-up clinical services to
participants if needed. Through the informed consent process, the researcher provided
participants with contact information for follow-up care (211), with an emergency plan to call
911 for a welfare check at the address the participant provided at the time of the interview if the
participant indicated they were in a clinical crisis. While the interview questions explored
participants’ lived experience of EOBD, the interviews were equally clinical in nature; and
clinical support and follow-up would have been preferred. While calling 911 was not needed,
several participants reported being currently or recently depressed at the time of the interviews
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and/or became tearful during the interview. The researcher debriefed with each participant
briefly following phone interviews; however, an improved research design would coordinate
with a clinical site to provide supportive services such as debriefing following interviews.
Furthermore, the study’s sampling method and composition resulted in a reliance on
retrospective data. While participants’ provided experience of EOBD augmented with the
perspective and maturity from adulthood, their descriptions of EOBD were less recent. A sample
of current adolescents may provide additional or different perspective or information on EOBD.
While not a weakness in phenomenological design, the absence of triangulation to
confirm participant EOBD diagnosis is perhaps an approach that could enhance the measurement
of EOBD. Use of diagnostic quantitative measures or referral from clinical diagnostician in
additional research of EOBD would assist in confirming EOBD diagnosis and maximizing study
validity.
The goal of this phenomenological study was to generate an improved understanding of
EOBD; and as such, generalizability of findings was not incorporated into the study’s design.
However, healthcare providers could aim to incorporate study findings into practice that are
consistent with the literature and theoretical framework. Such examples include maximizing
knowledge of EOBD, familiarity with adolescent developmental considerations, incorporation of
support system, and therapeutic interventions to promote healthy sense of self and protect against
internalizing stigma.
Conclusion
Current research and clinical knowledge base of EOBD consists primarily of quantitative
inquiries of etiology, neurobiology, and pharmacology. First-person qualitative inquiries are
absent within the literature; as a result, our knowledge and treatment of EOBD is severely
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limited. Current conceptualization and treatment of EOBD consists of extrapolating and
translating adult theoretical models to an adolescent population. This study explicates the lived
experience of EOBD, bringing to light considerations for treatment and research such as the
impact of labeling and stigma, the importance of knowledge and understanding of EOBD in
facilitating effective healthcare, and factors affecting adolescent identity development.
Furthermore, participants’ retrospective lens provides insights into treatment and experience of
bipolar disorder transitioning into emerging adulthood.
Summary
Bipolar disorder occurs in approximately 1% of the population; and while the average
age of diagnosis falls between ages 18 and 25, up to 66%of adults report onset of symptoms
between ages 13 and 17 (Perlis et al., 2004). Within the last 20 years, the prevalence of bipolar
diagnoses and pharmacological treatment for EOBD has increased; yet there is an absence of
research into the phenomenology of EOBD.
Collectively, healthcare providers and researchers have largely viewed and treated EOBD
by extending and applying conceptualization of adult-onset bipolar disorder—‘from the outside
in.’ By exploring and utilizing auto-biographical, retrospective data to construct the
phenomenology of EOBD, this research study begins the process of viewing and treating EOBD
‘from the inside out.’ Interviews with young adults who were diagnosed and treated for EOBD
during adolescence provide a first-person perspective on not only the experience of the illness
itself, but also the experience of labeling and stigma, identity development, interpersonal
relationships, mediating factors and life changes, reactions and coping efforts; as well as insights
into the transition from adolescence into adulthood.
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Appendix C
IRB Verbal Informed Consent Form

Obtaining Verbal Informed Consent
Researchers at the University of South Florida (USF) study many topics. To do this, we need the
help of people who agree to take part in a research study. We are asking you to take part in a
research study that is called: The Phenomenology of Early-Onset Bipolar Disorder.
The person who is in charge of this research study is Kristin Smyth. This person is called the
Principal Investigator.
You are being asked to participate because you received a diagnosis of bipolar disorder during
adolescence (between ages 13 – 17). The purpose of this study is to improve our understanding
of the experience of early-onset bipolar disorder.
If you take part in this study, you will be asked to participate in one telephone interview lasting
approximately 45 – 60 minutes to discuss aspects of your experience of bipolar disorder as an
adolescent. You may be contacted for a follow-up interview to provide clarification or additional
information if needed.
You have the alternative to choose not to participate in this research study.
You should only take part in this study if you want to volunteer and should not feel that there is
any pressure to take part in the study. You are free to participate in this research or withdraw at
any time. There will be no penalty or loss of benefits you are entitled to receive if you stop
taking part in this study.
For any student participants: Your decision to participate or not to participate will not affect your
student status or course grades.
We are unsure if you will receive any benefits by taking part in this research study.
This research is considered to be minimal risk.
Upon completion of your participation in this study via telephone interview, you will receive a
$20 gift card.
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We must keep your study records as confidential as possible. We may publish what we learn
from this study. If we do, we will not let anyone know your name. We will not publish anything
else that would let people know who you are. However, certain people may need to see your
study records. By law, anyone who looks at your records must keep them completely
confidential. The only people who will be allowed to see these records are:
• The research team, including the Principal Investigator, the Advising Professor, and all other
research staff.
• Certain government and university people who need to know more about the study. For
example, individuals who provide oversight on this study may need to look at your records. This
is done to make sure that we are doing the study in the right way. They also need to make sure
that we are protecting your rights and your safety.) These include:
•
•

The University of South Florida Institutional Review Board (IRB) and the staff that work
for the IRB. Other individuals who work for USF that provide other kinds of oversight
may also need to look at your records.
The Department of Health and Human Services (DHHS).

If you have any questions about this study, you can contact the investigator Kristin Smyth [407865-2404 or kristinsmyth@usf.edu]. If you have question about your rights as a research
participant please contact the USF IRB at 813-974-5638.
Would you like to participate in this study? [PI will record if verbal consent is given]
.
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Appendix D
Semi-Structured Interview
Today I’d like to ask you some questions to get a better understanding of your experience as a
teenager with bipolar disorder.
•

First, how old were you when you were diagnosed with bipolar disorder? How old are
you now?
o What was it like to receive the diagnosis of bipolar disorder? What did the illness
mean to you at that time?
o How would you describe your experience of bipolar symptoms during your
teenage years? What were your manic episodes like? Your depressive episodes?
o Did you feel that other people (friends, family, healthcare providers) understood
your experience of bipolar disorder?

•

Now I’m going to ask about some of the changes that may have taken place during your
teenage years as a result of bipolar disorder.
o After the onset of bipolar symptoms but prior to diagnosis, do you remember
whether any changes occurred in relationships with your family or with friends
during this time?
o After receiving the diagnosis of bipolar disorder, do you remember any changes
occurring in relationships with your family or friends during this time?
o Do you feel that your sense of self (sense of identity) changed due to your
experience of bipolar disorder during this time? If so, in what way?
o Did you feel that you understood the changes in your life that were occurring due
to bipolar disorder?
o How did these changes affect you as you moved from adolescence into young
adulthood?

•

Now I’m going to ask about how bipolar disorder may have affected you during your
teenage years.
o What were your greatest supports during this time? What were your greatest
challenges?
o Do you feel that you encountered stigma or labeling associated with bipolar
disorder during this time? If so, what was that like?
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o Did you experience self-stigma, in which you label or judge yourself, during this
time? If so, what was that like?
o Do you feel that any of the changes you experienced in your support system or
related to stigma or sense of self had an effect on your bipolar disorder and mental
health during this time?
•

Now I’m going to ask about your experience with the healthcare system during your
teenage years.
o Who diagnosed you with bipolar disorder? In what treatment setting (inpatient,
outpatient)?
o What events led up to the diagnosis?
o Did you have a psychiatrist? A therapist? What was your experience with them?
o Have you ever been hospitalized due to bipolar disorder? If so, what was that
like?
o Were you prescribed medication for bipolar disorder during this time? How
would you describe your experience with medication?
o Did you feel that the treatment you received was helpful? [Whether yes or no:] In
what way?
o Did your experience of bipolar disorder change during or after receiving
treatment? If so, in what way?

Appendix E
Codebook
code

family

definition

specifiers

when to use the
code

when not to use
the code

example quotation

absence of labeling
or stigma

labeling

absence of stigma

none

participant reports
lack of stigma

do not use if
stigma is endorsed

No, not from people close to me.

healthcare

accessing/utilizing
services; tx services are
accessible to participant;
includes referrals or
facilitation of healthcare
use by others

none

use of tx services
or ability (tx is
available to
access)

see inverse:
healthcare
difficult to
navigate

And I was lucky enough to get connected to the
campus health system and start receiving
treatment again

healthcare

participant states mixed
feelings, indifference, or
expressed hesitation
toward healthcare
services (including
medication)

specify if
psychotropic
medication is
source of
ambivalence

reflects
ambivalence,
mixed feelings
toward healthcare
system or tx of
any kind

if referring to
withdrawal from
tx or avoidance of
healthcare, use
avoidance of
healthcare system
or tx

… there’s been good things about the
medication and there’s been bad things about
the medication that I did really not sign up for.

accessibility or use
of healthcare/
treatment

ambivalence or
hesitation toward
healthcare/
treatment
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avoidance of
healthcare system or
treatment

challenging or
rejecting labeling

change in illness

healthcare

avoidance of health
services & tx
(medication, psychiatry,
therapist, hospitalization)

labeling

rejecting stigma; refusing
to endorse labeling or
apply to self as part of
identity

experience
of illness

refers to change in
symptomatic state;
includes succession of
symptoms or change in
episodic mood states;
increase or decrease in
state of illness
(symptoms); includes
recovery/remission and
recurrence of symptoms;
note: if participant
describes change in
illness and identifies
cause/trigger (i.e.,
relationships, stigma),

if referring to
ambivalence or
mixed feelings
toward healthcare,
provider, or tx,
use ambivalence
or hesitation
toward healthcare
or tx

And I was diagnosed with depression in 8th
grade, but didn’t take any antidepressants
because I didn’t believe in medication, and it
was only until I got diagnosed with bipolar
disorder when I was 17 that I considered taking
medications

And it’s funny that the Olympics are on right
now, because I compare it to the Olympics or a
race. And I say that I don’t feel like I’m in like
the Special Olympics for people who that have
a mental disorder. I don’t put myself in that
category of saying that I’m different from other
people.

specify if
psychotropic
medication is
what participant
is avoiding

participant
actively avoids or
withdraws from tx
or services
(including
psychotropic
medication)

none

participant,
family, or peers is
described as
disagreeing with,
challenging, or
rejecting labeling
or stigma
associated with
illness

do not use if
participant
endorses stigma
or reports stigma

none

description is of
the progression or
succession of
symptomatic/epis
odic states
(stages) of illness
(i.e., symptoms
improving or
worsening);
includes
participant
description of
cycling or
changing between
mood states

if referring to
concurrent
presence of nonbipolar symptoms,
use comorbid
symptoms/
diagnoses

I experienced depression for weeks at a time. It
would come and go. And then I have moments
of anxiety, aggravation, and irritability. And I
was really becoming passive-aggressive
towards everybody around me.
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code both 'change in
illness' and the
identified trigger

changes in decisionmaking

changes occurring in
relationships

impact on
identity

changes in focus, thought
and behavior patterns
before age 18

Interpersonal
relationships

changes in structure or
content of interpersonal
relationships; can be
positive, neutral, or
negative; includes family
and peers; can be
attributed to symptoms or
illness

none

description of
changes in
perspective; can
refer to maturity
or growth

if code applies to
experience over
age 17, use EA
version of code

specify peer or
family
relationships
(or other)

participant is
describing
changes that have
occurred
with/among
family members
or peers; i.e.,
family members
moving away

inverse: no
change in
relationships; if
referring to
participant's
difficulty
functioning
socially, use
'social
impairment'

I got into really bad habits. I started drinking at
parties, and smoking, and getting into a lot of
bad habits and getting in trouble a lot. And I
felt like before the diagnosis I had good grades
and everything, and then it all started to decline
rapidly.

But as far as family goes…yeah, my parents
definitely treated me differently from after I got
diagnosed.
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comorbid symptoms
/ diagnoses

denial of illness

depressive
symptoms

experience
of illness

reactions &
coping

experience
of illness

symptoms that are not
bipolar (i.e., substance
abuse, anxiety, selfinjury); participant report
of experiencing multiple
symptomatologies
(bipolar + other);
emphasis is on
concurrent symptom
states or presence of
non-bipolar symptoms

denial of illness;
resistance to diagnosis
(by participant, family,
peers)

DSM-5 depressive
symptoms

none

participant refers
to experiencing
other mental
health symptoms
outside the scope
of bipolar disorder
(past or present);

do not use with
bipolar
symptoms;
change in illness
reflects successive
change in
symptomatic
states (not
concurrent
symptoms)

specify
participant,
family, peers,
or other

description of
denying,
sublimating
presence of illness
(presence,
symptoms, course
of illness)

for avoidance or
resistance to tx,
use avoidance of
healthcare or tx;
inverse:
acceptance of
illness

none

participant is
recounting or
describing
depressive
symptoms

all other
symptoms

So before I hallucinated, I remember we were
watching a video on YouTube or something
and I had a panic attack, and I couldn’t breathe
or anything, and I was like ‘yo what is going
on, like I just can’t breathe.’ And so anxiety is
also something that goes along with a lot of
disorders. Like literally, a panic attack.

And my mom was also very adamant about the
fact that she didn’t want to have a child with
mental illness, and thought that it would reflect
on her as a parent if I did, and so she was also
very invested in making sure that she mitigated
my symptoms and basically just dismissed
them

When I was depressed I remember laying in
bed for months just watching tv, um, just
showering was hard, anything like that. I
played thoughts in my head over and over, like
I wasn’t good enough, like no one cared about
me, and just stuff like that. I would cry a lot, so
sometimes I would fall asleep crying and wake
up crying.
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difficulty in
relationships

difficulty trusting
self

disclosure of illness

Interpersonal
relationships

social impairment or
difficulty functioning in
interpersonal
relationships; losing
friends, inability to make
friends, losing family
relationships;
interpersonal
relationships present as
significant stressor or
challenge

impact on
identity

experience of difficulty
trusting their own
thoughts, emotions,
impulses, & realitytesting due to experience
of symptoms or illness;
related to distinction
between self and illness;
struggle to distinguish
between normative
emotions and
symptomatic episodes

Interpersonal
relationships

disclosure of illness or
openness re:
illness/symptoms to
others (can be open
disclosure in general or
referring to a singular
disclosure)

specify
participant,
family, peers,
or other

participant
description of
difficulty with
interpersonal
functioning due to
symptomatic
impairment;
description of
stress or conflict
in interpersonal
relationships

none

participant
describing
difficulty
distinguishing
self/sense of self
from symptoms/
illness

different from loss
of self or loss of
identity

let’s say me and my boyfriend get into an
argument. And I get kind of sad, right? I do
sometimes question myself, and I’m like ‘am I
sad because I have a disorder? Or am I sad
because this is how everybody else would be
feeling given the circumstance that they had an
argument with their boyfriend?

none

refers to
participant's
openness and
disclosure of
illness

for selective
disclosure use
'selective
disclosure of
illness'

And my parents…I’m pretty open with them so
I had talked about it with them pretty early on,
so they knew that I was having these really
severe bouts of sadness.

if participant is
describing
changes rather
than conflict, use
‘changes
occurring in
relationships’

I lost every single one of my friends in high
school. People just saw me as a freak. They
didn’t like…they didn’t like that I was just
unstable. And I can see from their point of
view. Who wants a friend, you know, who’s
going through a hard time? and they try to help
and nothing they do helps. So basically a lot of
friends would give up on me or people would
just walk out immediately. They just don’t
want to deal with it, or they don’t like it.

148

effecting greater
change (EA)

emotional response
to illness

fear of illness

emerging
adulthood

focus or awareness of
need for greater
change/improvement in
society or community;
related to activism and
advocacy; contributing to
others -- after age 18

reactions &
coping

description of emotional
adjustment in response to
diagnosis, symptoms, or
illness itself; includes
confusion, anger, shame,
blame, disbelief, shock,
sadness

reactions &
coping

expressing fear of illness
or symptoms; related to
fear of recurrence and
fear of losing control
over life due to illness

none

experience
occurred age 18+

experience
occurred ages 1317

So it’s been a challenge, but that’s why I
became a social worker, because I want to help
other people. And that’s what one of my
friends says. She’s like ‘you know social
workers…we become something that we didn’t
have growing up, that we didn’t have
ourselves. And so that that’s what shows us to
actually be that person that you wish you
would’ve had. So that is why I’m a social
worker. Because there are people out there that
go through even worse things, and I’m like ‘I’ll
help them get through it the way I helped
myself get through it when I wished I had
somebody to help me get through it.’

none

description of
emotional 'fallout'
following
symptomatic
episode or
diagnosis;
emotional impact
of illness

if participant
refers to
confusion (not
understanding
course of illness
or situation) 'lack
of knowledge/
understanding
(confusion)

It kind of made me frustrated, because it was
just like, damn I have a flaw now. That’s what
it was like. I was upset. That made me feel kind
of weak, because I was upset that I could let
something like that happen even though
obviously you know it’s genetic, and
sometimes different environments and stuff
like that…but I was kind of upset that it
happened to me.

none

expression of fear
of the illness
itself, including
feeling powerless
and/or loss of
control over self,
future, or illness

if code applies to
experience over
age 17, use an EA
code

I do always have this underlying feeling that
something will go wrong, like the medication
will stop working or something and I’ll have to
be dealing with it more heavily again. And I’m
afraid of that.
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feeling out of
control

focusing on self &
self-sufficiency
(EA)

functioning or
excelling despite
illness

healthcare or
treatment is
beneficial

sense of feeling
powerless or
helpless over life
circumstances,
self, or future

different from fear
of illness--this
code specifically
addresses
currently feeling a
loss of control/
autonomy

And because I didn’t know what was going on
and because I didn’t have control over myself I
didn’t want to hang out with anybody else

specify if
emphasis is on
increased
knowledge &
understanding
of illness

refers to change in
mentality
(maturity), not life
changes

do not use code if
participant is
referring to
changes in life
circumstances or
optimism/
possibility
(future)

I felt that maybe it was time for me to focus, to
really focus on what I wanted to achieve in life.
Focus on my goals.

Do not use if
participant is
describing decline
in functioning

I managed to keep really good grades

Inverse of
healthcare of
treatment is not
beneficial

I just know that since I started taking the
medication my life has improved immensely.
And there has not been a point where I have
gone off my medication and had issues. So I
think that is—that has to be what is helping

reactions &
coping

feeling helpless or
powerless; loss of control
over life, symptoms, self
due to illness; separate
from confusion

emerging
adulthood

focus has changed to self
and increasing selfsufficiency; changes in
perspective on life,
work, relationships,
behavior patterns after
age 18; refers to
internal/intrinsic process
moving into adulthood

impact on
identity

succeeding and/or
maintaining level of
functioning (e.g., in
school) following onset
of symptoms

none

discussing success
/ continuing
functioning
despite illness
between ages 1317

healthcare

discussion of experience
of healthcare system or
treatment interventions &
outcomes as positive or
beneficial (medication,
therapy, psychiatry,
hospitals) and/or
healthcare providers

specify if
participant
identifies
psychotropic
medication or
provider

description of
healthcare
treatment,
providers, or
services as
resulting in
positive outcomes

none
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healthcare or
treatment is not
beneficial

healthcare system
difficult to navigate

identity
development &
exploration (EA)

healthcare

healthcare

emerging
adulthood

discussion of experience
of healthcare system or
treatment interventions &
outcomes as ineffective,
detrimental, or negative;
includes lack of
supportive healthcare
providers, negative
experience with
providers/facilities;
medication side effects,
etc.

experience of difficulty
trying to find, access, or
continue healthcare
services

description of identity
development/growth and
enhanced sense of self
after age 18

specify if
participant
identifies
psychotropic
medication or
provider

description of tx
outcomes,
providers, or
services as
ineffective or
negative

none

none

Inverse of
healthcare or
treatment is
beneficial

I had been seeing a psychologist earlier in the
year who had not been very helpful and I had
stopped seeing her.

cannot find or
access tx services
(e.g., finances,
insurance,
healthcare
restrictions, etc.)

partial inverse of
accessibility or
use of healthcare;

And a huge issue at my school is that the whole
counseling and psychological services section
is not well-funded and does not have many
employees, so the wait to get in there is very
long. So I saw them for about three months
before they told me that I would need to get
providers elsewhere. So I got a referral

focus is on
identity/sense of
self & growth

if referring to
increased maturity
or focus on
independence, use
focusing on self
&self-sufficiency
(EA); if referring
to life changes,
use life changes
(EA)

Looking back I think I can see how significant
those changes were, and how it really pushed
me sort of to really develop a new sense of self
and how that self has changed since college is
also very interesting
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identity
development
(merging old & new
identities)

illness as a barrier or
obstacle

illness as a trauma

isolation or secrecy

impact on
identity

reactions &
coping

adjustment and
adaptation or integration
of illness with
preexisting sense of self;
creating a new normal

illness/symptoms
presenting as challenge,
barrier, or obstacle
toward goals or
relationships

reactions &
coping

experience of illness as
traumatizing; lasting
impact on identity;
related to fear of
recurrence

Interpersonal
relationships

deliberately limiting
social contact with
family and/or friends;
also includes the sense of
'hiding' part of their self
or identity from others in
terms of vulnerability
and self-protection

none

preserving sense
of self while
integrating 'new'
identity w/
addition of illness

if over 18, use EA
code

So previously I think my biggest challenge was
really just accepting this and honestly figuring
out how to make this fit with my life, and how
to still enjoy life and explore it, as well as live
with it responsibly and not have another
breakdown.
I think it was just hard because it added an
extra layer of already stressful—because I was
diagnosed my senior year, which is such a
horrifically stressful year because you are
applying to college and figuring out pretty
much where the next step of your life was—the
fact that I had this mental illness on top of it
was just incredibly hard.

none

(life) goals are
described as
unattainable or
difficult to attain
due to illness

do not use if
barrier is a factor
other than illness

none

description of the
experience of the
illness (including
symptoms and tx)
as an actual
trauma/
traumatizing

does not include
other traumatic
experiences (use
trauma code)

like I was so traumatized the first time that I
found out I was bipolar that I never wanted
anything like that to ever happen again

none

report of literal
isolation,
seclusion, and/or
avoidance of
social interaction;
includes 'hiding'
identity and self
due to
vulnerability

if referring to
hiding illness
(selective
disclosure), use
selective
disclosure

So I literally just isolated myself and didn’t
want to talk to anybody
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knowledge &
understanding of
illness

labeling or stigma

lack of knowledge
or understanding
(confusion)

reactions &
coping

knowledge &
understanding of EOBD;
description of
attaining/increasing
knowledge of symptoms,
course of illness;
understanding what's
going on (specific to
experience of the illness
itself)

labeling

description of labeling or
stigma associated with
bipolar disorder or
mental illness;
participant may specify
source (culture,
social/peers, family,
healthcare system)

reactions &
coping

absence / limited
knowledge of illness;
description of not
understanding or having
limited knowledge of
symptoms, course of
illness and related life
changes; includes
confusion related

can specify if
participant,
family, peer,
provider

expressing or
describing
understanding of
symptoms, course
of illness, or
symptoms; can
refer to
participant,
family, peers,
healthcare
providers etc.

specify source
of stigma family, peer,
community,
culture,
healthcare

participant
identifies or
describes
experience of
being labeled or
stigmatized

can specify if
participant,
family, peer,
provider

expressing
confusion or
describing lack of
knowledge
regarding illness
and related
symptoms or
changes

inverse: lack of
knowledge or
understanding
(confusion)

No, I definitely felt like I understood it the
whole time. The doctors explained to me what
it meant, and I definitely could relate to exactly
what they were saying about the symptoms of
it, and about what was going on with me. So I
could say like, ‘yeah that’s exactly what’s
going on with me, so these symptoms and this
thing going on in my head, that must be bipolar
disorder. That must be what I have,’ you know?

if referring to
internalized
stigma, use ‘selflabeling’

Mental illness is something that’s so undertalked about that when you do see it or when
you do hear it, nobody knows. Of course what
people think they know….do you know what
I’m saying? Homeless people are everywhere.
So you see mental illness or some type of
disorder everywhere. You see [them] there on
the street and nobody’s helping them. And
nobody essentially cares. And even in other
countries, if somebody is disabled or
disordered or mental, ‘oh they’re demonic!’ or
‘oh they’re possessed!’ Stigma is just
everywhere

inverse:
knowledge/
understanding of
illness

I think that at the time I knew very little about
the disorder so most of what I was basing my
experience off of was what I had heard of in the
media and, um, I definitely didn’t have a very
good understanding of, like, the realities of
bipolar disorder at the time.
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to/caused by the illness

lack of support

life changes

life changes (EA)

Interpersonal
relationships

mediating
factors

emerging
adulthood

absence of involvement
of participant's support
system

changes in life
circumstances between
age 13 - 17

major life changes
occurring after age 18;
change in direction
regarding interpersonal
relationships, work and
education goals

none

description of
limited or no
support
(emotional,
financial,
guidance etc.);
can refer to family
or peers

if referring to
healthcare, use
'lack of supportive
healthcare
providers' code

none

description of
major life
changes, such as
moving, school
change, changes
in family
structure,
birth/death, etc.

does not include
normative
developmental
changes

none

refers to literal
(external)
changes in
circumstance,
relationships,
situation etc. after
age 18

for intrinsic
changes related to
maturity and
focus/goals, use
focusing on self
(EA) code; if
referring to
identity
development,
growth, or sense

…and so I really didn’t feel support sometimes.
I really didn’t feel support from family, and
still don’t really feel support from family.

I moved from New York to North Carolina and
that was a huge shock.

But the path that I was on—all this partying
and drinking—probably I would not be in the
position that I am today had something not
happened, had something not forced me to get
my life together and forced me to focus on
myself and my well-being, my mental health,
physical health. Had something not happened I
don’t know where I would be today
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of self use
identity
development
(EA)

loss of autonomy
due to healthcare
system

loss of self

healthcare

impact on
identity

loss of independence or
sense of identity during
interactions with
healthcare system (as a
result of interaction with
healthcare providers or
tx)

perceived loss of self or
loss of identity due to
illness and/or stigma

none

none

participant
expressing
perceived loss of
self or
independence
attributed to
interactions with
healthcare
providers or tx
system

loss of self or
independence due
to other factors

And so…from ages 14 to 16 I didn’t administer
my own meds. My dad was the one who gave
them to me every night, and he kept them
locked up. And I don’t know if it was a lack of
trust or what…and my dad would frequently
come to my psychiatrist appointments and there
were times, especially if I was really depressed,
he would just talk to the psychiatrist instead of
me. And that made me feel really not included
in my own treatment plan.

description of loss
of self as a result
of illness; 'self' is
replaced or
changed due to
symptoms and/or
stigma

differs from fear
of illness (loss of
self is current and
code pertains to
identity rather
than illness); and
loss of control
(loss is the self vs
autonomy or
independence)

But after a while depression started to set in
and I didn’t feel like doing anything anymore. I
felt like I lost who I was before, and things
started to change around me.
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manic and/or
hypomanic
symptoms

experience
of illness

mistrust

Interpersonal
relationships

optimism/ sense of
opportunity &
possibility

reactions &
coping

DSM manic and/or
hypomanic symptoms

none

participant is
describing manic
or hypomanic
symptoms

all other
symptoms

distinct from 'lack
of support' and
'conflict in
relationships'
refers to
participant's
explicit lack of
trust
if code applies to
experience over
age 17, use EA

inverse; lack of trust in
family or peer
relationships

none

description of
mistrust in family
or peers

change in outlook that
includes increased focus
on opportunity and

none

expressing
possibility of
good and

I would say my manic episode probably started
sometime right around when high school
started, like the beginning of the year. And it
only took me 6 to 8 weeks into high school to
have full-blown manic feelings and to have my
mom realize ‘okay, you need to go to the
hospital.’ [laughs] But it was definitely a lot of
classic symptoms of bipolar mania…it was like
delusional thoughts, hard to relate to people in
social situations, grandeur thoughts,
grandiosity…towards the end was I was being
hospitalized there were some hallucinations
going on…just kind of out of touch, having that
out of touch feeling…feeling like you’re on top
of the world, you can get anything done…just
having really elated thoughts, elated emotions
that were blown out of proportion. And just
like overly emotional in situations, like no
control over.

I mean, I jumped from therapist to therapist
after that one therapist, because I didn’t—I
always thought they had different agendas so I
didn’t really trust a lot of them.

So I feel like there is hope for my adulthood.
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possibility; optimistic

optimism/ sense of
opportunity &
possibility (EA)

others involved in
treatment

emerging
adulthood

Interpersonal
relationships

participant explicitly
states hope/positive
outlook for the future;
discussion of increased
sense of possibility,
improvement of self &
circumstance, and
opportunity,
independence, and
increased autonomy -after age 18

participation or
involvement of family or
peers in tx of any kind

none

none

positivity

version of code

specific to
increased sense of
possibility in life
and increased
ability to enact
change (after 18)

if referring to
increased maturity
or focus on
independence, use
focusing on self
&self-sufficiency
(EA); if referring
to life changes,
use life changes
(EA); if referring
to identity
development, use
identity
development
(EA)

I think it changed me for the better. Even
though that’s like…it’s like a blessing in
disguise.

Does not refer to
healthcare
providers

” and then I had talked to a psychiatrist in
there, and then they brought my family in. and
so we had this group therapy counseling
session ‘your daughter has bipolar
disorder…can you recall”—and that I didn’t
like—“can you recall when you think the
symptoms started?” and that I didn’t like. I
didn’t think I should’ve been in the room, but I
was in the room. So it would be like my parents
and siblings talking about when they thought I
had episodes

family member
attends or
participants in tx;
facilitates
appointments or
medication
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psychoeducation

psychotropic
medication

relationships
affecting identity

healthcare

healthcare

Interpersonal
relationships

provision of
psychoeducation by
healthcare provider to
individual or family;
discussion of illness &
course of illness

discussion of experience
of medication (includes
discussion of treatment
and side effects)

family/peer relationships
impacting sense of
identity

none

referring to
education on
illness, symptoms,
course of illness;
can refer to
psychoeducation
of individual,
family, peers etc.

none

participant
discusses
experience/
reaction to taking
medication,
impact of
medication, side
effects of
medication (can
be positive,
neutral, or
negative)

specify family
or peer (or
other)
relationships

description of
change in
identity/sense of
self due to family
or peer
relationships

do not use with
other tx
modalities (e.g.,
supportive
psychotherapy)

Yes, they said it was a mood disorder mostly.
Nothing to do with physical or real bad mental
issues, but they said I would need to take
medicine for it, come back for treatment, and
basically get it in check to see if everything
was okay.

for other tx
interventions, use
healthcare or
treatment is/is not
beneficial

And so the one I switched to, I’ve been on it
this whole time. I’ve had the same prescription,
everything since I got diagnosed. And they said
they can reduce it, and I was like ‘no, let’s not
reduce it because I don’t want to have another
episode.’ The medicine I’m on now is just
like…it works, obviously.

report of no
change in identity
due to
relationships

And that was something that was so painful and
hurtful that it made me feel different from my
family, from my siblings. And it made me feel
like I had something that was wrong with me.
So that was rough. So that was one of the
relationships that had changed that impacted
how I identified my disorder and how I coped
with it. Which is probably why I’m so private
now, because even my own sibling had said
that and I was like, wow okay, that was harsh.
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relationships not
changing

religion/ spirituality

seeking help/support

selective disclosure
of illness

Interpersonal
relationships

no changes occurring in
interpersonal
relationships

mediating
factors

discussion of the role of
faith, religion, or
spirituality in
participant's experience - can be positive, neutral,
or negative; can also
refer to religion as a
support or a challenge

reactions &
coping

voluntarily seeking
support or treatment
(from others or
healthcare system);
includes seeking
healthcare providers, tx
services, medication

Interpersonal
relationships

selective disclosure of
illness by participant,
family or peers OR to
family or peers

none

participant reports
no changes
(positive, neutral,
or negative)
occurring in
relationships

inverse: 'change in
peer relationships'
and/or 'change in
family
relationships'

none

participant
discussing the
impact or role of
religion in
experience of
EOBD

If not referring to
impact on illness
(i.e., general
discussion)

My dad practices mindfulness and considers
himself Buddhist, so we were very not wanting
to medication for a long time.

none

Emphasis is on
act of voluntarily
seeking out
support
(clinical/tx or
emotional) from
healthcare or
support system

if describing use
of healthcare
services, use
accessibility or
use of
healthcare/tx

I voluntarily asked my parents to go to therapy
when I was 17 because I knew something was
wrong.

none

participant, family
members, peers
are selectively
disclosing or not
disclosing illness
(can have
positive, neutral,
or negative tone)

for open
disclosure use
'disclosure of
illness'

And even the person I’m dating now, they
don’t know that I’m bipolar.

I think it has been a problem that was ongoing
for such a long time before I got the diagnosis
that there wasn’t really a significant change.
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self-labeling /
endorsing stigma

suicidality

support

trauma

labeling

participant has applied
stigmatizing beliefs or
labels to themselves;
internalized/endorsed/
self-directed labeling &
judgment

experience
of illness

referring to the concept
of suicide; can be
abstract thought,
ideation, or plan; can
refer to participant,
family, peer, healthcare
provider etc.

Interpersonal
relationships

support from others
(emotional, financial,
guidance); family and/or
peer relationships as
source of strength and
help

mediating
factors

trauma or abuse
experienced by the
participant

none

participant
identifies selflabeling or
describes selflabeling or selfstigma (is
endorsing stigma
or labeling)

do not use if
participant is
referring to stigma
stemming from
outside source

none

discussion of
suicide or
possibility/though
t of suicide

distinct from selfinjury and
depressive
symptoms

specify source
of support family, peer,
community,
school, etc.

description of
emotional,
financial support
or guidance from
family, peers,
community

does not include
family
participation in tx
but can include
assistance
obtaining tx

none

participant
description of
trauma or abuse
(i.e., domestic or
family abuse,
rape, physical
abuse)

if participant
describes
additional
symptoms caused
by trauma (i.e.,
anxiety or ptsd),
use comorbid
symptoms to code
the traumainduced non-

Certainly identifying myself as crazy was not
helpful [laughs] in trying to recover. And also
trying to think that—well, buying into stigma
puts you in a deeper hole in trying to recover
and trying to see that you can be something
other than an image, to something other than an
unstable kind of person

And I always kind of knew I was kind of
defeated and I wanted to defeat myself, I
wanted to hurt myself, I wanted to end my life.
I did several suicide attempts to try to do that.
And all the suicide attempts that I have done
have failed.

And people I became friends with when I was
17—so the same year I was diagnosed—are
still some of my closest friends. They’ve kind
of watched the whole process go through, and
are really really supportive and were supportive
then too

Once again, with my specific situation it’s very
hard to explain because there were days where
I was literally not allowed to do anything by
someone I used to live with. To the point that
they would knock my door down if I wanted to
escape and go to my room…
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bipolar symptoms

use of coping skills

view of self as
different or
defective

reactions &
coping

impact on
identity

Participants’ use of
coping skills or symptom
management-based skills

description of feeling
'other' (liminality);
different from peers
and/or family; can also
include feeling abnormal,
damaged, defective,
weak, or flawed

none

discussing efforts
to alleviate
symptoms,
interpersonal
stressors, or cope
with difficulty
(situation-based
or emotion-based)

Does not include
medication
management

(as far as supports) I was a writer too.

none

description of self
as not being
normal; weak,
flawed or
damaged; can
include feeling '
undeserving, or
defective in some
way due to
illness; refers to
identity and sense
of self

Do not use if
participant is
describing stigma

I knew there was something wrong, and
because of that I thought I was like flawed and
I didn’t want to hang out with anybody. / I
didn't think I was a good person.
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Appendix F
Member Checking: Summary of Themes
Managing and Coping with EOBD
Experience of illness: Participants described their experience of EOBD itself, including
symptoms and course of illness. Three participants described the polarity of their first episode as
manic, while five participants described their first episode as depressive in nature. Participants
described manic and hypomanic symptoms in terms of increased energy and productivity,
impulsivity, decrease in rational decision-making, increase in risky behavior, increased social
activity, increased energy and hyperactivity, racing thoughts, decreased sleep, euphoria and
elation, agitation and aggression, delusional thoughts, grandiosity, and hallucinations.
Participants characterized depression as low mood, sadness, social isolation, decreased focus and
clarity of thought, decreased motivation, decreased ability to do things, crying, and spending a
great deal of time in bed.
Seven of the eight participants described experiencing symptoms of diagnoses of other mental
health conditions, including anxiety, self-injury, eating disorders, and substance abuse. Only one
participant described experiencing exclusively manic and depressive symptoms throughout
adolescence. Two participants reported experiencing suicidal ideation with suicide attempt.
Treatment and engagement with the healthcare system: Participants described their interactions
with the healthcare system, providers, and treatment as a core components of their experience of
EOBD. Participants reported receiving inpatient and outpatient care, including psychiatric
hospitalization, psychiatrists, and therapists. Some participants reported avoidance of aspects of
healthcare, including delay seeking treatment, medication noncompliance, and stopping
treatment.
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Psychotropic medication emerged as one of the largest components of participants’ experience of
EOBD. All participants reported taking medication. Most participants reported improvement in
symptoms, while some reported medications appeared to make symptoms worse. Participants
identified medication side effects as a significant challenge and the most commonly described
reason for discontinuing medication. Most participants reported continuing medication
throughout adolescence.

Perceptions of healthcare and treatment: Participants identified several components of healthcare
and treatment as beneficial, including therapists with whom they felt rapport, psychiatry, and
effective medication. Participants identified components of healthcare that were not beneficial,
including psychiatric hospitalization, staff who were undereducated or did not understand,
medication that was ineffective and/or had significant side effects, and judgment or labeling from
healthcare providers. Some participants reported difficulty accessing healthcare due to
considerations such as insurance, finding available providers (i.e., were wait-listed); getting
medication on time; and coordinating between providers (i.e., between pharmacy and
psychiatrist).
Use of Coping Skills: In addition to healthcare and treatment interventions, participants
described their own efforts to alleviate and manage symptoms through use of coping skills such
as writing/journaling, listening to music, playing sports, talking to others and utilizing support
playing video games, and reading inspirational success stories of other people.
Knowledge and understanding of illness: Participants described knowledge (and lack of
knowledge) of illness as an important component of illness management. Participants described
not understanding the experience of prodromal symptoms, or onset of symptoms; participants’
described attaining an increase in knowledge of EOBD throughout adolescence. Several
participants described a sense of knowing that ‘something was wrong’ prior to receiving
diagnosis. Participants described a general lack of understanding by family and peers.
Participants reported receiving psychoeducation from providers as well as self-educating through
their own research.
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Lack of knowledge and understanding was the most common sub-theme across all participants
and all domains of the study. Knowledge and understanding was described as the determining
factor in whether healthcare was beneficial; participants described providers with
knowledge/understanding of EOBD as helpful and beneficial, while providers perceived as
lacking of knowledge of EOBD were considered non-beneficial.
Effect on Relationships
Difficulty maintaining social functioning: Participants described difficulties in maintaining
relationships, social functioning, and experiencing conflict in family and peer relationships due
to EOBD symptomatology and isolative behavior. Participants described isolation as a
component of decline in social functioning through avoidance of social situations, pushing others
away, and selectively leaving their ‘safe space’ (i.e., house or bedroom).
Seeking and receiving support: All participants described experiencing support in some form
from family and/or peer relationships during adolescence. Support was described as others’
wanting the best interest of the participant, and was described as not contingent on possessing
knowledge/understanding of EOBD. Some participants described feeling lack of support from
family and peers, both prior to and following diagnosis; as well as from healthcare providers.
Participants described voluntarily seeking treatment or reaching out to support system for help
upon noticing prodromal symptoms. Involvement of others included referrals for treatment,
participation in treatment sessions, coordination with providers, and administration of
psychotropic medication.
Impact on Identity
Secrecy and selective disclosure of illness: Participants described experiencing a change in sense
of self that included viewing EOBD as something to be kept secret and selectively disclosed to
others. Participants described being ‘undercover’ to maintain their privacy; as well as hiding
their illness and their identity in effort to minimize vulnerability to judgment, rejection, and harm
from others.
Adaptation and integration: Participants described normative adolescent identity development as
a challenge due to EOBD. Participants described experiencing confusion and struggling to
maintain sense of self and self-image, and integration of ‘new’ self-image following diagnosis.
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Participants described efforts to maintain portions of their sense of identity following diagnosis
and experience of symptoms, most notably maintaining prior levels of academic performance
and motivation for prior goals.
Emotional adjustment: Participants described a range of emotional responses to receiving EOBD
diagnosis, including self-blame, frustration, shame, and feeling nervous and a sense of not
knowing what to expect. One participant described the diagnosis as “heartbreaking” while
another said it felt like their life would never be the same again. Participants described a fear of
EOBD itself; specifically the fear that symptoms would return and would not remit. Participants
described experiencing a perceived loss of self concurrent to symptomatic states and recovery
from symptomatic episodes. Participants similarly described feeling out of control over EOBD;
specifically inability to control symptoms and worrying the illness was controlling them.
Experience of Stigma and Labeling
Labeling or stigma: All participants described experiencing diagnostic labeling and stigma from
healthcare providers, as well as stigma from family, peers, community, and culture/society.
Self-labeling: Participants described applying stigmatizing beliefs to self-label, and described
increased distress, isolation, selective self-disclosure, and in some cases worsening of symptoms.
Self-labeling and labeling were described in conjunction with secrecy and selective disclosure of
illness, as well as perceived judgment and criticism from others.
Challenging or rejecting labeling: Participants described challenging and refusing to accept or
endorse stigmatizing beliefs and self-labeling; participants associated labeling (and rejecting
labeling) with resilience and significantly impacting their identity.
Change and Uncertainty
Change in illness: Participants’ overall experience of EOBD was characterized by change,
uncertainty, and instability. Duration of episodes varied from days to weeks or months, as did the
severity and frequency of symptoms experienced. The severity of manic and depressive episodes
was described as ranging from disruptive to debilitating. While some participants described an
experience dominated by depressive episodes, others described that manic episodes were more
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disruptive to their lives in adolescence. The presence of comorbid symptoms and suicidal
ideation were described as additional challenges to managing bipolar symptomatology.
Changes occurring in relationships: Participants described EOBD as disruptive of relationships.
Changes in family and peer relationships included family members moving away or becoming
estranged, changing friend groups and social patterns. Participants also described varying
changes in dynamic with their parents following diagnosis, including increased support,
increased stigma, and increased conflict.
Change in identity and sense of self: Participants described experiencing changes in thought,
perspective, and behavior associated with EOBD diagnosis and illness. Changes included
engaging in unhealthy behaviors (partying, substance use), choosing not to pursue goals, and
change in coping patterns. Participants described a change in identity and view of self as
defective, damaged, or different from others; sense of liminality and ‘otherness.’ Participants
described feeling flawed, abnormal, worthless, and weak. Participants stated they felt there was
something ‘wrong’ with them, that they were an outcast and different from their peers, and that
they felt others may not know how to handle them if symptomatic.
Life changes: Participants reported experiencing significant life changes, often prior to onset of
symptoms. Changes included moving, changes in school/beginning new school, and changes in
family relationships. One participant described becoming a mother at age 15 as a significant life
change.

